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2Summary
English version
Damage to the spinal cord leads to severe, and often permanent, motor, sensory and
autonomic disturbances. A multitude of mechanism may contribute to spinal cord injury
(SCI), including apoptotic and necrotic death of neurons, astrocytes and oligodendrocytes,
axonal injury, demyelination, excitotoxicity, ischemia, oxidative damage, and inflammation.
The lack of axonal regeneration is not primarily due to an inherent lack of capacity for
axonal growth potential, but rather to the overall balance of axon-growth promoting (e.g.
migration of Schwann cells into the lesion site and the local presentation of growth promoting
factors and extracellular matrix proteins) and axonal growth inhibitory/repulsive molecules
(e.g. myelin-associated proteins, the presence of a physical barrier presented by the glial
scar and the development of fluid-filled cystic cavities) at- and around the lesion site. Over
recent years, increasingly more detailed knowledge has been gained that demonstrates the
potential for axonal regeneration within the nervous system of both experimental animals
and humans. While the strongest regenerative capacity has been identified in the lesioned
peripheral nervous system (PNS), it could also be demonstrated that axonal regeneration
and compensatory sprouting takes place in the injured central nervous system (CNS). Such
findings have led to the development of a number of interventional approaches to support
or enhance the regenerative capacity of the CNS. Within the CNS, the main thrust of
these approaches has focused either on new surgical methods, novel medications (including
the use of blocking/neutralising antibodies and peptides), cell-based intervention strategies
(including stem/progenitor cells) or, most recently, the application of tissue engineering
strategies using biomaterials.
The aim of the present study was based on the two latter approaches, combining the
growth promoting properties of human neural progenitor-derived astrocytes and a highly
3orientated three dimensional collagen matrix in a tissue engineering strategy to bridge acute
spinal cord lesions in adult rats.
The present investigation is separated into two parts:
The first part of the thesis addresses the issue of cell characterization, cell-cell and cell-
substrate interactions in vitro. Human neural progenitor cells (hNPC) are characterized
by their expression of certain stem/progenitor markers as well as for their ability to show
multi-potency. Furthermore their ability to generate highly enriched populations of human
neural progenitor-derived astrocytes (hNP-AC) is demonstrated. The axon growth promot-
ing effects of the hNP-AC are shown in a simple 2D- as well as in a more complex 3D-culture
system. After seeding onto orientated electrospun nanofibres hNP-AC show the ability to
adhere, extend processes and migrate. Following seeding onto 3D collagen scaffolds, hNP-
AC survive, proliferate and form columns of cells along the orientated pores of the scaffold.
The highly orientated, porous microstructure of the scaffold also supports substantial inter-
mixing of hNP-AC and migrating Schwann cells / fibroblasts from the DRG explant, cell
populations that are normally mutually repulsive. This suggests that the topography of
3D scaffolds may not only influence cell-substrate interactions but also cell-cell interactions
within the scaffold.
The second part of the thesis addresses the integration and functional benefits of trans-
planting hNP-AC into spinal cord injured rats in vivo. Two different types of experimental
spinal cord injuries are investigated. In the first in vivo SCI model, hNP-AC are trans-
planted one week after a balloon compression injury and animals are subjected to standard
behavioural tests (i.e. BBB, open field and gridwalk scores, as well as the Hargreaves’ heat
sensitivity test) with correlative morphological investigations (i.e. amount of spared tissue,
survival of transplanted cells, glial scarring, microglia activation, Schwann cell migration and
axonal regeneration).
Transplantation of hNP-AC promotes a better functional recovery compared to the control,
but not the control + immunosuppression and the hFbl + immunosuppression (cell control
group). hNP-AC integrate well into the host spinal cord in 90% of host animals, where they
reduce glial scarring and promote a greater extent of axonal regeneration into the lesion site.
Furthermore, Schwann cell migration into the lesion site is enhanced in the presents of hFbl
and microglia activation is enhanced by immunosuppression.
4In the second in vivo SCI model, hNP-AC seeded collagen scaffolds are implanted into
a partly transected spinal cord directly after lesion. Since the lesioned animals show a faster
recovery with this lesion model (compared to the compression model), more sophisticated
behavioural analyses are possible (CatWalk, gridwalk (footfalls) and von Frey filaments).
Morphological analysis includes survival of the transplanted cells, integration of the scaffold,
neurite regeneration into the scaffold, glial scarring and microglia activation.
Survival of the cells within the implanted collagen scaffold is surprisingly low, with only
half of the animals demonstrating morphological signs of viable donor hNP-AC, and only
10% for the donor hFbl. Although the hNP-AC fail to promote a greater functional recovery
than the other investigated control groups (i.e. scaffold + immunosuppression (IS) and hFbl-
seeded scaffold + IS), they lead to a greater graft-host integration and reduced host glial
scarring. Furthermore microglia activity is reduced by hNP-AC compared to the control +
IS, indicating a modulated immune response.
5German version / deutsche Version
Verletzungen des Rückenmarks führen zu schwerwiegenden und meist permanenten Schädi-
gungen motorischer und sensorischer Nerven sowie des autonomen Nervensystems. Eine
Vielzahl von Mechanismen können zu Rückenmarksverletzungen beitragen, dazu zählen
apoptotischer und nekrotischer Tod von Neuronen, Astrozyten und Oligodendrozyten, Schädi-
gungen des Axons, Demyelinisierung, Excitotoxizität, Ischämie, oxidativer Stress und Entzün-
dungen.
Die ausbleibende axonale Regeneration liegt nicht an einem fehlenden inhärenten Po-
tential für axonales Wachstum, sondern eher an einem generellen (Un-)Gleichgewicht von
wachstumsfördernden (z.B. der Migration von Schwann-Zellen in die Läsionsstelle und die
lokale Bereitstellung von Wachstumsfaktoren und extrazellulärer Matrix) und wachstumsin-
hibierenden, -repulsiven Molekülen (z.B. Myelin-assoziierte Proteine, der Ausbildung einer
physikalischen Barriere in Form der glialen Narbe und die Entwicklung von mit Flüssigkeit
gefüllter Hohlräume) an der Läsionsstelle und um sie herum.
Im Laufe der letzten Jahre wurde ein immer detaillierteres Wissen über das regenerative
Potential von Axonen im Nervensystem von Tieren und Menschen gewonnen. Das periph-
ere Nervensystem weist dabei ein großes regeneratives Potential auf, jedoch konnte darüber
hinaus gezeigt werden, dass axonale Regeneration und kompensatorisches Nervenwachstum
auch im verletzten zentralen Nervensystem (ZNS) selbst stattfindet. Diese Erkenntnisse
führten zur Entwicklung einer großen Anzahl von verschiedenen Strategien, um die Regen-
eration im ZNS zu unterstützen und zu fördern. Im Bereich des ZNS fokussieren sich diese
Strategien vor allem auf neue operative Methoden, neue Medikamente (zu denen auch block-
ende/neutralisierende Antikörper und Peptide gehören), zellbasierte Strategien (u.a. Stamm-
und Vorläuferzellen) und neuerdings die Anwendung von Biomaterialien als eine Zell- und
Gewebeersatz-Strategie.
Die vorliegende Studie basiert dabei auf den beiden letztgenannten Ansätzen und beschreibt
die Nutzung der wachstumsfördernden Eigenschaften von aus humanen neuralen Vorläuferzellen
gewonnenen Astrozyten (hNV-AZ) alleine oder in Kombination mit einer orientierten drei-
dimensionalen Kollagenmatrix in einer Zell- und Gewebeersatz-Strategie, um funktionelle
Regeneration nach akuten Rückenmarksverletzungen in erwachsenen Ratten zu fördern.
Die Dissertation gliedert sich in zwei Teile:
6Der erste Teil der Dissertation befasst sich mit Zellcharakterisierung, Zell-Zell- und Zell-
Substrat-Interaktionen in vitro. Humane neurale Vorläuferzellen werden sowohl anhand der
Expression verschiedener Stamm- und Vorläuferzellenmarker charakterisiert als auch an-
hand ihrer Fähigkeit, Multipotenz zu zeigen. Zudem wird ihre Fähigkeit, sich in nahezu
reine Populationen von hNV-AZ zu differenzieren, dargestellt. Die wachstumsfördernde
Eigenschaft der hNV-AZ auf Axone wird sowohl in einem relativ einfachen 2D- als auch
in einem komplexeren 3D-Zellkultur-System gezeigt. Die hNV-AZ sind in der Lage, auf
elektro-gesponnenen Nanofasern zu adhärieren, Fortsätze zu bilden und entlang der Fasern
zu migrieren. Nach Besiedlung auf eine 3D-Kollagenmatrix überleben die hNV-AZ, pro-
liferieren und bilden Zellkolumnen entlang der orientierten Poren der Matrix. Die stark
orientierte, poröse Mikrostruktur der Matrix fördert zudem die Vermischung von hNV-AZ
mit aus DRG Explantaten, migrierenden Schwann-Zellen und Fibroblasten. Diese Zellpop-
ulationen bilden normalerweise klare Grenzen zwischen einander. Dies deutet an, dass die
Topographie der 3D-Kollagenmatrix nicht nur die Zell-Substrat, sondern auch die Zell-Zell-
Interaktionen innerhalb der Matrix beeinflusst.
Der zweite Teil der Dissertation befasst sich mit der Integration und den funktionellen
Vorteilen nach Transplantation von hNV-AZ in das verletzte Rückenmark von Ratten in vivo.
Zwei verschiedene Arten von experimentellen Rückenmarksverletzungen werden untersucht.
Bei dem ersten in vivo Rückenmarksverletzungs-Modell werden die hNV-AZ eine
Woche nach einer Ballon-Kompressions-Verletzung transplantiert und die Tiere den üblichen
Verhaltenstests (BBB, Gridwalk und dem Hargreaves Hitze Sensitivitäts Test) und mor-
phologischen Untersuchungen unterzogen (Anteil des verschonten Gewebes, Überleben der
transplantierten Zellen, Ausmaß der glialen Narbe, Aktivierung von Mikroglia, Migration
von Schwann-Zellen und axonale Regeneration).
Die Transplantation der hNV-AZ führt zwar zu einer besseren funktionellen Regeneration
im Vergleich zu der Kontrolle, aber nicht im Vergleich zu der Kontrolle + Immunsuppression
(IS) oder den humanen Fibroblasten + IS (hFbl, Zell-Kontrolle). Bei 90% der untersuchten
Versuchstiere sind die hNV-AZ in der Lage, sich gut in das Gewebe zu integrieren. Dort
reduzieren sie die gliale Narbe und fördern das Wachstum von Axonen in die Läsionsstelle.
Zudem fördern die hFbl die Migration von Schwann-Zellen in die Läsionsstelle und die Im-
munsuppression bewirkt die Aktivierung von Mikroglia.
7In dem zweiten in vivo Rückenmarksverletzungs-Modell wurde die Kollagenmatrix
mit hNV-AZ besiedelt und direkt in das teilweise durchtrennte Rückenmark implantiert. Da
diese Tiere schneller regenerieren als die Tiere in dem Kompression-Modell sind technisch
versiertere Verhaltenstests möglich (CatWalk, Griwalk (Anzahl der Fehltritte) und der von
Frey Filamenten-Test). Mit Hilfe morphologischer Methoden wurden das Überleben der
transplantierten Zellen, die Integration der Matrix, das axonale Wachstum in die Matrix,
das Ausmaß der glialen Narbe und die Aktivierung von Mikroglia untersucht.
Die Zellen überleben überraschenderweise nur sehr schlecht in der implantierten Matrix:
Am Ende wurden nur bei der Hälfte der Versuchstiere noch lebende hNV-AZ nachgewiesen
und lebende hFbl nur bei 10% der Versuchstiere. Obwohl die hNV-AZ nicht in der Lage
sind, eine bessere funktionelle Regeneration als bei den anderen untersuchten Gruppen (naive
Matrix + IS und hFbl besiedelte Matrizes + IS) zu fördern, kann eine bessere Integration der
Matrix in das Rückenmark und eine Reduzierung der glialen Narbe hervorgerufen werden.
Zudem reduzieren die hNV-AZ die Aktivierung von Mikroglia im Vergleich zu der Kontrolle
+ IS, was auf eine Modulation der Immunantwort hinweist.
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1. Introduction
The devastating consequences of traumatic spinal cord injury (SCI) depend on the level and
severity of the injury but include permanent locomotor and sensory deficits, neuropathic
pain, spasticity, urinary and respirator dysfunction, metabolic problems as well as obvious
psychological problems associated with a poor prognosis. The first medical documentation
of SCI was recorded on Egyptian papyrus, dating from the sixteenth century B.C. (Figure
1.1). The first indications of the cellular basis for the poor outcome after SCI were described
by Santiago Ramón y Cajal and his students in the late early 20th century using silver
impregnated tissue sections of experimental spinal cord lesions. Ramon y Cajal reported
that "In adult centres the nerve paths are something fixed, ended, immutable. Everything
may die, nothing may be regenerated. It is for the science of the future to change, if possible,
this harsh degree" [70]. For a long time, the apparent inability of the mature mammalian
central nervous system (CNS) to generate new neurons (neurogenesis) and the failure of axons
to regenerate were generally regarded as "laws of nature" [70, 82, 149]. This was in stark
contrast to the behaviour of lesioned peripheral nervous system (PNS) axons, which could
undergo successful regeneration leading to the re-innervation of their targets [69, 176, 180,
401]. The opinion that brain and spinal cord lesions were irreversible has now been revised,
partly due to Cajal’s original descriptions, showing damaged CNS axons forming regenerative
sprouts that were unable to extend for more than 1-2 mm alone, but much further with the
use of peripheral nerve grafts [70]. A few examples of endogenous axonal regrowth were
demonstrated in recent years [33, 58, 94, 458] and the existence of multi-potent progenitor
populations was demonstrated in the adult hippocampus (dentate gyrus), sub-ventricular
zone and spinal cord [6, 7, 21, 122, 155, 199, 223, 229, 273, 344]. Thus it has become clear
that the adult CNS is able to respond to CNS injury by: (i) the anatomical reorganization
of spared axonal connections (plasticity) and (ii) the generation of new precursor cells. This
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has motivated numerous scientific studies to better understand the pathophysiology of SCI
and to further challenge the dogma of the irreversibility of CNS injury.
Figure 1.1.: Instructions concerning a dislocation of a vertebra in the neck. “If you examine a man with a neck injury... and
find he is without sensation in both arms and both legs, and unable to move them, and he is incontinent of urine... it is due to
the breaking of the spinal cord caused by dislocation of a cervical vertebra. This is a condition which cannot be treated.” Edwin
Smith Surgical Papyrus, Case 31. Thebes, c. 1550 BC. Taken from Breasted. J.H. (ed.) The Edwin Smith Surgical Papyrus c©
The University of Chicago Press, 1930.
1.1. Pathophysiology of Spinal Cord Injury
Traumatic human SCI is widely acknowledged to be a highly heterogeneous disorder and the
characteristics of the lesion site are known to depend on a number of parameters including
type of injury, severity and time after injury. Nonetheless, 4 main types of injury have been
identified [65, 66]: (i) compression injury, (ii) contusion injury, (iii) laceration injury, and (iv)
solid core lesions. This has resulted in the development of a number of experimental models
of SCI, which mimic (to a greater or lesser degree) the pathophysiology seen in the range of
different human spinal cord injuries. These models have also been used to investigate the
cascade of cellular and molecular events that are initiated by the primary insult, as well as
for the development and evaluation of a range of therapeutic strategies intended to promote
tissue repair e.g [416].
Immediately after SCI, numerous descending and ascending nerve fibre pathways are me-
chanically damaged and the highly organised cytoarchitecture of the spinal cord white matter
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is disrupted. Since primary, mechanical injury to the CNS gray and white matter results
directly from the trauma, such destruction cannot be avoided and may result in immediate
partial or total paralysis. Such primary degenerative events are followed by a cascade of sec-
ondary degenerative events including bleeding, ischaemia, free-radical production, oedema,
excitotoxicity, inflammation, programmed cell death, scarring and cystic cavitation, all of
which contribute to the augmentation of tissue loss [65, 369] (see schematic illustration in
Figure 1.2). The dynamics of the secondary degenerative events take place over a time
scale of hours, days, weeks and even months after the injury [201, 248, 368]. Inflammatory
processes are a major contributor to secondary degeneration. The current view is that the
inflammatory response after CNS injury is a "double-edged sword", having both early neu-
rodegenerative and later neuroprotective aspect [74, 248]. Disruption of the blood-spinal cord
barrier leads to the recruitment of intrinsic (microglia) and extrinsic inflammatory cells (neu-
trophils, macrophages, lymphocytes, natural killer cells), which express proteolytic enzymes
that in turn, degrade extracellular matrix proteins and contribute to blood-brain barrier
degradation and oedema. The processes initiated by the pro-inflammatory cytokines and
chemokines (i.e. IL-1, IL-α, IL-β, IL-6, interferon (INF)-γ, macrophage colony stimulating
factor (MIP-1), tumor necrosis factor (TNF)-α) as well as reactive oxygen species, oxidative
enzymes, and metalloproteinases exacerbate secondary tissue damage and the formation of
an inhibitory glial scar [141, 142, 220, 253, 325, 326, 482]. Cell death resulting from all
these mechanisms occurs through necrotic or apoptotic phenomena [117] as well as through
autophagia [368]. Inflammatory processes also participate in the demyelination of still intact
axons [31]. The body’s immune response may facilitate the recovery from injury by reducing
the size of lesion, facilitating wound repair by clearance of hemorrhagic and necrotic tissue
as well as by releasing trophic factors and cytokines which can be neuroprotective and stim-
ulate axonal regeneration (e.g. interleukin (IL)-10, transforming growth factor (TGF)-β)
[25, 48, 74, 111, 116, 138, 139, 237, 253, 404].
Wallerian degeneration, with death of oligodendrocytes, cyst formation within grey and
white matter and the development of scar tissue (mainly composed of astrocytes and fibrob-
lasts [8]) represent the final histopathologic evolution of SCI in the chronic stage [31, 369].
The evolution of the cellular and molecular responses to SCI may result in the re-organisation
of spinal cord circuitry that could be functionally useful (e.g. spasticity) or detrimental (e.g.
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neuropathic pain [31]). It is now widely acknowledged that the lack of any functionally
significant axon regeneration in the lesioned CNS is due to an imbalance of local axon
growth-promoting and growth-inhibitory mechanisms, including the relatively poor expres-
sion of neurotrophic factors and guidance cues at the lesion site, as well as the presence
of potent molecular (myelin inhibitors) and physical barriers (glial scar) to axon growth
[130, 199, 201, 381].
Figure 1.2.: Schematic diagram of the pathological events initiated by compression- or contusion-type traumatic injury to
the spinal cord. The injury causes rapid degeneration of the neural cell bodies and processes within the spinal cord grey
matter at the lesion epicentre, accompanied by local bleeding. The ensuing ischaemia, free-radical production, excitotoxicity,
inflammation, oedema and programmed cell death all contribute to secondary degeneration which increases the size of the lesion
over time. Reactive astrocytes express elevated levels of CSPGs and contribute to scar formation. Oligodendrocytic necrosis
and apoptosis result in myelin debris being released at and around the lesion site and some degree of demyelination of spared
axons. Mild- and moderate compression and contusion injuries often demonstrate some sparing of axons at the outermost
aspect of the white matter.
1.2. Myelin-Associated Axon Growth Inhibitors
The primary and secondary degenerative events caused by traumatic injury release, as de-
bris, a number of potent myelin-associated axon growth-inhibitory molecules into the lesion
site and surrounding tissues. The first of these molecules to be identified was NI-35/250
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(recently cloned and renamed NOGO-A) [79, 170, 330]. This membrane-bound glycopro-
tein constitutes only a few percent of the total protein content of mature central myelin
but is an extremely potent inhibitor of axon growth. It induces the rapid, Nogo recep-
tor (NgR)-mediated collapse of axonal growth cones by activation of the small GTP-ase
RhoA [145, 146, 299]. The development of a monoclonal antibody (IN-1) which blocks the
inhibitory activity of NOGO-A has proved to be extremely useful in promoting regenera-
tion of axotomised corticospinal axons, as well as substantial sprouting and re-organisation
of non-lesioned axonal projections [22, 54, 427, 479]. Other potent myelin-associated in-
hibitors are myelin associated glycoprotein (MAG) and oligodendrocyte-myelin glycoprotein
(OMgp), both of which also act via NgR and share the same intracellular signalling pathway
[109, 282, 293, 455, 456]. NOGO-A, MAG and OMgp have also recently been found to act
via a supplementary receptor system, via paired immunoglobin like receptor B (PirB) [15].
However, it seems that MAG plays no significant role in the inhibition of CNS axons in
vivo [29, 259] and is lost or degraded very early after SCI [68]. Recent investigations have
clearly demonstrated that the myelin-associated axon growth inhibitory molecules stabilise
existing connections within the mature CNS and suppress plasticity. In this context, the
use of anti-NOGO-A antibodies or blocking peptides has been shown to promote functional
recovery by supporting some degree of regeneration by lesioned corticospinal axons as well
as compensatory (or collateral) sprouting [166, 260]
1.3. Astroglial Scarring & Axon Growth-Repulsive
Molecules
It has been known for over 100 years that lesion-induced scars of the CNS were inhibitory
to axon regeneration. The long-standing emphasis on inhibitory glia has led to a general-
ized notion that reactive astrogliosis per se is a detrimental phenomenon contributing to
neurotoxicity, inflammation and chronic pain [397].
A prominent hallmark of reactive gliosis is hypertrophy of the astrocytic cell body and
processes with increased production of intermediate filaments, such as glial fibrillary acidic
protein (GFAP, [27, 119]), as well as renewed expression of vimentin [95, 96, 267, 465] and
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nestin [59, 81, 152]. The hypertrophic processes extend and interweave with each other at the
edge of the injury site; eventually forming a thick mesh-work of cells and processes, supported
by tight- and gap junctions. The resulting astroglial scar represents a major mechanical and
molecular barrier to axonal regeneration [151, 185, 473]. In lesions that spare the dura
mater, the scar is composed primarily of astrocytes, but in more severe lesions (which open
or rupture the meninges) invading connective tissue elements (e.g. fibroblasts, endothelial
cells, ependymal cells) and Schwann cells come into close contact with the reactive astrocytes
[33, 58, 60, 381]. Other inflammatory cell types such as microglia, macrophages and also
oligodendrocytes participate to scar formation [31]. Eventually, a scar-encapsulated cavity
forms, which may be many times the size of the initial wound [17].
Further proof that the SCI-induced glial scar presented an inhibitory environment to ax-
ons was the identification of the re-expression of axon-repulsive extracellular matrix (ECM)
molecules such as tenascin and four classes of proteoglycans [219, 227, 281, 393, 418]. Mem-
bers of the proteoglycans that were detected included the large family of chondroitin sulphate
proteoglycans (CSPG), of which aggrecan, brevican, neurocan, neuronglial antigen 2 (NG2),
phosphacan and versican are prominent members [173, 292]. In addition, a number of other
extrinsic and intrinsic factors have been shown to be axon growth-inhibitory, including the
up-regulation of ECM-related molecules such as ephrins and semaphorins, [129, 173, 315], as
well as the intrinsic neuronal molecules phosphatase and tensin homolog (PTEN), a negative
regulator of the mammalian target of rapamycin (mTOR) pathway [313].
Nevertheless, axon growth-supportive molecules are also expressed by reactive astrocytes,
for example laminin, fibronectin, and poly-sialylated neural cell adhesion molecule (PSA-
NCAM) have also been reported [174, 345, 381, 394, 422]. Although the expression of both
growth-inhibitory and growth-promoting ECM molecules increases in reactive astroglia, the
inhibitory ECM components are almost always more markedly up-regulated [280]. The in-
teractions of these and other axon growth-repulsive and growth-promoting molecules results
in an environment which is overall supportive or inhibitory to axon regeneration [202, 394].
However, other studies have shown a beneficial role of the glial scar during the acute
phase (1-2 weeks) after spinal cord injury. Elimination of reactive astrocytes or prevent-
ing their proliferation and contribution to scar formation after CNS injury resulted in a
failure of blood-brain barrier repair, accompanied by massive inflammatory cell infiltration
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and increased loss of neurons and oligodendrocytes and the eventual worsening of the func-
tional outcome [127, 305]. Moreover, transgenic mice showing enhanced astrocytic migration
and premature glial scar formation facilitated recovery [305]. Thus, an acute astrocytic re-
sponse appears important to limit and restrain the inflammatory response, but this may
be at the expense of reduced axonal regrowth. Since the late 90’s, many studies using
transgenic and experimental animal models have provided compelling evidence that reac-
tive astrocytes are important for the protection of the CNS by: (1) uptake of potentially
excitotoxic glutamate [67, 349, 410], (2) protection from oxidative stress via glutathione
production [80, 378, 410, 444], (3) neuroprotection via adenosine release [268], (4) protec-
tion from NH+4 toxicity [340], (5) neuroprotection by degradation of amyloid-beta peptides
[240], (6) facilitating blood-brain barrier repair [67], (7) reducing vasogenic oedema after
trauma, stroke or obstructive hydrocephalus [67, 475], (8) stabilizing extracellular fluid and
ion balance and reducing seizure threshold [475], and (9) limiting the spread of inflamma-
tory cells or infectious agents from areas of damage or disease into healthy CNS parenchyma
[67, 110, 127, 194, 258, 295, 305, 397, 448]. Together, these findings indicate that there is
a normal process of reactive astrogliosis and glial scar formation that exerts various bene-
ficial functions, including protecting neural cells and their function, restricting the spread
of inflammation and infection, as well as promoting tissue repair. It is important to distin-
guish this normal response to injury with the potential of dysfunctional reactive astrocytes
to contribute to CNS disorders.
1.4. Spontaneous Axon Sprouting and Regeneration
Although there is no spontaneous functional axon regeneration by long distance projecting
neurons after SCI, it has become clear that axonal sprouting and cellular re-organisation
following SCI are more extensive and organised than had previously been appreciated. Ex-
perimental models of SCI (i.e. compression- and lacerating-type injuries) have revealed that
the ECM framework deposited during early bleeding in the lesion site supports the migration
of different populations of cells, i.e. polymorphonuclear neutrophils, followed by endothelial
cells, meningeal fibroblasts, macrophages, activated microglia and Schwann cells [369]. The
presence of migrating Schwann cells appears to tip the balance of growth-promotion versus
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growth-inhibition towards the support of axon regeneration, predominantly by populations of
local intrinsic spinal cord GABAergic and glycinergic interneurons [33, 57, 60, 177]. All of the
axonal re-growth taking place after compression- and laceration-type injuries appears to be
associated with a framework of overlapping Schwann cell bodies and processes which present
important growth promoting cell adhesion molecules, such as L1 [60]. The glial framework is
remarkable in that, in many places, it demonstrates a high degree of orientation, in parallel
with the longitudinal axis of the spinal cord. Similar observations of orientated Schwann
cells and axons have been reported within human spinal cord lesions [458].
An even more striking, plasticity-mediated return of function has been demonstrated fol-
lowing partial thoracic (hemisection-type) injuries [23]. Lesioned lumbar-projecting corti-
cospinal axons were found to sprout and innervate short- and long distance projecting pro-
priospinal neurons (PSN). With time, contacts with the short distance projecting PSN were
lost, while those with the long distance projecting PSN were maintained. The long distance
projecting PSN extended synaptic contacts to include deafferented lumbar motoneurons.
The spontaneously sprouting corticospinal axons, thus established contacts which effectively
by-passed the lesion site [23]. A better understanding of the regulation and restrictions of
these spontaneous events may lead to the identification and manipulation of novel targets
which enhance and maintain endogenous tissue repair processes.
1.5. Strategies to Promote Recovery after SCI
The complex nature of SCI has resulted in the development of many different repair strate-
gies. Of the myriad of intervention strategies, cell-implantation therapies may offer a
number of advantages: in addition to presenting an avenue for continuous growth factor
delivery, transplanted cells may act as a bridge across the lesion across which axonal re-
growth may occur. Donor cells may replace lost glia and neurons, and contribute to the
re-establishment of new functional local circuits.
In the early 1980s, pioneering research demonstrated that adult CNS neurons could re-
generate axons into implanted PNS or foetal CNS tissues [98, 303]. In later experiments,
successful axonal regeneration could also be supported after implantation of foetal spinal cord
[10]. Grafting of peripheral glia (either alone or in combination with a growth promoting
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scaffold) into the lesion site to promote axon regeneration was the next step. Both Schwann
cells [64, 239, 261, 471] and olfactory ensheathing cells [337, 338] have been extensively in-
vestigated and have generated promising results. However, more recently the potential of
progenitor cell-based strategies has become apparent. The potential sources of such donor
progenitor cells include embryonic- [277], foetal- or adult-derived neural progenitors cells
(NPC, [231, 321, 322, 359, 367]), and more recently, induced pluripotent stem cells (iPS)
[436]. Such neural progenitor-based strategies have been reported to promote functional
improvement in experimental models of CNS injury, but their beneficial mechanism(s) of ac-
tion remain poorly defined [52, 114, 121, 156, 306]. Furthermore, mesenchymal stromal cells
(MSC) have also been suggested as potential candidates for neural repair. This suggestion is
particularly interesting bearing in mind the relative ease of harvesting such autologous cells:
being readily isolated from bone marrow, adipose and other tissues [16, 243, 331]. Motor
and sensory improvements in rodent models [11, 196, 411] as well as in phase I clinical trials
[311, 412] have been reported following implantation of MSC.
A variety of studies have also suggested that the inhibition or stimulation of inflam-
matory responses can be beneficial to functional recovery following SCI. Experimental
studies investigating inhibitors of cellular inflammatory responses include the administra-
tion of corticoids [9, 368], the depletion or suppression of mononuclear phagocytes [44, 325],
inhibition of leukocyte, macrophage/monocyte, and neutrophil infiltration [160, 419, 420],
inhibition of inflammatory angiogenesis [453], administration of classical immunosuppres-
sives [32], administration of anti-inflammatory cytokines [36, 37, 55], or pharmacological
agents capable of reducing macrophage activation [400, 482]. All the above studies sug-
gested that inhibition of inflammation was important for the promotion of tissue sparing
and/or improvement of functional recovery in animal models of SCI [9].
In contrast to these findings, other work has demonstrated that stimulation of cellular
inflammatory responses via administration of activated T-cells , implantation of stimulated
homologous macrophages, vaccination with myelin self-antigens or NOGO-A-derived pep-
tides can promote functional recovery after SCI [186–188, 233, 341, 370, 474]. A Phase I
clinical trial applying anti-Nogo-A antibody to subjects with acute SCI has been successfully
conducted and a multicentric, multinational Phase II trial is in preparation [485].
In most of these studies, recovery was improved, but the orientation of axonal regeneration
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within the lesion site was poorly controlled. Since the orientation of axonal regeneration is
likely to play an important role in the eventual efficiency of bridging strategy, a number of
orientated scaffolds have been developed. The first of such guidance channels were simple
hollow tubes, into which the proximal and distal stumps of transected spinal cord could be
inserted and the tube filled with a gel-like matrix or with donor glia [291, 469, 470]. Such
guidance channels supported significant axonal in-growth, which mainly occurred on the
inner surface on the tubes.
Recent advances in bioengineering have resulted in the development of a number of
artificial 3D, highly orientated, biodegradable matrices [200, 316, 426] which have been
transplanted into the injured spinal cord. It is assumed that the biodegradability of these
scaffolds plays an important role in promoting tissue repair, since non-degradable matrices
could induce a harmful foreign body response, potentially leading to the constriction of the
scaffold [484]. Significantly, it has been recognized that such bioengineering strategies are
sufficiently versatile to be able to import functional molecules, drugs or cells into areas of
pathology.
Although a large number of intervention strategies have been investigated, it is unlikely
that any one strategy, alone, would be able to promote dramatic functional improvement.
It is more likely that combined approaches will yield greater benefits: for example the com-
bination of grafting PNS nerves [432], Schwann cell-seeded guidance channels [76] or neural
stem/progenitor cell [206, 225] with the administration of the enzyme chondroitinase ABC
(ChABC) has resulted in improved axonal regeneration in all cases. The ChABC is impor-
tant for breaking down sugar side-chains of inhibitory CSPGs. Similarly, the combination of
growth factor treatment via genetic modification of donor cells (such as fibroblasts, NPC and
Schwann cells) has resulted in enhanced axonal regeneration and, in many cases, functional
recovery [171, 172, 217, 232, 269, 285, 294].
1.6. Neural Progenitor Cells
Stem cells are non-specialized cells that have the capacity to give rise to more stem cells
(termed self-renewal) for an extensive period of time, as well as producing progeny that
undergo terminal differentiation into the major cell types of their tissue of origin (termed
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multi-potency) [154, 372]. It is widely appreciated that adult neural stem cells in vivo
are slowly dividing, long-term BrdU-retaining cells that exhibit several common features of
subventricular radial glia-like astrocytes and ventricular ependymal cells, including morpho-
logical characteristics and expression of the glial fibrillary acidic protein (GFAP) and the
glycoprotein CD133 [274]. However since only a small proportion of cells in an in vitro neu-
rosphere population seems to fulfil the criteria of a stem cell, here the term neural progenitor
cells (NPC) is used to describe a more restricted oligopotent cell population, which has only
a limited capacity of self-renewal [343].
NPC may be obtained from the inner cell mass of the blastocyst, from embryonic- [235,
429] and foetal-tissue [409, 440], and from neurogenic regions in the adult CNS [165, 398].
Even post mortem CNS tissue has been suggested to be a source for NPC [133, 252, 371],
where harvested cells maintain the capacity for self-renewal, and the generation of neurons,
astrocytes and oligodendrocytes [154, 278, 398, 425].
In spite of many studies indicating a beneficial role of stem cell transplantation following
SCI, there is still limited mechanistic insight. The simplest interpretation of how trans-
planted stem cells promote functional recovery is that donor cells replace lost neurons and
glia. Other possible, but more indirect mechanisms include (i) the expression and release of
growth factors, cytokines and neurotrophic factors (trophic support); (ii) effects on the vas-
culature or the modulation the inflammatory response; (iii) acting as a substrate for axonal
regeneration; (iv) the promotion of endogenous progenitor proliferation [24, 314].
The use of NPC isolated from foetal tissues attenuates the risk of oncogenic transfor-
mation (as observed with embryonic stem cells), especially after they have undergone dif-
ferentiation prior to transplantation [230]. Undifferentiated foetal human NPC have been
transplanted into mice [92, 93, 359], rat [224, 264, 304, 421, 460, 468] and primate [212]
models of spinal cord injury, with encouraging results. Following transplantation of human,
rat or mouse NPCs into the intact or injured murine spinal cord, donor cells were only
found to primarily differentiate into astrocytes and, to a lesser extent, into oligodendrocytes
[71, 100, 264, 367, 379, 395, 421, 450, 460]. However transplantation of NPC-derived oligo-
dendroglia has been shown to promote remyelination and improvement in locomotor function
after spinal cord injury [126, 230, 301]. Promoting the generation of oligodendrocytes (at
the expense of astrocytes) by transplanted neural stem cells further facilitates sensory and
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locomotor recovery [197]. Following a similar logic, the transplantation of foetal hNPC-
derived astrocytes might represent an attractive cell type to support spinal cord repair by
an alternative mechanism, namely by promoting axon regeneration.
1.7. Astrocytes as Promoters of Axon Regeneration
Astrocytes are phenotypically heterogeneous, and it is not clear to what extent different
phenotypes play different roles in the pathophysiological response to traumatic injury. The
glial scar is composed of both local hypertrophic astrocytes and newly formed astrocytes,
derived from stem/progenitor cells that invade the lesion area [397]. However, it is clear that
the developmental status of the astrocytes exerts a marked influence on the axon growth-
inhibitory/promoting properties of the reactive cells [28, 381]. The first indications of the
beneficial (i.e. axon growth promoting) effects of reactive immature astroglia to injury were
reported in the late 1980s: astrocytes from the developing brain were suggested to be an
ideal substrate for neuron regeneration in vitro [124, 125, 131, 302, 433, 434] and in vivo
[380, 382, 390, 391]. Since then, numerous studies have suggested that immature astrocytes
may provide a favourable substrate for axon regeneration following SCI [38, 99, 100, 128, 431].
Most importantly, in contrast to type I astrocytes, which induced robust axonal regeneration,
differentiation and grafting of type II astrocytes has been reported to induce allodynia-
like symptoms (pain in response to a normally nonpainful stimuli) [99, 197]. The axon
growth promoting properties of different subpopulations of animal-derived astroglia (e.g.
immature and reactive astrocytes) were reported to be due to the production of particular
ECM components (including laminin and fibronectin) as well as to the expression and release
of certain growth factors (including bFGF, BDNF, NGF) [113, 329, 463].
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1.8. Hypotheses Investigated in this Thesis
Following the simple idea that immature rat astrocytes promote axonal regeneration and
scaffold integration [236, 380, 389–391], the main hypothesis investigated in this thesis can
be formulated as: “Human immature neural progenitor-derived astrocytes are capable of pro-
moting axon regeneration and scaffold integration, similar to properties demonstrated for
immature rat astrocytes.”
To answer this hypothesis the following goals were formulated:
1. To generate highly enriched populations of immature astrocytes derived from human
neural progenitor cells (hNP-AC).
2. To determine cell-substrate interactions between hNP-AC and orientated bioengineered
substrates.
3. To identify the axon growth-promoting properties of the hNP-AC in 2D and 3D systems
using adult neuronal populations.
4. To determine the axon growth promoting properties/graft-host interactions of hNP-
AC when implanted into experimental models of SCI, either alone- or in combination
with a 3D collagen scaffold.
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2. Material & Methods
2.1. Tissue Culture
2.1.1. Human Neural Progenitor Cells (hNPC)
Cells were purchased from Lonza Sprl. (Verviers, Belgium). The donated cells had been ob-
tained from anonymous human foetus’ (week 18) according to state and federal guidelines.
Cells were cultured as neurospheres in neural progenitor proliferation medium (NPPM) con-
sisting of Dulbecco’s modified Eagle medium (DMEM)/F12 (high glucose, 1:1) containing
Glutamax (1:100, Invitrogen), human recombinant epidermal growth factor (EGF 20 ng/ml,
Cell Concepts), human recombinant basic fibroblast growth factor (bFGF 20 ng/ml, Invitro-
gen), neuronal stem cell supplement (1:50, PAA) and penicillin/streptomycin (1:100, PAA)
at 37◦C with 5% CO2. Medium was changed every 2-3 days. Spheres were passaged follow-
ing incubation in Accutase (undiluted solution, PAA) and triturated as described by others
[451]. Multi-potency of hNPC was monitored by in vitro differentiation to astrocytes, neu-
rons and oligodendrocytes. To induce differentiation, hNPC were plated onto poly-L-lysine
(0.01%, Sigma-Aldrich, Steinheim, Germany) and laminin (10 µg/ml, Roche, Mannheim,
Germany, PLL/laminin) coated 8-well chamber slides (Nunc, Langenselbold, Germany) and
cultured in neural basal progenitor media (NPBM, Lonza) supplemented with nerve survival
factor (NSF-1), gentamicin (both ready for use solutions, Lonza), B27 (1:50 Invitrogen) and
platelet-derived growth factor AA (PDGF-AA, 20 ng/ml, Peprotech).
2.1.2. Human Neural Progenitor-Derived Astrocytes (hNP-AC)
hNPC were grown as spheres as described previously [461] in neural progenitor differentiation
medium (NPDM) composed of Neurobasal A (Invitrogen) containing EGF (20 ng/ml), bFGF
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(20 ng/ml), human recombinant leukemia inhibitory factor (LIF, 10 ng/mL; Chemicon), hu-
man recombinant bone morphogenetic protein (BMP4, 20 ng/mL; R&D Systems), neuronal
stem cell supplement (1:50, PAA), Glutamax (1:100, Invitrogen) and penicillin/streptomycin
(1:100, PAA), leading to the generation of a highly enriched population of progenitor-derived
type I astrocytes after 8 passages [461].
2.1.3. Preparation of hNP-AC Extracellular Matrix (hNP-AC-ECM)
hNP-AC cultures were seeded onto PLL/laminin coated 24-well plates and maintained in
NPDM. At 1 week after reaching confluency, cells were lysed by incubation in distilled water
for 30 min at 37◦C. The excess cell debris was removed by washing the substrate several
times in 0.1M phosphate buffered saline (PBS); the remaining ECM substrate was stored in
PBS at 4◦C and used within 2 days of preparation [287].
2.1.4. Preparation of hNP-AC Conditioned Media (hNP-AC-CM)
hNP-AC cultures were grown to confluence in 12-well plates and fed with fresh dorsal
root ganglia medium (DRGM) composed of Neurobasal A supplemented with B27 (1:50
Invitrogen), Glutamax (1:100 Invitrogen), 10% fetal bovine serum (FBS, PAA), and peni-
cillin/streptomycin (1:100 PAA). After 3 days conditioning, the medium was removed from
the cultures and mixed 1:1 with fresh DRGM prior to being given to the cultured DRG
neurons.
2.1.5. Human Foreskin Fibroblasts (hFbl)
Purified hFbl were used a control cell type for the in vivo investigations. They were donated
following informed consent following approval of the local ethics committee of the University
of Montpellier. Fibroblasts were cultured on normal tissue culture plastic in DMEM/F12
containing 10% FBS and penicillin/streptomycin (1:100 PAA).
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2.1.6. Cell Counting
To estimate the proportion of undifferentiated or differentiated hNPC that were immunore-
active for a particular antigen, cell numbers were quantified by counting at least 9 non-
overlapping, randomly chosen, microscopic fields (200x magnification, area of interest: 280
µm x 212 µm) from three independent experiments.
2.1.7. Fixation
For Fluorescence microscopy, samples were exposed to cold 4% paraformaldehyde (PFA,
AppliChem) and allowed to fix at room temperature (RT) for 30 min. For scanning electron
microscopy, samples were exposed to 2.5% glutaraldehyde for 2 h. .
2.2. Immunohistochemistry
After fixation, samples were processed for immunocytochemical staining as described pre-
viously [137, 159]. Primary antibodies were diluted in 0.1 M PBS with 1% BSA and 3%
normal goat serum (NGtS, Sigma-Aldrich) and incubated with the preparations overnight at
room temperature. The following polyclonal antibodies were used: anti-fibronectin (1:500,
DAKO), anti-glial fibrilary acidic protein (GFAP, 1:2000, DAKO, Hamburg, Germany), anti-
Iba1 (1:1000, Wako), anti-laminin (1:200, Sigma-Aldrich), anti-Musashi (1:2000, Millipore),
anti-nestin (1:500, Millipore), anti-neurofilament (1:2000, Sigma-Aldrich), anti-p75 (1:1000,
Sigma-Aldrich), anti-S100ß (1:2000, DAKO) and anti-sox2 (1:2000, Millipore) as well as the
following monoclonal antibodies: anti-A2B5 (1:200, Millipore), anti-CD44 (1:200, Sigma-
Aldrich), anti-CSPG (1:200, Sigma-Aldrich), anti-ED1 (1:500, Santa Cruz), anti-human
nestin (1:200, Millipore), anti-human nuclei (1:200, Millipore), anti-Map2a+b (1:500, Sigma-
Aldrich), anti-neurofilament 200kDa (1:2000, Sigma-Aldrich), anti-04 (1:200, Millipore),
anti-p75 (1:1000, Millipore), anti-TuJ1 (1:500, Sigma-Aldrich) and anti-vimentin (1:10.000,
Sigma-Aldrich). Primary antibodies were detected by a combination of secondary anti-
bodies for 2.5h at RT: Alexa Fluor c© 488 goat anti-rabbit IgG (1:500, Invitrogen), Alexa
Fluor c© 488 goat anti-mouse IgG (1:500, Invitrogen), Alexa Fluor c© 594 goat anti-rabbit
IgG (1:500, Invitrogen) and Alexa Fluor c© 594 goat anti-mouse IgG (1:500, Invitrogen)
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diluted in 0.1 M PBS with 1% BSA. Cell nuclei were counterstained with 4,6-diamidino-2-
phenylindole dihydrochloride (DAPI; 1 µg/ml, Invitrogen). For a complete overview of all
antibodies/counterstains used, see Table 2.1. Coverslips were then mounted onto the sam-
ples using Fluoroprep (BioMerieux, Nürtingen, Germany) and, unless otherwise mentioned,
samples were visualized using an inverted Zeiss Axioplan/Apotome fluorescence microscope
coupled to an on-line digital camera (Axiovision software) for evaluation of the dissociated
DRG and spinal cord sections, or an inverted Leica fluorescence microscope coupled to an
on-line digital camera (Discus, Leica software) for evaluation of hNPC, hNP-AC and the
scaffold preparations.
Table 2.1.: Antibodies
Monoclonal antibodies
Antibody Dilution Supplier
A2B5, clone A2B5-105 1/200 Millipore (MAB342R)
CD44, clone A3D8 1/200 Sigma-Aldrich (C7923)
CSPG, clone CS-56 1/200 Sigma-Aldrich (C8035)
ED1, CD68 1/500 Santa Cruz (SC-59103)
Human nestin, clone 10C2 1/200 Millipore (MAB5326)
Human nuclei, clone 3E1.3 1/200 Millipore (MAB4383)
Map2a+b, clone AP-20 1/500 Sigma-Aldrich (M1406)
Neurofilament 200kD, clone NE14 1/2000 Sigma-Aldrich (N5389)
O4, clone 81 1/200 Millipore (MAB345)
p75, clone 192 1/1000 Millipore (MAB365)
TuJ1, Clone SDL 3D10 1/500 Sigma-Aldrich (T8660)
Vimentin, clone V9 1/10000 Sigma-Aldrich (V6630)
Polyclonal antibodies
Antibody Dilution Supplier
Fibronectin 1/2000 DAKO (A0245)
GFAP 1/2000 DAKO (Z0334)
Iba1 1/1000 Wako (019-19741)
Laminin 1/200 Sigma-Aldrich (L9393)
Musashi 1/2000 Millipore (AB5977)
Nestin 1/500 Millipore (AB5922)
Neurofilament 1/2000 Sigma-Aldrich (N4142)
p75 1/1000 Sigma-Aldrich (N3908)
S100ß 1/2000 DAKO (Z0311)
Sox2 1/2000 Millipore (AB5603)
Secondary antibodies / nuclear counter stain
Antibody Dilution Supplier
Alexa Fluor 488, goat anti-mouse 1/500 Invitrogen (A11029)
Alexa Fluor 488, goat anti-rabbit 1/500 Invitrogen (A11034)
Alexa Fluor 594, goat anti-mouse 1/500 Invitrogen (A11032)
Alexa Fluor 594, goat anti-rabbit 1/500 Invitrogen (A11037)
DAPI (1 µg/ml) 1/1000 Invitrogen (D1306)
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2.3. Scanning Electron Microscopy (scanning EM)
Scanning EM was used to visualise the fine details of hNPC and hNP-AC, as well as their
interactions with nanofibers and the 3D collagen scaffold. The 2.5% glutaraldehyde-fixed
samples were dehydrated in acetone using a Polaron E3000 critical point dryer. The speci-
mens were then mounted on stubs and sputter coated with gold, loaded into an ESEM XL30
FEG scanning electron microscope (Philips EO, Eindhoven, Netherlands) and viewed under
an accelerating voltage of 5 kV. In this context, I would like to thank Manfred Bovi (De-
partment of Pathology, UK Aachen) for the excellent technical support with the scanning
EM.
2.4. Production of the Orientated Nanofibers
The glass coverslips and orientated nanofibers were kindly provided by José Gerardo-Nava
and were prepared as described previously [159]. Experiments were performed on low density
fibers.
2.4.1. Glass-Coverslip Preparation
Glass coverslips (12 mm diameter; Marienfeld Lauda-Königshofen, Germany) were surface-
functionalized, dried with toluene and placed in a N2-containing glove box prior to nanofiber
collection, as described previously [175]. Within the glove box, 20 mg of star-shaped poly-
ethylene glycol (sPEG, MW 12000 Da) was dissolved in 0.2 ml tetrahydrofuran. Before use,
1.8 ml deionized water was added and the mixture was allowed to partially crosslink for 5
min. The sPEG solution was sterile-filtered (0.2 µm filters) and applied to coverslips by
spin-coating, undergoing 5 s of acceleration to 4000 rpm and then maintaining this speed
for 40 s. Approximately 30 min was allowed for crosslinking between the sPEG and the
activated cover-slips prior to binding with the nanofibers. Poly-L-lysine (100 ng/ml, 1 h)
coated coverslips were used as a positive-control substrate.
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2.4.2. Electrospinning of Oriented Nanofibers
Pure PCL (Sigma-Aldrich, MW 65000 Da), dissolved in chloroform/methanol (75:25 vol%)
or a blend of PCL and calf skin type I collagen (Sigma-Aldrich, 75:25 wt%), then dissolved
in 1,1,1,3,3,3-hexafluoro-2-propanol (Sigma-Aldrich) was prepared as a 9 wt% solution and
electrospun as described previously [364]. Electrospun nanofibers were deposited between
parallel metal bars (4 cm apart), which were positioned 20 cm from the spinneret and acted
as grounded nanofiber collectors. The nanofibers were then collected by passing the sPEG-
coated glass coverslips through the array [364].
2.4.3. Seeding of the Orientated Nanofibers
Nanofiber-coated coverslips were placed in four-well plates, sterilized with 70% ethanol (30
min) and washed twice with sterile PBS before cell seeding. hNP-AC cell suspension was
prepared in DMEM/F12 (1:1, Invitrogen) with 10% FBS (PAA), penicillin/streptomycin
and Glutamax (both 1:100, Invitrogen; 10,000 cells/well). Culture medium was replaced
every third to fourth day.
2.4.4. Cell-Adhesion Assay & Cell-Number Counting
The cell-adhesion assay, based on crystal-violet staining 90 min after cell seeding, was per-
formed as described previously [364]. Cell proliferation/survival was determined by count-
ing the number of DAPI-stained cell nuclei that were associated with the PCL or C/PCL
nanofiber preparations after 1, 4 and 7 days in vitro (DIV). The cell counts were performed
in five rectangular fields of 345 x 435 µm (0.15 mm2) that were selected randomly for each
sample.
2.4.5. Process Length
Process lengths of hNP-AC were measured from the edge of the DAPI-labeled cell nucleus to
the tip of the cell’s longest process. The lengths of the longest 10% of at least 50 randomly
chosen processes were measured for each sample.
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2.4.6. Cell-Migration Assay
Astrospheres of hNP-AC were used for the migration assay. Migration away from the
spheres was assayed on three different substrates: (I) orientated C/PCL nanofibers, (II)
PCL nanofibers, and (III) PLL-coated tissue culture plastic which served as a non-oriented
adhesion/migration-promoting substrate. Each assay was performed in triplicate, with a
total of 12-15 spheres of uniform diameter (242 ± 18.5 µm) being plated in wells containing
the different substrates. After 2 days, the spheres were fixed and processed for immunocyto-
chemistry. Samples were observed and photographed with an inverse microscope (Leica, 10x
objective) coupled to an online digital camera (Leica, Diskus software). For quantification,
nine spheres from each condition were evaluated. The distance of the 10% farthest migrating
DAPI nuclei along the axis of the oriented nanofibers was measured using ImageJ software.
For estimation of cell migration on the non-oriented PLL substrate, a line was drawn at
random through the centre of the sphere. The farthest 10% migrating cells along this axis
was then measured.
2.5. Gene Expression Analysis
RNA was isolated using the RNeasy Mini Kit (Qiagen, Hilden, Germany) according to the
manufacturer’s protocol. RNA concentrations were measured using a Nanodrop photometer
(Nanodrop Technologies, Montchanin, USA). For PCR analysis, 2 µg RNA was reverse
transcribed to cDNA with Omniscript Reverse Transcriptase (Qiagen, Hilden, Germany)
according to the manufacturer’s protocol using oligo-d(T) primers and random hexamers.
For amplification of target genes, 0.2 units Taq polymerase (Amersham Biosciences, New
York, USA) were used with a standard PCR program (denaturation: 10 sec at 96◦C; primer
hybridisation: 2 min at various target specific temperatures, see Table 2.2; elongation: 2
min at 72◦C). PCR products were analyzed by electrophoresis on a 1.7% agarose gel and
visualized with 0.5 µg/ml ethidium bromide. The cDNA from the human astrocytoma cell
line (U373) and human leukemia cell line (ThP-1) were used as positive controls. Evaluation
of mRNA expression: The optical density of the PCR bands were analysed with ImageJ
(http://rsbweb.nih.gov/ij/index.html) and calculated as a ratio in relation to the house
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keeping gene, GAPDH (internal control).
Table 2.2.: Forward and reverse primer sequences used for the detection of RT-PCR for GFAP, CD44 and GAPDH.
Primer forward (5´- 3´) reverse (5´- 3´) hybridization cycles amplicon
temperature size (bp)
GFAP gtg gta ccg ctc caa gtt tgc ag aat ggt gat ccg gtt ctc ctc 59 ◦C 40 373
CD44 tgc ttc aat gct tca gct cca cct g tga ttc aga tcc atg agt ggt atg 64 ◦C 33 375
GAPDH tga agg tcg gag tca acg gat ttg gt cat gtg ggc cat gag gtc cac cac 62 ◦C 30 983
2.6. Preparation of Adult Rat Dorsal Root Ganglia Neu-
rons
DRG neurons were harvested from adult female Lewis rats (Charles River, Sulzfeld, Ger-
many) as described elsewhere [102, 137]. Briefly, rats were killed by terminal inhalation
anaesthesia (Isofluran, Abbott GmbH, Wiesbaden, Germany), DRG rapidly dissected and
either used for the generation of neuronal suspensions for 2D tissue cultures or were hemi-
sected and placed on top of cell seeded- or non-seeded (control) collagen scaffolds for 3D
tissue cultures. DRG were maintained in DMEM/F12 (1:1) containing Glutamax (1:100),
10% FBS and penicillin/streptomycin (1:100) for 3D experiments. For 2D tissue culture,
DRG were dissociated in collagenase (0.8% w/v collagenase CLS I, Biochrom AG, Berlin,
Germany) for 2 hours followed by 0.5 ml of 0.25% trypsin (Invitrogen) for 30 min at 37◦C.
Trypsinisation was stopped by removal of the digestion solution and washing with DRGM. To
remove myelin debris and the majority of Schwann cells, the solution was centrifuged (1200
g for 12 min at room temperature) through a freshly prepared Percoll density gradient (GE
Healthcare Europe GmbH, Munich). The resulting pellet was resuspended in l ml of DRGM
and the viable cells counted in a haemocytometer. Approximately 400-500 neurons were
seeded with DRGM on to (A) PLL/laminin (positive control) substrate, (B) PLL/laminin
in combination with hNP-AC-CM, (C) confluent layers of hNP-AC or (D) hNP-AC-ECM in
12 mm microwells (Figure 2.1). After 24h the preparations were fixed.
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Figure 2.1.: Schematic diagram of the experimental design for studying the axon growth promoting properties of hNP-AC.
Dissociated DRG neurons were seeded onto PLL/laminin positive-control substrate (A), PLL/laminin with hNP-AC conditioned
media (B), hNP-AC confluent monolayers (C) or hNP-AC-ECM (D).
2.7. Evaluation of Axonal Growth on 2D Substrates
All experiments were performed in duplicate and a total of 100 DRG neurons per condition
were evaluated. Digital images of MAP2a+b/NF200-positive DRG cell bodies and neurites
were acquired for all experimental conditions. Total neurite length was measured by manually
tracing all processes using Adobe Photoshop, followed by single pixel skeletonisation of the
images using ImageJ. The total length of the neurites was estimated by counting the total
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number of pixels per neuron. All analyzed data was standardised in relation to the values
obtained using the PLL/laminin positive control.
2.8. Orientated 3D Collagen Scaffold
2.8.1. Preparation
The sterile scaffolds (diameter: 5 mm; thickness: 3 mm) used in this study were supplied by
Matricel GmbH (OptiMaix-3D, Herzogenrath, Germany). The 3D-collagen scaffolds contain
densely packed, longitudinally orientated micropores and were prepared according to the
patented directional freezing process, as described previously [50, 245].
2.8.2. Cell Seeding
Scaffolds were seeded by dropping the dry scaffold into a 200 µl cell suspension (in vitro
studies: hNP-AC: 20,000 cells/µl; in vivo studies: hNP-AC: 30,000 cells/µl, hFbl: 20,000
cells/µl). The seeded scaffolds were further processed for cell proliferation and distribution
data after 1, 7 and 14 days in vitro. Other hNP-AC seeded scaffolds were kept in an
incubator overnight prior to having the hemisected DRG placed on their open, porous ends
(as described earlier [50]) or prior to transplantation into the injured spinal cord (lateral
funicolotomy, see below).
2.8.3. Processing
Scaffolds were fixed and after multiple washes in PBS either frozen and cut on a cryostat (100
µm thick sections for the proliferation assay) or embedded in gelatine for the preparation of
thinner (25µm) cryostat sections to assess DRG neurite in-growth. For embedding, samples
were incubated in a 5% (w/v) gelatine (Merck), 5% (w/v) sucrose (Merck) solution in 0.1M
PBS and kept in a humidified chamber at 45◦C overnight. Gelatine was allowed to polymerize
the next day, at 4◦C, for half an hour and was then frozen at -80◦C in isopentane.
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2.8.4. Evaluation of Proliferation
DAPI nuclei from fifteen non-overlapping, randomly chosen, microscopic fields (100x magni-
fication) from three sections obtained from three scaffolds were counted to estimate prolifer-
ation activity. The doubling time was calculated using the number of DAPI positive nuclei
from days 7 and 14.
2.8.5. Evaluation of Axonal Growth on 3D Substrates
For measuring DRG neuritic length through the scaffold, 8-9 hemisected DRG were placed
on top of the scaffolds and cultured for 21 days (DRG isolated from 2 animals). Three
scaffolds were processed per group for evaluation (i.e. hNP-AC-seeded and control, non-
seeded samples). Adjacent serial sections (following the longitudinal axis of the micropores)
were collected onto adjacent slides. At least six slides, evenly spaced throughout the scaffolds,
were then processed for immunohistochemical demonstration of regenerating axons and the
different cell types. All neurite lengths were measured and the figure for the longest 10%
calculated.
2.8.6. Evaluation of Schwann Cell Migration
The proportion of migrating p75-positive Schwann cells (expressed as a percentage of the
total population of cells within the initial part of the scaffold) was calculated using a series
of images taken with 100x magnification (area of interest: 4100 x 850 µm)
2.8.7. Preparation for in Vivo Studies
The seeded scaffolds were incubated in growth medium for 1 day to assure cell adhesion to
the matrix. Before implantation, the scaffolds were washed in Hank’s buffered salt solution
(HBSS). Scaffolds were then kept in cooled HBSS and cut into approximately 1-2mm thick
slices prior to implantation.
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2.9. Animals
Animals were socially housed on sawdust, 4-5 animals/cage, in standard type 4 macrolon
cages, with free access to water under a 12:12 h light regime. All procedures involving animals
in this study were approved by the responsible ethical committee (Aachen: AZ 50.203.2-Ac
23,11/06, Liège: 814).
2.10. Balloon Compression Injury
These investigations were performed at the Institute for Anatomy, University of Liège. Com-
pression injury was performed as described earlier [443]. Briefly, under isoflurane inhalation
anaesthesia, the Th10 vertebra of adult female Wistar rats (body weight approximately 270
g) was exposed and a Fogarty 2F inflatable balloon passed into the epidural space via a small
burr hole and gently moved rostrally for approximately 1 cm. The compression injury at
level Th8 was caused by inflation of the balloon (15 µl of water for 5 minutes), after which
it was deflated and removed. The dura was then closed using 10/0 suture, and the muscle
layers closed using resorbable 6/0 suture. The skin was closed using 4/0 sutures and the
animals were allowed to recover.
2.10.1. Cell Transplantation
One week post operation, animals were reanaesthetised and the original surgical wound re-
opened. Small bur-holes were drilled into the vertebral laminae to allow the transplantation
of either (I) hNP-AC, or (II) hFbl (as a control cell population). Donor cells were grafted
into the lesion epicentre (5 µl) as well as 1 cm rostral and caudal to the injury (2.5 µl each,
therefore a total volume of 10 µl at 100,000 cells/µl, Figure 2.2). All transplantation pro-
cedures were performed using a glass micropipette under stereotaxic control as described
earlier [118]. After the grafting of cells was completed, the muscle layers and skin were
again closed using sutures (see above) and the animals received 10 ml of saline, immunosup-
pression (cyclosporine, methylpredisolone and azathioprine, see below), antibiotics (0.01%
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baytril) and were allowed to recover. Non-implanted controls groups included lesioned ani-
mals without- or with immunosuppression (i.e. control group (III) and control + IS group
(IV), respectively). Those animals only received the initial lesion with no further surgical
intervention. Animals were sacrificed 9 weeks after injury. Animals that were not correctly
lesioned (based on BBB score 1 day postoperative) were excluded from the study.
Figure 2.2.: Schematic diagram of the experimental design for the balloon compression injury model. The spinal cord was
compressed (A) and left either untreated without (B-I) or with (B-II) immunosuppression (IS), or animals received transplants
of hFbl (B-III) or hNP-AC (B-IV) one week after injury. Nine weeks after injury, animals were transcardially perfused with
4% PFA, the spinal cords removed, divided into three blocks and processed for serial longitudinal (block A and block C) or
transverse (block B) cryosectioning.
2.11. Lateral Funiculotomy
Adult female Lewis rats (age > 3 month) were used for this in vivo study (mean body weight
200 g; range 178-227 g). The low thoracical lateral funiculotomy (Th10) was performed as
described earlier for the cervical area [269]. Under isoflurane inhalation anaesthesia, the
back was shaved and the skin sterilized with 70% alcohol prior to incision along the midline,
exposing the back musculature. Using blunt dissection, the superficial muscle layers were
cleared from the deeper layers, a midline incision was made and the superficial and deep
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muscle layers retracted to expose the dorsal surface of the Th9 - Th12 vertebrae. Fine
bone rongeurs were used to perform a laminectomy of the Th10 and the Th11 vertebra,
exposing the dorsal surface of the spinal cord. The dura was cut and reflected, after which
a simple lateral funiculotomy involving the resection of 1-2 mm lateral spinal cord tissue
was performed. The animals then received scaffold implants as follows: (A) non-seeded with
IS, (B) hFbl-seeded with IS, or (C) hNP-AC-seeded with IS (Figure 2.3). The dura was
then closed using 10/0 suture, and the muscle layers closed using resorbable 6/0 suture.
The skin was closed using 4/0 sutures. After the operation, animals received 10 ml of
saline, immunosuppression (cyclosporine, methylpredisolone and azathioprine, see below)
and antibiotics (0.01% baytril) and were allowed to recover. The following day, the vast
majority of the animals moved freely in their cage, fed and drank without any indication of
pain or discomfort. While bladder dysfunction lasted - usually for not more than 7 days -
the bladders were manually voided. Animals were sacrificed 8 weeks after injury.
Figure 2.3.: Schematic diagram of the experimental design for the lateral funiculotomy. Part of the lateral white matter tract
was resected (A) and substituted by a non-seeded scaffold (control, B-I), a hFbl-seeded scaffold (B-II) or a hNP-AC-seeded
scaffold (B-III). Eight weeks after injury, animals were transcardially perfused with 4% PFA, the spinal cords removed and a 1
cm block containing the scaffold was processed for serial longitudinal cryosectioning (C).
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2.12. Immunosuppression
The lesioned animals receiving cell transplants as well as those controls receiving immunosup-
pression were administered intraperitoneal (i.p.) injections of a combination of cyclosporine
A (Novartis), azathioprine (GlaxoSmithKline) and methylpredisolone (Sanofi Aventis) in the
following concentrations: 10 mg/kg cyclosporine starting from one day before transplantation
(lateral funiculotomy injury model) / injury (compression injury model) and every day until
animals were sacrificed, 4 mg/kg azathioprine starting on the day before transplantation as
well as on the day of transplantation (subsequent daily injections included azathioprine at 2
mg/kg), 2 mg/kg methylpredisolone for one week starting at the day of transplantation, for
the second week the dose was reduced to 1 mg/kg after which all remaining daily injections
contained methylpredisolone at 0.5 mg/kg [5, 34, 204, 255, 318, 335].
2.13. Behavioural Analyses
2.13.1. Behavioural Studies for Animal Groups Subjected to Balloon
Compression
These investigations were performed at the Institute for Anatomy, University of Liège, and
were subject to the local ethics committee permission. The "Basso, Beattie, Bresnahan or
BBB open field" locomotor rating scale was used to assess general locomotor performance
[30]. In addition, fine motor coordination was assessed using a horizontal wire grid (Gridwalk,
50-cm long runway grid with 50 X 50 mm spacings, Table 2.3) [247], and a commercially
available "plantar test" apparatus was used to assess sensitivity of the plantar hind-paws to
a brief noxious heat stimulus in unrestrained rats (Hargreaves heat test [183]). The different
test scores were assessed before injury and at 5 and 9 weeks post injury by 2 observers.
Table 2.3.: Gridwalk test score
0 No foot placement
1 Attempted foot placement, but grid is missed
2 Foot is occasionally placed on the grid, but slips
3 Foot is placed, but slips
4 Foot is placed, but does not grip the grid, many footfalls
5 Foot is placed and the grids are gripped, few footfalls
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2.13.2. Behavioural Studies for Animal Groups Subjected to Lateral
Funiculotomy
Function was assessed before injury and at 4 and 8 weeks after injury using the CatWalk
gait analysis system, a gridwalk test and a sensory function test (von Frey filament test).
CatWalk data could be acquired only after the animals regained body weight supporting
stepping (BBB 11 or higher). Most animals achieved this level of recovery by one one week
after injury, but some required a longer recovery time of up to three weeks.
CatWalk
The analysis of gait using the CatWalk system and the required training protocol has been
described in detail elsewhere [181, 241, 449]. Briefly, during a 2-3 week-period in which a 12
g/day food restriction protocol was used (to provide for motivation), the animals were trained
to make consecutive runs (without any stops or hesitation) over a glass runway. Each run
made by the animals was rewarded by receiving foot pellets (Noyes Precision pellets PJPPP-
0045; Sandown Chemical Ltd., Hempaton, UK) which were placed at the end of the runway.
For correct locomotor analysis, the following criteria concerning walkway crossing were used:
(1) the rat needed to cross the walkway, without any interruption or hesitation, and (2) a
minimum of three correct crossings per animal were required (eight were usually recorded).
For reliable comparison between the gait parameters of animals in the different groups it is of
utmost importance that there is no difference in speed of gait [241]. This could be controlled
by monitoring the time taken to cross the walkway. For this purpose, the 3 crossings closest
to 1.4 seconds were chosen. In the present study, all individual crossings were analyzed for
the duration of walkway crossing, the regularity index, base of support (for the fore- and
hind-limbs), intensity of signal on paw placement, paw print area and maximum area, stance
duration, swing duration, stride length and duty cycle (hind limbs).
Values for the duty cycle (stance duration divided by the sum of stance and swing du-
ration), stride length, stance duration, swing duration, max area, print area and intensity
were always calculated as the ratio of the ipsilateral (i.e. affected) side to the contralateral
(i.e. unaffected, control) side and standardised in relation to the preoperative values.
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Gridwalk
Fine motor coordination was assessed using a horizontal wire grid (50-cm long runway grid
with 50 X 50 mm spacings) [247]. Animals were trained for 1-2 weeks until they were able
to cross the grid without any interruption or hesitation to reach their food pellet rewards. A
minimum of four correct crossings were performed and recorded using a digital video camera
(Sony). Those videos were then used for slow motion replays to allow the quantification of
the number of footfalls made.
Von Frey Filaments
Paw withdrawal in response to a mechanical stimulation to the plantar surface was deter-
mined using a series of von Frey filaments (Stoelting, Wood Dale, IL), which were graded
from 1.08 to 21.09 g. For this test, animals were placed in a perspex box containing a
metal mesh floor, where they were allowed to get accustomed to their surroundings for ap-
proximately 15 min prior to testing (by which time cage exploration and major grooming
activities had ceased). Von Frey filaments were then applied to the mid-plantar surface of all
four paws through the wire mesh floor. Probing was only performed when the animal’s paw
was in contact with the floor. Each probe was applied to the foot until the filament bent,
and was kept in this position for 6-8 s [75]. The time interval between consecutive filament
tests was at least 5 s. The 50% withdrawal threshold was determined using the up-down
method of Dixon [75, 108]. In this paradigm, testing was initiated with the 2.0 g filament
(i.e. the filament in the middle of the series). Stimuli were always presented in a consecutive
fashion, whether ascending or descending. In the absence of a paw withdrawal response to
the initially selected filament, the next strongest filament was presented; in the event of paw
withdrawal, the next weakest filament in the series was chosen. The first paw withdrawal
response was selected as the second response in one series. Four additional responses, either
up or down, based on the rat’s respone completed the series (in total six responses, all close
to the 50% threshold).
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2.14. Tissue Fixation and Processing:
Animals in experimental groups were terminally anaesthetized and transcardially perfused
either 8 or 9 weeks after injury (for the lateral funiculotomy- and balloon compression models
respectively) with 4% PFA (pH 7.4). For a list of animal numbers per experimental group,
see Table 2.4. The spinal cords were removed, post-fixed, cryoprotected with 30% sucrose
and, for tissues obtained from the lateral funiculotomy lesion model (e.g. Figure 2.3), were
processed for serial longitudinal cryosectioning (section thickness, 20 µm). Sections were
collected onto 15 adjacent slides such that the effective interval between neighbouring sec-
tions on the same slide was 300 µm. For tissue obtained from the balloon compression injury
model, the spinal cord was divided into three blocks. Blocks A and C contained the trans-
plant areas caudal and rostral to the lesion epicentre (block lengths: 1.5 cm, Figure 2.2) and
block B contained the lesion site itself (block length 1 cm, Figure 2.2). Block B was processed
for serial transverse crysoectioning (section thickness, 20 µm), every fifth section was col-
lected onto 20 adjacent slides such that the effective interval between neighbouring sections
on the same slide was 2000 µm. A sample series, composed of each 4th slide was stained
with thionin (a form of Nissl stain) and were then used for morphometric analysis. In total,
twenty-five thionin stained sections per animal (with a spatial sampling interval of 400 µm)
were used to assess the amount of tissue sparing. The section with the least amount of tissue
sparing was considered to be the epicenter of the lesion. Block A and C were processed for
serial longitudinal cryosectioning (section thickness, 20 µm). Serial sections were collected
on 20 adjacent slides such that the effective interval between neighbouring sections on the
same slide was 400 µm. Two different slides (representating a total of 8 sections equally
distributed throughout the spinal cord) were processed for double immunofluorescence using
a range of different primary antibody combinations.
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Table 2.4.: List of animal numbers used in each experimental group.
Lateral funiculotomy lesion model N Balloon compression injury model N
plus implantation strategy
Lesion only 8
(control group)
Lesion + empty scaffold implantation + IS 9 Lesion + IS 8
(control group) (control group)
Lesion + hFbl seeded scaffold + IS 10 Lesion + hFbl implantation + IS 7
(control group) (control group)
Lesion + hNP-AC seeded scaffold + IS 11 Lesion + hNP-AC implantation + IS 8
(test group) (test group)
2.15. Morphological Investigations
2.15.1. Axon Regenerating/Axonal Sparings
In the compression injury model, the amount of regenerated and/or spared nerve fibers
was estimated by counting the number of NF200-positive pixel in three randomly chosen
images/section (400x magnification, area of interest: 222 µm x 166 µm, Figure 2.4A). To
assess the amount of axonal regeneration into the implanted scaffold, the number of NF200-
positive axons crossing 3 virtual lines within the scaffold were counted. These lines were
drawn 100 µm from the rostral and caudal graft-host interface and also at the mid-point of
the scaffold (Figure 2.5A).
2.15.2. Schwann Cell Migration
In the compression injury model, the extent of Schwann cell migration was estimated by
counting the number of p75-positive pixels within three randomly chosen images/section
(400x magnification, 222 µm x 166 µm, Figure 2.4B). Only limited migration of p75-positive
Schwann cells was observed following lateral funiculotomy and implantation of the collagen
scaffold, therefore quantitative evaluation was omitted.
2.15.3. Inflammatory Response
To assess the inflammatory response in the compression injury model, three randomly chosen
images/section were processed for Iba1-immunohistochemistry (e.g. Figure 2.4D). To assess
the extent of the inflammatory response to the implanted scaffold and/or cells, four images
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per antibody were chosen to represent the events at the rostral, caudal and lateral interfaces,
as well as within the centre of the scaffold (400x magnification, area of interest: 222 µm x
166 µm; e.g. Figure 2.5B). The inflammatory response to scaffold implantation was assessed
using ED1- and Iba1-immunohistochemistry. The intensity (i.e. mean grey value) of the
immunoreactivity was assessed in images that were captured using the same exposure time
using ImageJ. Data was standardised to the maximal possible mean grey value (i.e. value of
a completely white image).
2.15.4. Reactive Gliosis/CSPG Immunoreactivity
To assess the extent of reactive gliosis and CSPG deposition, immunostained sections were
photographed as described above for the inflammatory response (400x magnification, area
of interest: 222 µm x 166 µm for the compression injury model and area of interest: 116 µm
x 105 µm for the scaffold implantation strategy; Figure 2.4C and Figure 2.5C respectively).
The intensity of GFAP- and CSPG-(CS-56)-immunoreactivity was measured as described
above. For the comparison of the immunohistochemistry for particular antigens, the staining
procedure for all relevant samples were processed at the same time.
2.15.5. Survival of Transplanted Cells
Survival of transplanted cells was estimated by counting the number of animals with cells that
could be identified by immunohistochemistry for species specific antigens, e.g. antibodies
against human nuclei (i.e. for hFbl and hNP-AC) and human nestin (i.e. for hNP-AC).
2.15.6. Spared Tissue
Thionin staining was performed to enable (1) the identification of white matter and grey
matter in the spinal cord at low magnification, and (2) a clear discrimination between the
spared tissue and newly formed connective and vascular scar tissue following compression
injury. For morphometry, sections were captured by digital camera, and high-resolution
images were used to trace the areas of spared grey matter and white matter, respectively.
The identified areas in individual sections were measured using image analysis software
(GIMP). The graphical presentation of this data resulted in a U-shaped curve, and the
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center of the lesion was defined as a level at which the 2 halves of the U-shaped curve could
be most evenly divided.
Figure 2.4.: Schematic diagram of the evaluation of block B in the balloon compression injury model. To estimate the amount
of neurite ingrowth, Schwann cell migration, inflammatory response, gliosis and CPSG deposition three images for each antibody
were taken randomly (blue boxes). For an estimation of the neurite ingrowth into the lesion site, the number of pixels relating
to NF200-positive axons were counted (A). P75-positive Schwann cell migration was evaluated in the same manner (B). CSPG,
GFAP (C) and Iba1 (D) immunoreactivity were estimated by measuring the intensity of the immunofluorescence.
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Figure 2.5.: Schematic diagram of the morphometric evaluation of graft-host interactions after the lateral funiculotomy and
scaffold implantation. For an estimation of the neurite ingrowth into the scaffold after injury, all NF200-positive fibers crossing
the three individual lines (dotted, blue lines) were counted (A). The inflammatory response was assessed by taking four different
images at the indicated locations (blue boxes) for ED1 and Iba1 stained sections (B). CSPG and GFAP expression was also
measured using a similar protocol to that used for the inflammatory response. For this purpose the line of GFAP-positive cells
followed the midline of the images (dotted line, except for the dark shadowed middle box, C).
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2.16. Statistical Analysis
Data are plotted as mean ± standard error of the mean (SEM). Data was subjected to
an analysis of variance (ANOVA) followed by a Bonferroni’s test for multiple comparisons
between pairs of means (for the in vitro investigations) or followed by a Dunnett’s test for
comparisons between means (for the in vivo investigations). p values of < 0.05 were regarded
as significant (i.e * p < 0.05, ** p < 0.01, *** p < 0.001). All tests were performed using
statistical software GraphPad Prism version 4.0.
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3. Cell Characterisation, Cell-Cell and
Cell-Substrate Interactions
3.1. Introduction
Attempts to bridge the axon growth-inhibitory environment of the lesioned adult mam-
malian spinal cord have included the implantation of oriented growth-promoting tissues
(e.g. peripheral nerve) and, more recently, various biomaterials including oriented structures
that are capable of supporting directional axon regeneration and tissue repair (reviewed in
[14, 97, 308, 363, 480]). Attempts to design the ideal scaffold for such bridging strategies have
prompted numerous investigations of cell-substrate interactions. The influence of substrate
topography and chemical composition on cell form and function has thus become a subject of
increasing interest in the field of tissue engineering research [77, 78, 107, 384, 385, 480]. The
size and shape of 2D substrates coated with purified extracellular matrix (ECM) molecules
clearly influence the fate and function of adherent cells; for example, relatively large islands
of ECM have been reported to promote proliferation while, in stark contrast, small islands
induce apoptosis [77, 78, 384]. Furthermore, vascular endothelium cell-cell interactions have
been demonstrated to be critically dependent on the width of ECM substrate stripes: 50-
100 µm wide stripes only resulted in cell proliferation, while 30 µm wide stripes supported
cell-cell interactions that resulted in the formation of tubular (capillary-like) structures [107].
Other studies have shown that aligned ECM, as well as the micron-scale topography of fibres
or grooves, exert substantial effects on the guidance and orientation of neural cells and their
processes [50, 51, 159, 266, 289, 364, 462]. This is of particular interest in the development
of biomaterial-based scaffolds intended to promote the repair of nervous tissues which are
endowed with their own highly orchestrated and longitudinally oriented topographies, such
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as nerves of the peripheral nervous system (PNS) or white-matter tracts of the central ner-
vous system (CNS) [35, 276, 360, 407, 408]. In vitro studies have demonstrated the influence
of fibre diameter on the orientation of process outgrowth. The greater surface curvature
of small-diameter fibres prompted an increasing tendency for neurite outgrowth to follow
the longitudinal axis of the fibres: small-calibre fibres (5-30 µm diameters) promoted much
greater oriented process growth than large-calibre fibres (up to 500 µm diameter). It is
believed that this phenomenon is not due to chemotropism but rather to the topographical
effect of the fibre on neurite growth [386, 387]. Recent advances in nanotechnology and a
renewed focus on electrospinning has led to an interest in cell interactions with substrates in
the sub-micron range [364]. The ability of fibres with diameters in the sub-micron range to
affect the behaviour of non-neural cells [290, 406, 483] as well as neural cells of the PNS has
been demonstrated in in vitro assays [47, 86, 364]. Oriented fibres promoted longer axonal
extension than non-oriented fibres but fibre composition also has a role; functionalization
of polycaprolactone (PCL) fibre surfaces with type I collagen (C/PCL) or with the peptide
sequence GRGDS supported improved glial attachment, proliferation, migration, process ex-
tension and an enhanced rate of axonal growth [47, 86, 87, 364]. Collagens are among the
most popular materials in bioengineering, being used for soft- and hard-tissue (e.g. bone) re-
construction [346]. Biomaterials made from collagen have, until recently, offered a number of
advantages over many synthetic polymers, including biocompatibility, non-toxic degradation
products, and the induction of minimal foreign body responses [354, 355]. Collagen is also
amenable to controlled manipulation of its shape, microstructure, and stability including the
possibility to prepare 3D constructs [13, 84, 211]. The recent advances in surface modifica-
tion of electrospun substrates have resulted in many of the above mentioned advantages also
being applicable to synthetic polymer nanofibres [169]
Investigations of biomaterials in the context of regenerative medicine and nerve repair
have recently expanded to include the seeding of 3D scaffolds with neural progenitor cells
(or their derivatives) as a means of promoting optimal cell survival, integration and regen-
eration, e.g. [327]. Such studies have made it increasingly clear that a better understanding
of cell-substrate interactions, as well as cell-cell interactions within 3D scaffolds, is required
for the optimal design of biomaterial-based scaffolds and tissue engineering strategies in-
tended to promote functional repair. Although the potential benefits of implanting neural
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progenitor-derived type I rat astrocytes into experimental models of spinal cord injury have
been demonstrated [99], the axon growth promoting effects of the equivalent human cells,
alone or in combination with bio-engineered 3D scaffolds remain poorly defined, and in some
aspects are completely unknown. It is possible that the influence of scaffolds on the in-
teractions of (donor) neural progenitor-derived astrocytes with other populations of (host)
cells may have important consequences on the extent of graft-host integration as well as the
development of scarring or barrier-forming tissues around the implant.
Schwann cells and astrocytes occupy mutually exclusive territories within the nervous
system, being located in the PNS and CNS respectively. The only point where they come
into close contact with each other, in normal development, is in dorsal and ventral roots,
at the transitional zone where the spinal nerve roots enter the brain stem and spinal cord
[147, 148]. A boundary forms at such transitional zones between the PNS Schwann cells
and CNS astrocytes and these boundaries have been identified as natural barriers to cell
migration and axon regeneration, e.g. [73, 162, 270]. The formation of similar boundaries
has also been described following the implantation of peripheral nerve segments into the
CNS [98, 383, 470]. The cell-cell interactions that are pivotal to the establishment of such
boundaries include Schwann cell - astrocyte and fibroblast - astrocyte interactions, both of
which have been modelled in relatively simple 2D in vitro confrontation experiments [2–
4, 459, 464]. Although bioengineered 3D scaffolds intended for PNS or CNS repair will
ultimately host the infiltration and migration of a number of different cell types following
implantation into the recipient, the possible influence of scaffold topography on the ensuing
cell-cell interactions remains obscure.
The present in vitro investigation includes a study of the growth promoting properties of
hNP-AC in a simple 2D culture system. Astroglial interactions with electrospun PCL and
C/PCL fibres (i.e. adhesion, morphology, proliferation and migration) were also studied.
Although morphology and alignment of human astrocytes were clearly influenced by their
interactions with both fibre-types, the functionalisation of the surface of the nanofibres by
incorporation of type I collagen significantly improved the extent of cell migration by hNP-
AC. Furthermore the axon growth promoting effects of hNP-AC were investigated in more
complex 3D culture systems. The influence of a micro-structured, 3D collagen scaffold on
cell-cell interactions between the seeded hNP-AC and migrating Schwann cells/fibroblasts
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was also studied, revealing an interesting and possibly novel aspect in cell-substrate biology.
3.2. Results
3.2.1. Cell Characterisation
Characterisation of hNPC
The hNPC were grown as neurospheres which, by scanning EM, appeared as large, tightly
bound clusters of cells with heterogeneous morphologies: small diameter, rounded cells being
found on the surface of the neurospheres which were otherwise composed of a smoother, more
flattened population of cells (Figure 3.1A). Plating of the neurospheres onto PLL/laminin-
coated substrates caused rapid adherence, with the flattening of the sphere as cells migrated
away in a radial pattern. Scanning EM showed a close relationship between the flattened,
(presumably) astrocytic precursors and the migrating, bipolar, spindle-shaped (presumably)
neuronal precursors (Figure 3.1B). Immunocytochemistry of these non-differentiated migrat-
ing hNPC demonstrated a filamentous cytoskeletal distribution for nestin (91 ± 3% of cells;
Figure 3.2A), a diffuse cytoplasmic stain for Musashi (92 ± 2%; Figure 3.2B) and a nu-
clear distribution for SOX2 immunoreactivity (89 ± 3%; Figure 3.2C). Differentiated hNPC
demonstrated a few rounded, multiple process-bearing, O4-positive oligodendrocytes (6 ±
4% of cells; Figure 3.2F), as well as many flattened and process bearing astroglia and glial-
restricted progenitors which expressed GFAP- (30 ± 3%; Figure 3.2D), S100β- (66 ± 8%;
Figure 3.2E) and A2B5- (12 ± 9%; Figure 3.2D) immunoreactivity respectively, and also
bipolar, spindle-shaped, TuJ1-positive neuronal cells (32 ± 4% of cells; Figure 3.2E).
Figure 3.1.: Scanning electron microscopy of hNPC A: Low magnification image of a neurosphere. B: A bipolar cell (likely
neuroblast) growing on top a flattened cell (likely astrocytic).
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Figure 3.2.: Stem cell marker expression and differentiation capacity of hNPC. A-C: Characterization of undifferentiated
cells plated onto PLL/laminin for 1 day, with antibodies recognising nestin (A), Musashi (B) and SOX2 (C ). The expression of
these markers shows the progenitor characteristics of these neural cells. D-E: Cells grown in differentiation media for 1 week
showing immunoreactivity for GFAP (green, D) and A2B5 (red, D), S100b (green, E) and Tuj1 (red, E), and O4 (red, F ).
These markers show the potential of the hNPC to differentiate into astrocytes, neurons and oligodendrocytes. Scale bar in E
for B-E.
Characterisation of hNP-AC
Plating of the differentiated hNP-AC astrospheres onto a PLL/laminin-coated substrate
also caused rapid adhesion and flattening of the sphere with a radial pattern of cell migra-
tion. Immunocytochemistry of these differentiated, migrating hNP-AC revealed that they
were GFAP- and vimentin-positive (>95% purity; Figure 3.3A-C), as well as CD44-positive
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(Figure 3.3A). Only occasional TuJ1- or Map2a+b-positive neurons could be found after
incubation in the LIF- and BMP4-containing differentiation medium (arrow; Figure 3.3D).
Gene expression analysis: RT-PCR was used to confirm that the LIF/BMP4-mediated dif-
ferentiation was associated with a significant up-regulation of GFAP- and CD44-mRNA (p
< 0.01 and p < 0.001 respectively; Figure 3.3E, F).
Figure 3.3.: hNP-AC express GFAP, vimentin and CD44 A-C: Immunofluorescence of hNP-AC at passage 3. A: Cells are
positive for the astroglial marker GFAP (green) and the surface marker CD44 (red). B: The vast majority of cells are GFAP
(green)-positive astroglia while only occasional cells were positive for the early neuronal marker TuJ1 (red, arrow). C: Almost
all cells GFAP (green)-positive hNP-AC are also vimentin (red)-positive. The expression of the markers GFAP, vimentin and
CD44 together identifies the cells as immature astrocytes. D: Histogram showing the estimated purity of the hNP-AC cultures.
Only 4.1% and 1.2% of cells stained with the neuronal markers MAP2a+b and TuJ1 respectively (n=9 images). E: RT-PCR
of hNPC and hNP-AC: Differentiation to hNP-AC is associated with an increased expression of GFAP and CD44 mRNA. F:
Quantification of CD44 and GFAP up-regulation following hNP-AC differentiation. Values normalised to GAPDH expression
(n=4). Data represent means ± SEM, ** p < 0.01, *** p < 0.001.
Chapter 3. Cell Characterisation, Cell-Cell and
Cell-Substrate Interactions 60
3.2.2. Axon Regeneration by Dissociated Adult Rat DRG
Quantification of DRG axon regeneration over 2D hNP-AC substrates: Dissociated DRG
were seeded onto PLL/laminin-coated tissue culture plastic and incubated in DRGM as an
example of axonal growth on a positive control (i.e. axon growth-promoting) substrate (e.g.
Figure 3.4A). DRG outgrowth was also assessed on the PLL/laminin-coated substrate follow-
ing incubation in hNP-AC conditioned medium (hNP-AC-CM, e.g. Figure 3.4B), as well as
on confluent hNP-AC cultures (e.g. Figure 3.4C) and on hNP-AC-derived ECM (e.g. Figure
3.4D). Seeding onto the PLL/laminin, positive control substrate, confirmed the presence of
enriched populations of DRG neurons with rounded cell bodies (55±6 µm in diameter) from
which multiple regenerating primary neurites grew (e.g. Figure 3.4A-D). There was very
little glial contamination of such cultures, as reported by others [102, 366]. The regenerat-
ing DRG neurites achieved substantial growth and arborisation patterns within 24 hours,
generating a relatively symmetrical halo of NF200/MAP2a+b-positive neurites around a
centrally-positioned cell body (Figure 3.4A-D). Quantification of total neurite length re-
vealed that axonal growth over hNP-AC was significantly greater than that seen over the
PLL/laminin, positive control substrate (p < 0.001; Figure 3.4E, Table 3.1). Similarly strong
neurite outgrowth was supported by the hNP-AC-ECM but the greatest overall neuritic ex-
tension was seen over the PLL/laminin substrate supported by hNP-AC-CM (p < 0.001;
Figure 3.4E, Table 3.2). This however, did not reach statistical significance when compared
with neuritic growth over the hNP-AC or hNP-AC-ECM (p > 0.05; Figure 3.4E, Table 3.1).
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Figure 3.4.: hNP-AC-ECM as well as the conditioned medium enhance neurite outgrowth. A-D: NF200/MAP2a+b im-
munoreactive DRG neurite regeneration over PLL/laminin control substrate (A), over PLL/laminin plus hNP-AC-CM (B),
over confluent, viable hNP-AC (C ), and over hNP-AC-ECM (D). E: Histogram of the overall neurite outgrowth, standardized
to that over the PLL/laminin control substrate. Significantly greater neuritic outgrowth is observed over hNP-AC, hNP-AC-
ECM and PLL/laminin plus hNP-AC-CM. Scale bar in D for A-D. Data represent means ± SEM, n=100, *** p < 0.001
compared to PLL/laminin positive-control substrate
Table 3.1.: Quantification of the extent of neuritic outgrowth from dissociated DRG neurons over the different substrates.
PLL/laminin hNP-AC hNP-AC-ECM hNP-AC-CM
Overall neurite outgrowth [µm] 3581±236 5083±174 9206±471 10633±503
standardised 1±0.07 1,419±0.05*** 1,413±0.07*** 1,633±0.08***
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3.2.3. Orientated Nanofibres
Scanning EM of oriented PCL & C/PCL nanofibres: Highly oriented PCL or the blended
C/PCL nanofibres were prepared by electrospinning and collected onto sPEG-coated glass
coverslips. Similar to previous reports [364], the diameter of both types of nanofibre was
in the sub-micron range (PCL nanofibres mean diameter ± standard deviation: 564.4 ±
208.8 nm; C/PCL nanofibres: 601.4 ± 151.2 nm) [159]. These fibres were uniform in di-
ameter, highly oriented and could be collected at both high and low density (Figure 3.5).
An estimation of the density of nanofibres collected under low density conditions (i.e., short
electrospinning times) was obtained by counting the number of fibres crossing a sample line
(345 µm in length) drawn perpendicular to the axis of the fibres. Under these conditions,
the density of oriented PCL nanofibres was 60 ± 14 fibres/mm (average interfibre distance
16.6 µm) and, for C/PCL fibres, was 57 ± 7 fibres/mm (average interfibre distance of 17.4
µm) [159]. High-density fibres were spun to generate a dense mat of oriented fibres that
covered the glass coverslips completely.
Figure 3.5.: Scanning electron microscopy of oriented PCL nanofibers. Electrospun C/PCL fibers are similar and therefore
are not shown. A: Low density, oriented nanofibers. B: High density, oriented nanofibers. Electrospun nanofibers of either
polycaprolactone or C/PCL are largely uniform in diameter and unbranched.
Cell Adhesion & Proliferation/Survival
Adhesion and proliferation/survival assays were used to establish the cytocompatibility of
the PCL and C/PCL nanofibres. Very few cells bound to the poorly adhesive sPEG sub-
strate (which served as a negative-control substrate). The functionalised C/PCL nanofibres,
however, demonstrated a significant improvement in adhesion when compared with the PCL
Chapter 3. Cell Characterisation, Cell-Cell and
Cell-Substrate Interactions 63
nanofibres or PLL substrates (p < 0.05; Figure 3.6H). As a second measure of the suitability
of the nanofibres for CNS-related cell interactions, the survival and proliferation of the cells
that were bound to the nanofibres were assessed by comparing the number of bound cells
detected at 1, 4 and 7 DIV to the number of cells that were initially seeded. No proliferation
of hNP-AC could be detected over 1, 4 and 7 DIV on either PCL or functionalised C/PCL
nanofibres. This effect was not brought about by nanofibre-induced cytotoxicity to hNP-AC
because both immunocytochemistry and DAPI staining failed to reveal necrotic cells, cellular
debris or fragmented nuclei. The only statistically significant increase of hNP-AC numbers
was observed on the PLL-substrate between 4 and 7 days post-seeding (p < 0.05; Figure
3.6G).
Cell Morphology & Process Length
The morphology of hNP-AC on all substrates was investigated by double immunofluores-
cence for the cytoskeletal proteins GFAP (green) and vimentin (red; Figure 3.6A-F) as well
as by scanning EM (Figure 3.7). hNP-AC grown on the PLL surface adopted a pleiomor-
phic, “fried-egg”-type morphology with only a small proportion of cells showing clear process
formation (Figure 3.3C). All hNP-AC were vimentin- and GFAP-immunoreactive. By 1 and
4 DIV, most nanofibre-bound hNP-AC had adopted either a unipolar or bipolar morphology
(e.g. Figure 3.6A-F). The length of the processes of hNP-AC had already reached well over
100 µm by 1 DIV on both fibre types (hNP-AC on PCL: 124 ± 25.9; hNP-AC on C/PCL:
125.3 ± 27.2; p > 0.05 for all comparisons; Figure 3.6I). Scanning EM clearly revealed the
close interaction between hNP-AC and the nanofibres. Single cells that adhered to individual
fibres demonstrated a strong tendency to align their processes in parallel with the orientation
of the nanofibres, the slender processes growing directly over the surface of the nanofibres
(Figure 3.7A-B). Following the seeding of hNP-AC suspensions onto nanofibres, cells occa-
sionally managed to span the gap between adjacent fibres, spreading their cell bodies in a
flattened, sheet-like manner (Figure 3.7A-B). This behaviour was even more pronounced in
the area of cell migration immediately adjacent to the zones of astrosphere placement (Fig-
ure 3.7A). In areas where hNP-AC suspensions settled, by chance, in higher numbers they
demonstrated the capacity to form bundles of multiple processes that followed the orienta-
tion of single nanofibres. Where the cell density was high enough, even the areas between
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nanofibres became populated with oriented cell bodies and processes (Figure 3.7A-B).
Figure 3.6.: hNP-AC align their processes along PCL and C/PCL nanofibres. A-F: Immunofluorescence for GFAP (green)
and vimentin (red). Morphology and aligned process extension of hNP-AC along PCL (A-C ) and C/PCL nanofibres (D-
F ). A non-oriented pleiomorphic appearance is adopted by most hNP-AC when allowed to spread freely on a non-oriented
substrate (see Figure 3.3C for an example). Orientation of nanofibres is indicated by the double-headed arrow. G: Survival and
proliferation of cells on PCL and C/PCL nanofibres after 1, 4 and 7 days. hNP-AC demonstrate no proliferation over 7 days on
either PCL or C/PCL nanofibres (p > 0.05). Cell proliferation is, however, apparent on the PLL (positive control) substrate,
being significantly greater than that on PCL or C/PCL at 7 days (** p < 0.01, *** p < 0.001; n=15 images). H: Quantification
of cell adhesion of hNP-AC to sPEG (negative control), PCL nanofibres, C/PCL nanofibres and PLL (positive control) positive
control substrate. Few hNP-AC adhere to the sPEG substrate. hNP-AC adhere equally well to PCL nanofibres and the PLL
substrate (p > 0.05). hNP-AC adhesion to C/PCL nanofibres is significantly greater than that on PCL nanofibers or PLL (** p
< 0.01; n=15 images). I: Quantification of process length, measured at 1 DIV after seeding onto PCL and C/PCL nanofibres.
hNP-AC extend processes of similar length on both types of nanofibre (p > 0.05; n=50 processes). Scale bar in F for A-F.
Extent of Cell Migration along Nanofibres
The migration of hNP-AC along PCL and C/PCL nanofibres was investigated at 2 DIV after
astrosphere adherence to the fibres. Cell migration away from the astrospheres resulted in an
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elliptical distribution of cells around the astrosphere, with the greatest migration following
the orientation of the nanofibres (Figure 3.7A-B). In contrast cell migration away from
astrospheres plated onto the PLL-coated substrate was uniform in all directions. The PLL-
coated substrate acted as a non-oriented, positive control for cell migration. Migration by
hNP-AC on both nanofibre substrates was significantly better than that demonstrated on
PLL and was clearly enhanced on the functionalised C/PCL nanofibres (p < 0.01; Figure
3.7C).
Figure 3.7.: hNP-AC migrate further on C/PCL nanofibres compared to PCL nanofibres or PLL substrate. A-B: Scanning
electron microscopy of migrating hNP-AC from astrosphere preparations. A: Low magnification of the sheet of densely packed
cells, having just migrated away from the astrosphere. To the left of the image, individual cells associated with single fibres
have adopted an elongated, spindle-shaped morphology. Migration of cells away from the astrosphere is strongly influenced by
the nanofibre substrate; cells following the orientation of the fibres migrate for significantly greater distances than those that
attempt to migrate perpendicular to the main axis of nanofibre orientation. This results in an ovoid distribution of cells around
the astrosphere. B: Higher magnification of hNP-AC that have migrated a short distance away from the astrosphere. Sheets of
overlapping, flattened cells can be seen that still adopt a longitudinal orientation. Other more rounded and process bearing cells
can be seen growing over the surface of the flattened cells. Orientation of nanofibres is indicated by the double-headed arrow.
C: Quantification of migration of hNP-AC along PCL and C/PCL nanofibres after 2 days. hNP-AC migration is significantly
improved by functionalization of the nanofibre surface, being significantly greater on the C/PCL than on the PCL nanofibres
(*** p < 0.001; n=9 spheres).
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3.2.4. Micro-porous Collagen Scaffolds
Scanning electron microscopy of the 3D type-I collagen scaffolds: scanning EM revealed
that the scaffolds were composed of tightly packed and longitudinally oriented pores (Figure
3.8A-C). Higher magnification demonstrated that the longitudinally oriented pores were
interconnected via numerous fenestrations in the scaffold walls (Figure 3.8B). Scanning EM of
cross sections of the collagen scaffold demonstrated that the micro-channels had a profile that
was disc-shaped (e.g. highlighted in red Figure 3.8C). Quantitative morphometry revealed
that the shortest distance between the flattened edges of the disc-like micro-channels was
approximately 84 ± 4.5 µm.
Figure 3.8.: Scanning EM of the highly orientated collagen scaffold. A-B: Low and high magnification images demonstrate
the uniform orientation of the microchannels. The average distance between the (roughly) parallel walls of the scaffold is
84±4.5 µm. C: Scanning EM of a cross section of the collagen scaffold demonstrates that the microchannels have a transverse,
disc-shaped, profile (e.g. highlighted in red).
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Cell-Substrate Interactions Following the Seeding of hNP-AC on to 3D Collagen
Scaffolds
The 3D collagen scaffolds were hydrophilic and became rapidly hydrated when incubated
with an excess volume of cell suspension. By as early as 1 day in vitro (DIV), hNP-AC
demonstrated an even distribution throughout the whole scaffold (e.g. Figure 3.9A). How-
ever, by 14 DIV, proliferation and redistribution had resulted in the formation of cell columns
which followed the internal orientation of the scaffold micro-channels (Figure 3.9B, D). Quan-
tification of the DAPI-labelled nuclei within the sections demonstrated an increase in the
number of hNP-AC over the 14 day period (Figure 3.9E). This rate of proliferation is the
equivalent to a doubling time of 5.0 ± 0.1 days which compares with that of 3.2 ± 0.06 days
by hNP-AC on PLL/laminin-coated tissue culture plastic.
Figure 3.9.: hNP-AC proliferate and grow as orientated columns of cells which follow the orientation of the micro-channels.
A-B: Cryosections reveal DAPI-labelled hNP-AC within the collagen scaffolds at 1 day (A) and 14 days (B) post-seeding. The
double headed arrow in (B) indicates the orientation of the pores. C-D: High magnification scanning EM of the orientated
scaffold (C ) and the DAPI-labelled hNP-AC (D). E: Quantification of the DAPI-labelled hNP-AC nuclei demonstrates cell
proliferation on the scaffold. The different symbols represent the data from three independent experiments. Scale bar in B for
A and B.
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Cell-Cell Interactions and Axon Growth Promoting Properties of hNP-AC Seeded
Collagen Scaffolds
Hemisected DRG adhered well to the surface of both seeded- and the non-seeded scaffolds
and extended NF200-positive axons into the orientated micro-channels (e.g. Figure 3.10A,
red signal). Regenerating neurites were mostly associated with migrating, S100β-positive,
GFAP-negative spindle-shaped, Schwann cells (Figure 3.10A, F for an example of neurofil-
ament (red) and S100β (green) staining). However, some of the regenerating axons were
also associated with either cell-free regions, or with S100-negative fibroblasts or GFAP-
positive hNP-AC. Seeded hNP-AC were immunohistochemically identifiable by their intense
staining for human nestin and human nuclei (Figure 3.10D-E). Double immunofluorescence
demonstrated that hNP-AC were also intensely immunoreactive for S100β and GFAP (Fig-
ure 3.10D-E). The majority of the seeded hNP-AC adopted a flattened morphology with no
clear indication of cell orientation (e.g. Figure 3.10E and Figure 3.11D), however, in those
instances where processes were detectable, they tended to demonstrate an orientation that
followed the longitudinal axis of the micro-channels (e.g. Figure 3.10D and Figure 3.11A).
Where seeded hNP-AC happened to be located near the surface of the scaffold (i.e. close
to the cut surface of the hemisected DRG), they were often found to be intermingled with
columns of NF200-positive axons and Schwann cells (Figure 3.10G). Rather surprisingly,
migrating vimentin-positive fibroblasts and p75-positive Schwann cells exhibited close spa-
tial relationships with the seeded hNP-AC (Figure 3.11A-C, Figure 3.11D-F respectively).
The migrating fibroblasts possessed large, DAPI-labelled nuclei with a polymorphic, flat-
tened vimentin-positive/GFAP-negative cell cytoplasm and appeared to intermingle freely
with the vimentin-positive/GFAP-positive hNP-AC (Figure 3.11A-C). The cell bodies and
processes of migrating Schwann cells were p75-positive/GFAP-negative and followed the lon-
gitudinal orientation of the scaffold, often following a trajectory that brought them in close
association with the seeded hNP-AC (Figure 3.11D-F). A fibronectin-rich ECM was found
to be evenly distributed throughout the whole scaffold (Figure 3.11G-I).
Quantification of cell migration and axonal growth into the scaffold demonstrated that the
presence of hNP-AC had no effect on the migration of p75-positive Schwann cells from the
hemisected DRG explants (Figure 3.12B). However, hNP-AC did influence the extent of axon
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growth, with a statistically significant increase of the 10% longest NF200-positive neurites
found within the scaffold. The 10% longest axons within non-seeded scaffolds extended for
737±15 µm while the value for axon regeneration in to hNP-AC seeded scaffolds was 817±24
µm (p < 0.01; Figure 3.12A).
Figure 3.10.: Cell-substrate and cell-cell interactions in the 3D collagen scaffold. A: S100β-positive Schwann cell (green)
migration and NF200-positive (red) axon regrowth from hemisected adult rat DRG closely follow the orientation of the mi-
crochannels. B,C: Schematic diagram of the experimental design for investigating cell migration and axon growth from hemi-
sected DRG (red) placed onto the surface of non-seeded (B) and hNP-AC seeded (green stars, C ) scaffolds. D: Small clusters of
S100β-positive (green)/human nestin-positive (red) hNP-AC within the microchannels. Unlike the migrating Schwann cells, the
seeded hNP-AC generally fail to extend long processes that follow the orientation of microchannels. E: Flattened morphology
of the seeded GFAP-positive (green)/human nuclei-positive (red) hNP-AC within the microchannels. F: Not all bundles of mi-
grating Schwann cells deep within the scaffold are associated with regenerating axons. Only 1 of these 2 parallel S100β-positive
(green, arrow) Schwann cell bundles contains NF200-positive (red) axons. G: GFAP-positive (green) hNP-AC can be found in
association with the regenerating NF200-positive (red) axon bundles, close to heir exit point form the hemisected DRG. Double
headed arrows indicate the pore orientation for each series of images.
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Figure 3.11.: Cell-cell interactions within the 3D collagen scaffold. A-C: Some GFAP-positive (green) seeded hNP-AC extend
processes which appear to follow, to some extent, the orientation of the scaffold, where they can be seen intermingling with
vimentin-positive (red) fibroblasts. D-F: The majority of the GFAP-positive (green) hNP-AC adopt a flattened morphology
which does not follow the orientation of the scaffold, but which comes into close contact with the cell bodies and orientated
process of migrating p75-positive (red) Schwann cells. G-I: The loose fibrillar distribution of the ECM molecule, fibronectin
(green), is extensively distributed throughout the whole scaffold and is most likely produced by the migrating vimentin-positive
(red) fibroblasts. Double headed arrows indicate the pore orientation for each series of images.
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Figure 3.12.: hNP-AC promote greater neurite extension into the scaffold. A: The seeded hNP-AC significantly increase the
extent of axon regeneration through the scaffolds. B: Non-seeded (control) collagen scaffolds supported migration by Schwann
cells, the extent of which was not affected by the presence of hNP-AC (** p < 0.01; n=6 slides).
3.3. Discussion
Advances in biomaterial engineering and their potential contribution to regenerative medicine
for neural tissue repair is a rapidly expanding area of interest. The development of scaffold
concept and design requires a fundamental understanding of the influence that such engi-
neered substrates may exert on adherent cell morphology and function, e.g. [77, 384]. This
not only includes the ability of substrate bound cells to promote axon regeneration but also
the influence of the substrate on cell-cell interactions. Substrate geometry has demonstrated
a profound influence on adherent cell behaviour [77, 78, 107, 384, 385]. Aligned ECM, as
well as micron- and submicron-scale topography of the substrate have been demonstrated to
exert substantial effects on neural cell form and function [50, 51, 86, 159, 266, 289, 364, 462].
This is of particular interest for the development of biomaterial-based scaffolds intended to
promote regeneration of peripheral nerves or CNS white matter tracts which are endowed
with their own, highly orchestrated geometries, e.g. [35, 276, 360, 407, 408]. The intrinsic
geometry of such PNS and CNS fibre pathways has been reported to play an important role
in the success or failure of axonal regeneration [319, 320]. Earlier cell implantation studies
of grafting immature astrocytes into experimental animals with CNS or spinal nerve root le-
sions (either alone or in combination with crude scaffolds composed of Millipore filters) have
demonstrated some beneficial effects in terms of reduced host scarring and increased host
axon regeneration [236, 390, 454]. More recent studies have identified that type I rat astroglia
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are capable of promoting CNS tissue repair in the absence of unwanted side-effects [99, 100].
The mechanisms by which the equivalent, human-derived cells exert their axon growth pro-
moting effects in simple 2D culture systems as well as in more complex, scaffold-associated,
3D systems remain largely unknown. Furthermore, the interactions between immature astro-
cytes and the crude scaffolds of earlier studies or with more modern, sophisticated scaffolds
or nanofibers have been obscure.
3.3.1. Cell Characterisation
In the present investigation, it was important to demonstrate that the human cells un-
der investigation actually conformed to the current descriptions of neural progenitors and
progenitor-derived type-I astrocytes. The hNPC were characterised by the expression of
progenitor-related markers nestin, SOX2 and Musashi [256, 358, 476] and were able to dif-
ferentiate into neurons, astrocytes and oligodendrocytes. Differentiation with BMP4 and
LIF induced elevation of mRNA levels and immunoreactivity for GFAP and CD44, confirm-
ing the generation of human neural progenitor-derived immature astrocytes, as described
by others [461]. Mature, adult rat-derived DRG neurons were chosen for the axon growth
promoting assays because their properties were likely to be more representative of the cell
types that would be axotomised by traumatic injury to the nervous system. The use of im-
mature, embryo-derived DRG by other groups might be less representative since they have
been shown to be less responsive to inhibitory cues in their environment [18, 131].
3.3.2. Axon Growth Promoting Properties of hNP-AC in 2D Cul-
tures
Previous studies had demonstrated that the axon growth promoting properties of experimen-
tal animal-derived astroglia are likely to be due to the production of extracellular matrix
(including laminin and fibronectin) as well the expression and release of certain growth factors
(including bFGF, BDNF and NGF) [113, 329, 463]. It was possible to extend this informa-
tion by demonstrating that both ECM- and growth factor-mediated mechanisms were also
involved in the potent axon-growth promoting effects of the human progenitor-derived as-
troglia. However, the identification of the specific ECM- and growth factor-related molecules
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involved in this process was beyond the scope of the present investigation. The influence
of the ECM, particularly of laminin, on axonal growth and regeneration is well established
[173, 272]. Therefore PLL/laminin substrate coating was chosen as a positive control for
the 2D experiments. Even though this control substrate was able to support extensive neu-
ritic outgrowth, surprisingly greater regeneration was supported by the viable hNP-AC, by
hNP-AC-ECM and by hNP-AC-CM. This suggests that hNP-AC represent a promising cell
type for consideration in future tissue engineering strategies to promote functional repair in
animal models of traumatic CNS and spinal root injury.
3.3.3. Cell-Substrate Interactions of hNP-AC on Orientated Nanofi-
bres
Advances in nanotechnology have led to an interest in cell interactions with substrates in
the sub-micron range. Electrospun nanofibres have been used to generate oriented and
non-oriented structures that, to some extent, can mimic the properties of the extracellu-
lar environment [49, 480]. The ability of nano-structured surfaces or nanofibres to affect
the behaviour of non-neural cells [290, 406, 452, 483] as well as neural cells of the PNS
has been demonstrated in vitro [86, 364]. Cell adhesion, survival and proliferation were
well supported but morphology and alignment were altered strikingly by oriented nanofi-
bres, promoting longer axonal growth than seen on the non-oriented fibres [86, 87]. It has
therefore become clear that oriented nanofibres may have a significant role in the design
of scaffolds intended to promote axon regeneration in the PNS. However, their potential
role in bridging CNS lesions remains uncertain. As a first step in assessing this potential,
nanofibre-astroglial interactions were studied in vitro. Both cell adhesion and migration by
hNP-AC were significantly enhanced by nanofibre functionalisation with collagen. However
no proliferation on the nanofibres was observed. The lack of an effect of type I collagen
on hNP-AC proliferation supports previous in vitro investigations, which demonstrated in-
creased proliferation of rat astrocytes only when grown on laminin and fibronectin, but
not on type I collagen [296]. Cells grown on the unpatterned PLL substrate spread freely
and adopted a pleiomorphic appearance, whereas most of the cells that were seeded onto
nanofibres had small cell bodies and long, thin, unipolar- or bipolar morphologies. A clear
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relationship between cell spreading and proliferation has been demonstrated by Ingber and
colleagues. Cells growing on uniform, unpatterned surfaces showed the highest proliferation
rate, whereas cells grown on progressively smaller islands of adhesive substrate showed pro-
gressively restricted spreading and lower proliferation rates, and the smallest islands induced
apoptosis [77, 384]. Although the present investigation compared cell-substrate interactions
on two types of nanofibres, it would have been of interest to include observations of the
behaviour of cells seeded onto smooth surfaces coated with either PCL or C/PCL. Such
comparisons, enabling the demonstration of the roles played by substrate nanofeatures, were
unfortunately not included. Migration of hNP-AC on PCL nanofibres was greater than on the
PLL-positive-control substrate. However cells migrated furthest on the C/PCL nanofibers.
Cell migration requires the formation of focal-adhesion points between the cell and the ex-
tracellular substrate. Focal adhesions are macromolecular complexes that physically link the
ECM to the contractile actin cytoskeleton [457]. The most important molecular receptors for
ECM binding are integrins [20]. Since integrins bind directly to collagen [254], the improved
cell migration of hNP-AC on C/PCL nanofibres might not be a surprise. In addition, an
indirect binding between collagen and integrin receptors may be mediated by fibronectin
[157]. This may also have occurred in our cell cultures because fibronectin may have been
present in the serum-containing medium or may have been secreted by the cells themselves.
ECM-integrin interactions are known to activate a variety of intracellular signal cascades.
This may result in potential synergistic effects between growth factor and integrin signal-
ing [157]. It might thus be possible to further increase the migratory behaviour of cells on
electrospun fibres by (I) incorporation of other ECM molecules, e.g. fibronectin or laminin
into the blend for electrospinning; (II) chemical modification of PCL fibres to present spe-
cific integrin-activating peptides, such as GRGDS, IKVAV and YIGSR; and (III) combining
ECM molecules with soluble factors that may act synergistically with the integrin-activated
pathways (e.g., bFGF, TGF-β or PDGF) [47, 97, 135]. Functionalisation of the scaffold, as
seen here, by the incorporation of ECM components (i.e., type I collagen) or even by the
incorporation of growth factors (or other growth-promoting molecules) has the potential of
improving the performance of such scaffolds [214]. The ECM molecule, type I collagen, was
chosen for surface functionalisation of the PCL nanofibres because it is a natural polymer
that can be mixed and electrospun with PCL and is known to activate axonal and glial inte-
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grin receptors capable of supporting cell adhesion and migration [423, 437]. However, it has
recently been reported that electrospinning results in the denaturation of up to 99% of the
collagen to gelatine, especially when fluoroalcohols are used as a solvent [478]. The extent
to which collagen was denatured to gelatine in the present investigation remains uncertain,
however, the effect of surface functionalisation of the interactions of hNP-AC were clear.
3.3.4. Cell-substrate Interactions between hNP-AC and Orientated
3D Collagen Scaffolds
Scanning EM demonstrated that the scaffold was composed of large diameter (84±4.5 µm
for the shortest distance), highly oriented pores that, when viewed in transverse section had
an overall flattened or disk-like appearance. This is somewhat different to honeycomb-like
appearance of a small-pore scaffolds that were described earlier [50, 51, 289]. The initial
seeding of the scaffolds in the present study was highly efficient with a rapid and even distri-
bution of the hNP-AC throughout the entire structure. This observation is in contrast to the
seeding efficiency of the smaller pore sized collagen scaffold reported earlier, where seeding
of rat Schwann cells, olfactory ensheathing cells, early postnatal astrocytes or differentiated
human neuroblastoma cells (SH-SY5Y) cells showed only limited penetration of the scaffold
followed by subsequent migration to deeper regions [51, 289]. The hNP-AC of the present
study demonstrated a novel cell-substrate interaction within the scaffold: by 14 days, there
was a clear redistribution of the cells such that columns of densely packed hNP-AC could be
seen throughout the scaffold. It is possible that this redistribution took place by migration
and accumulation of the cells at particular foci, suggesting that cell-cell adhesive interac-
tions between hNP-AC may have been greater than those between the seeded cells and the
substrate e.g. [356]. An alternative explanation might be the occurrence of cell death in
some regions of the scaffold being counter-balanced by proliferation in others. Counting of
the DAPI labelled nuclei did reveal a significant increase of hNP-AC numbers within the
scaffold over the 14 days in vitro (calculated doubling time of 5.0±0.1 days), but there were
no indications of extensive cell death, such as by the presence of nuclear fragmentation.
Although others have described type-I collagen to be a poor substrate for astrocyte prolif-
eration in 2D cultures [296], the present data supports the now widely acknowledged notion
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that cell behaviour in 2D studies does not necessarily reflect their behaviour in 3D environ-
ments [1, 26, 91]. The proliferation of hNP-AC within the scaffold is of major importance
because it not only shows the ability of the scaffold to act as a cell carrier but also allows
the diffusion of sufficient nutrients to support proliferation.
3.3.5. Axon Growth Promoting Properties of hNP-AC Seeded 3D
Scaffolds
Previous studies have demonstrated that non-seeded, micro-structured collagen scaffolds are
able to support significant orientated axon regeneration [50, 51, 153, 289]. The present ob-
servations revealed that hNP-AC seeded scaffolds support significantly greater DRG axon
regrowth than non-seeded scaffolds. Most of the axonal growth through the scaffold was
closely associated with bundles of Schwann cells that had migrated out of the DRG explant
and which followed the longitudinal orientation of the micro-structured pores. Schwann cells
are potent axon growth-promoting cells which present directional cues to regenerating ax-
ons [33, 58, 428]. However axonal growth was occasionally not found to be associated with
Schwann cells or their processes, but could be seen to be associated with acellular regions
of the scaffold or with fibroblasts or hNP-AC. Although DRG axon growth in the acellular
regions of orientated collagen scaffolds has been reported by others (e.g [50]), the present
investigation extends the understanding of such events by demonstrating that substantial
deposits of the ECM molecule, fibronectin, could be found within the porous micro-channels.
Fibronectin has already been demonstrated to support axon regeneration and is mainly ex-
pressed by fibroblasts, but also by Schwann cells and astroglia [88, 112, 350, 353, 441]. This
raises the possibility that axons not only used the type I collagen micro-channel walls as
substrates for growth but also local ECM deposits. Others have reported that loading colla-
gen scaffolds with fibronectin leads to axon regeneration by DRG but the authors failed to
compare fibronectin containing scaffolds with empty scaffolds [153]. The relatively low seed-
ing density of hNP-AC made it unlikely that contact-mediated mechanisms would account
for much of the enhanced DRG axon regeneration. However, it is possible that the release
of soluble factors (which would have become trapped and accumulated within the inter-
nal micro-architecture of the scaffold) may have influenced the extent of axon regeneration.
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Astrocytes have been reported to express a range of growth factors including bFGF, NGF
and BDNF [113, 463] and the present investigation has shown that hNP-AC conditioned
medium has potent effects on DRG axon growth in simple 2D cultures. It was also feasible
that factors produced by hNP-AC may have altered the number of Schwann cells migrating
into the scaffold [3, 4], and thus influenced axon growth via an indirect mechanism, however
quantification of Schwann cell migration proved that this was not the case.
A surprising observation was the extent to which migrating Schwann cells and fibroblasts
intermingled with the seeded hNP-AC. Under normal conditions, Schwann cells and astro-
cytes form distinct territories with a clear boundary [270], as do fibroblasts and astrocytes
[376, 377]. Such boundaries exert considerable influence over the ability of regenerating ax-
ons to cross from one territory to the other and their effects have been studied in detail in
2D in vitro assays [163, 164, 377]. The present investigation has demonstrated that when
these cells encountered each other within an orientated 3D scaffold, substantial intermixing
- rather than mutual repulsion was evident. This raises the exciting possibility that the
topography of the scaffold may have altered the properties of one or more populations of
cells. However, one cannot discount the possibility that the intermixing of the cells was also
encouraged by the relatively low densities of the 2 populations of cells within the scaffold.
Nonetheless, under other experimental conditions, Schwann cells and astrocytes have also
been encouraged to intermingle with each other extensively [56, 61]. Microtransplantation of
highly purified populations of Schwann cells, in the form of elongated columns of cells, into
the adult rat CNS resulted in the eventual intimate mixing of orientated donor Schwann cell
processes with similarly oriented reactive host astrocytic processes within individual basal
lamina tubes. The Schwann cells and astrocytes within the resulting chimeric PNS-CNS
pathway were subsequently seen to cooperate with each other in supporting directional host
axon regeneration [56, 61]. A novel outcome of the present investigation is that the micro-
topography of the 3D collagen scaffold may have also encouraged a similar type of mixing
behaviour between Schwann cells/fibroblasts and hNP-AC.
The ability of biomaterials to influence the behaviour of neural progenitor-derived astro-
cytes, shifting their shape from a pleiomorphic appearance to a highly oriented one (as seen
with nanofibres) and reducing the tendency of CNS and PNS glia to form mutually exclusive
territories (as seen with the 3D collagen scaffold), may be of particular interest for CNS-
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repair strategies. Lesions to the CNS induce a reactive astroglial response that includes
scarring and new basal lamina and chondroitin sulfate proteoglycans deposition. Such re-
active astrocytic responses are important for protecting adjacent intact nervous tissue from
further damage but also contribute to the axon-growth inhibitory environment at and around
the lesion site [129, 376, 396]. However, axon growth-promoting properties of such reactive
astrocytes have also been described [265]. Furthermore, the processes of activated/reactive
astrocytes can be encouraged to support CNS axon regeneration, effectively chaperoning
re-growing axons across a host-graft interface [61, 228]. It is possible that the ability of bio-
materials to modify astrocytic morphology/behaviour at graft-host interfaces may be useful
in supporting improved graft-host integration; promoting astroglial attachment and aligned
migration into the scaffold rather than astroglial scarring which would effectively isolate the
graft. Both PCL and collagen reduce astrocytic activation [467]. Thus, implantation of a
collagen scaffold or of collagen-PCL nanofibre scaffold might be anticipated to reduce (or
at least modify) astrocytic scarring at the graft-host interface and thereby improve oriented
cell and tissue integration. However, it is possible that the real extent of scaffold-host tissue
interactions may be somewhat different than anticipated in the vastly more complicated
setting of in vivo implantation.
3.4. Conclusion
The experiments conducted in the present thesis have demonstrated the potent axon growth
promoting effects of hNP-AC in simple 2D culture systems. These effects of hNP-AC ap-
pear to be due to the production of ECM as well as the production and release of diffusible
molecules. The interactions of these cells with nanostructured and microstructured sub-
strates were also investigated in vitro. The sPEG-mediated attachment of low density, ori-
ented nanofibres to glass coverslips enables interactions between single cells and single nanofi-
bres to be studied in relatively simple 2D cultures. The potential value of using nanofibres for
CNS-based regenerative strategies was addressed by studying astroglia-nanofibre interactions
in vitro. The morphology and alignment of processes of hNP-AC were strikingly influenced
by both types of orientated nanofibres. Furthermore fibre functionalisation greatly enhanced
cell adhesion and cell migration. However, hNP-AC revealed no proliferative activity on ei-
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ther PCL or C/PCL nanofibres. Both types of nanofibres present strong topographical cues
for the oriented growth and migration of hNP-AC. In this context, even small numbers of
nanofibres were able to control the orientation of large numbers of cells, suggesting that
fewer nanofibres than anticipated may be required to promote directed tissue repair in a 3D
scaffold. However, this hypothesis can only be tested by in vivo implantation of 3D scaffolds
into experimental models of spinal cord injury.
The ability of the topography of a scaffold to influence cell-cell interactions has also been
suggested by the present investigations. The fundamental properties of normally mutually
repulsive cell types (i.e Schwann cells/fibroblasts and astrocytes) appeared to be over-ridden
or modified by the micro-structure of the 3D substrate that they were located in. Although
some of the basic principles controlling cell-substrate interactions have already been estab-
lished in relatively simple 2D systems, the future design of biomaterial-based scaffolds that
are intended to promote nervous tissue repair will require a better understanding of such
principles in more complex 3D situations.
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4. Experimental Spinal Cord Injury
4.1. Introduction
Biomaterial- and tissue engineering-based intervention strategies for the treatment of spinal
cord injury (SCI) have become rapidly expanding areas of research. Traumatic spinal cord
injury (SCI) causes severe and permanent functional deficits due to the primary mechanical
insult followed by secondary tissue degeneration. The loss of function is dramatic and often
permanent due to presence of axon-growth inhibitory/repulsive molecules at- and around
the lesion site, combined with the presence of a physical barrier presented by the glial scar
and the development of fluid-filled cystic cavities [140, 141]. One of the numerous strategies
adopted for spinal cord repair has been the grafting of peripheral glia (i.e. Schwann cells
[239, 261, 471] and olfactory ensheathing cells [337, 338]), either alone or in combination with
a growth promoting scaffold, into the lesion site to promote axon regeneration. However,
more recently the potential of stem/progenitor cell-based strategies has become apparent.
The potential sources of such donor cells include embryonic- [277], foetal- or adult-derived
neural stem cells and neural progenitors (NPC, [321, 322, 367]) and, most recently, induced-
pluripotent stem cells (iPS) [436]. Such neural stem/progenitor-based strategies have been
reported to promote functional improvement in experimental models of CNS, but the mech-
anism(s) of action remain poorly defined [52, 114, 121, 156, 306]. However transplantation of
neural stem/progenitor-derived oligodendrocytes have been shown to be more efficient for re-
myelination mediated-repair than grafting non-differentiated or uncommitted cells [62, 481].
Following a similar logic, one may hypothesise that the axon-growth promoting properties of
neural stem/progenitor-derived astrocytes will be greater than those of the un-differentiated
progenitor cells. Therefore, the present investigation has focussed on the properties of neu-
ral stem/progenitor-derived astrocytes for tissue repair. Silver and colleagues showed in the
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late 1980s that immature forebrain astrocytes reduced glial scarring and promoted axonal
regeneration in vitro and in vivo [380, 389–391]. Furthermore it was identified that type
I astrocytes (rather than type II astrocytes) from the rat are capable of promoting CNS
tissue repair in the absence of unwanted side-effects, like allodynia or hyperalgesia [99, 100].
It is highly likely that the orientation of axonal regeneration will play a crucial role in the
efficiency of any tissue repair strategy, however, such orientation is only poorly controlled in
simple cell transplantation studies. Therefore, a number of orientated scaffolds of varying
complexity have been developed to support this behaviour. Simple tubes wrapped around
the proximal and distal stumps of transected spinal cord and filled with a gel-like matrix
or glial cells were the first attempts for biomaterial-based guidance channels [291, 469, 470].
These guidance channels supported significant axonal in-growth, however the majority of
regenerated axons were loacted on the inner surface on the tubes. Further advances in bio-
material engineering have resulted in the development of artificial, 3D, highly orientated and
biodegradable matrices [200, 316, 426] which have been transplanted into the injured spinal
cord. It has been recognized that such bioengineered matrices can be used to import a range
of functional molecules, drugs or cells into areas of pathology.
Since many populations of CNS neurons and their local circuits, both rostral and caudal
to the lesion site, remain intact following SCI (e.g. the central pattern generator for stepping
movements, [134]), substantial effort has been spent trying to promote functional repair by re-
connecting severed nerve fibres to their original targets. These efforts have been encouraged
by the fact that only a small percentage (1-10%) of the original nerve fibre projection is
needed for the maintenance of useful motor or sensory function [132, 263]. Over recent
years, a range of increasingly sophisticated natural and synthetic polymer nerve guides and
hydrogels have been developed in an attempt to bridge spinal cord lesions, supporting optimal
graft-host integration to allow axon regeneration across both interfaces (i.e. rostral and
caudal) of the implant-host transitional zone.
The present investigation follows the hypothesis that implantation of human neural progenitor-
derived astrocytes (hNP-AC), alone or in combination with an orientated collagen scaffold
will promote functional tissue repair in experimental models of spinal cord injury.
The in vivo investigations comprise animals subjected to a spinal cord compression injury
by the inflation of a sub-durally positioned balloon. The effects of cell implantation strate-
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gies were then assessed. Animal groups of the study were group I: lesioned but untreated
rats, group II: lesioned rats receiving immunosuppression, group III: lesioned animals
receiving donor human foreskin fibroblasts (hFbl) plus immunosuppression, group IV: le-
sioned animals receiving donor human neural progenitor-derived astrocytes (hNP-AC) plus
immunosuppression. As a more sophisticated intervention strategy, a second model of SCI
was adopted in which part of the lateral white matter tracts were resected. The effects of a
tissue engineering strategy of donor cells plus scaffold were then assessed. Animal groups for
these studies were group I: lesioned animals receiving naive scaffolds and immunosuppres-
sion (control + IS), group II: lesioned animals receiving donor hFbl-seeded collagen scaffolds
plus immunosuppression, and group III: lesioned animals receiving donor hNP-AC-seeded
scaffolds with immunosuppression.
4.2. Results
4.2.1. Characterization of hFbl
Human foreskin fibroblasts were chosen to serve as a “neutral” or control cell population
for the in vivo investigations. They appeared as large flat cells on tissue culture plastic,
which grew in an orientated manner and expressed vimentin, CSPG and fibronectin (Figure
4.1A-F). When seeded onto the collagen matrix they also adopted an elongated morphology
and followed the orientation of the pores (Figure 4.1G-I). They still expressed large amounts
of fibronection, which was deposited throughout the porous microstructure of the scaffold
(Figure 4.1H-I).
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Figure 4.1.: hFbl express fibronectin and CSPG in tissue culture. A-F: hFbl appear as large flat cells and grow in an orientated
manner on normal tissue culture plastic. They express vimentin (A-C), fibronectin (B, C and D-F) and CSPG (E, F). G-I:
When seeded onto the collagen matrix, hFbl also adopt an elongated form which follows the orientation of the pores (double
headed arrow). Scale bar in I for A-I.
4.2.2. Balloon Compression Model with Cell Implantation
The results of the behavioural analyses conducted at 5 weeks and 9 weeks were chosen to
represent functional outcomes at mid-point and end-point stages of the investigation. For a
list of animal numbers per experimental group, see Table 2.4.
Behavioural Analysis
BBB: All animals had a baseline score of 21 (highest possible score), which dropped to an
average score of 1 by one week after injury (data not shown). After 5 and 9 weeks groups
with cell transplants (hFbl, hNP-AC) showed occasional weight supported stepping, reaching
a BBB score of slightly less than 10 at the intermediate time point (5 weeks: 9.9±0.5 and
9,7±0.5 for hFbl and hNP-AC transplants respectively) and above 10 at the end time point
(9 weeks: 11.1±0.3 and 10.6±0.5 for hFbl and hNP-AC transplants respectively). This
was significantly greater than the score for the control animals (5 weeks: 7±0.7, end-point:
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8.6±0.6) for both time points (p < 0.01, p < 0.05 respectively), but not compared to the
control + IS group (5 weeks: 9±0.6, end-point: 9.8±0.5, p > 0.05,), which showed some
degree of weight support when stationary (Figure 4.2A).
Gridwalk: The overall impression of functional improvement was supported by the grid-
walk analysis. Here the animals dropped from the highest possible score of 5 (baseline) to
the lowest possible of 0 (data not shown). At the mid- and end-point hFbl (5 weeks: 2.8±0.2,
end-point: 3.3±0.2) and control + IS (5 weeks: 2.9±0.2, end-point: 3.2±0.2) groups were
significantly better compared to the control group (5 weeks: 1.6±0.3, end-point: 2.3±0.2, p
< 0.01) At the end-point, the hNP-AC group (5 weeks: 2.2±0.3, end-point: 3.3±0.2) had
also reached a significantly better performance than the control (p < 0.01; Figure 4.2B).
Hargreaves’ heat sensitivity test: All groups showed an increase in the latency of paw
withdrawal when exposed to a heat stimulus. This effect increased over time without sig-
nificant differences between the groups (i.e. hFbl: 5 weeks: 4.2±0.4, end-point: 5.5±0.4;
hNP-AC: 5 weeks: 4.9±0.3, end-point: 5.4±0.4; control + IS: 5 weeks: 4.5±0.4, end-point:
5.5±0.4; control: 5 weeks: 4.6±0.3, end-point: 6.2±0.4; Figure 4.2C).
Although there were time-related changes in the extent of functional deficits observed
throughout the investigation, the values for all animal groups remained significant below-
(i.e. for BBB and gridwalk tests) or above (i.e. for the Hargreaves’ heat sensitivity test)
their corresponding pre-lesion baseline values (p < 0.01; Figure 4.2).
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Figure 4.2.: Animals receiving transplants of cell suspension show better functional recovery than control animals after ballon
compression injury. A: BBB test: Groups receiving donor cell transplants (i.e. hFbl, hNP-AC) show a statistically greater
degree of functional improvement over control animals for both time points (++ p < 0.01, + p < 0.05), but not compared to
the control + IS group (p > 0.05). B: Gridwalk test: donor hFbl + IS and control + IS groups performed significantly better
compared to the control group (++ p < 0.01) at 5 weeks post injury. At the end-point, the donor hNP-AC + IS group has
also reached a significantly better level of performance than the control group (++ p < 0.01). C: Hargreaves’ heat sensitivity
test: All groups showed an increased latency of paw withdrawal when exposed to heat stimuli (no difference between groups).
All groups remained significantly below- (i.e. BBB, gridwalk) or above- (i.e. Hargreaves’ heat sensitivity test) the pre-injury
baseline values (** p < 0.01; control, control + IS and hNP-AC: n=8, hFbl: n=7).
Survival of Transplanted Cells
Transplanted hFbl generally survived well but integrated poorly within the host tissue when
transplanted rostral to (Block A, 30%), caudal to (Block C, 70%) and at the lesion site
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(Block B, 60%) (Figures 4.3A-I, 4.5A). The donor cells typically formed well defined, ellip-
tical clusters of cells which were strongly fibronectin-positive (Figure 4.3A-D, H, I). Higher
magnification demonstrated the close interactions with some host cells, especially at the le-
sion site, as many human nuclei-negative cells could be found inside of the elliptical clusters
(Figure 4.3E-G).
Similarly, transplanted hNP-AC survived and integrated well (Block A: 40%, Block B:
90%, Block C:90%; Figure 4.5A), but in contrast to the donor hFbl, were able to migrate a
greater distance in the host tissue, particularly along the longitudinal axis (Figure 4.4A, B,
H, I; Figure 4.6A, C). Transverse sections revealed that hNP-AC, despite their longitudinal
migration, still showed a tendency to form clusters (Figure 4.4C, D; Figure 4.6B). In general
they were able to spread widely throughout the host tissue, in some cases nearly throughout
the whole width of the spinal cord section (Figure 4.4A, B; Figure 4.6A) and continued to
express GFAP and human nestin (Figure 4.4; Figure 4.6). In the caudal block, donor cells
could be found to be relatively evenly distributed throughout the host grey matter, with
fewer cells within the white matter. Often they formed larger clusters with closely intermin-
gled processes which surrounded smaller clusters of host cells (Figure 4.4E-G). Individual
migrating donor astrocytes, locateds next to the larger clusters of grafted cells, had a more
elongated morphology, which followed the axis of the spinal cord (Figure 4.6C, J-L).
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Figure 4.3.: Donor hFbl survive but intermingle poorly with host cells after transplantation into balloon compression injury
of the spinal cord. A-D, H, I: Transplanted cells survive when grafted rostral to- (A, B), within- (C, D) and caudal (H, I) to
the lesion site as shown by the detection of human nuclei-positive staining (hNuc). Donor hFbl form elliptical clusters, which
stain strongly for fibronectin (A-I). E-G: Higher magnification, together with a nuclear counterstain (DAPI) reveals a high
amount of hNuc-negative cells inside of these clusters.
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Figure 4.4.: Donor hNP-AC survive and spread throughout the balloon compression injured spinal cord. A, B: Low magnifi-
cation image demonstrating that transplanted hNP-AC are capable of spreading throughout the whole width of the spinal cord
rostral to the injury site and that they continue to express GFAP after transplantation. C-G: Dense cluster of donor hNP-AC
at the lesion site. Higher magnification demonstrates that most of the cells are human nuclei- and GFAP-positive (E-G). The
GFAP-positive processes inside of the cluster of transplanted cells are non-oriented. H, I: Similar to the rostral transplantation
site, donor hNP-AC also survive and spread when transplanted caudal to the lesion.
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Figure 4.5.: Proportion of host animals in which surviving donor cells could be identified. The histogram demonstrates a
higher survival rate of donor hNP-AC compared to donor hFbl transplants. Furthermore fewer host animals showed signs of
transplanted donor cells at the rostral transplantation site (hNP-AC: n=8, hFbl: n=7).
Regeneration/Sparing of NF200-Positive Axons at the Lesion Site
Quantification of the amount of NF200-positive axons (as indicated by the number of NF-
positive pixels) revealed an enhanced ingrowth of neurites into the lesion site of hNP-
AC treated animals (23.5±0.7%), which reached statistical significance over the control
(20.1±0.7%) and the control + IS (20.1±0.6%, p < 0.01), but not over the hFbl (22±0.6%, p
> 0.05; Figure 4.7E). Donor hFbl supported a significantly greater amount of neurofilament
positive axonal ingrowth than the control + IS group (p < 0.05). At the lesion epicenter, the
distribution of the neurofilament-positive axons was closely associated with laminin-positive
structures (Figure 4.7C, D, G, J, H, K) and is most likely to represent regenerating axons.
The NF-positive axons in the tissue blocks rostral- and caudal to the epicenter, however,
showed a different distribution being more evenly dispersed and showing no co-localisation
with laminin-stained structures (e.g. Figure 4.7A, B), probably indicating their intermin-
gling with spared axons. Double immunofluorescence with human nestin demonstrated a
close relationship of the regenerating/spared axons with the transplanted hNP-AC rostral,
at- and caudal to the lesion site (Figure 4.6D-L). Furthermore, a high density of NF200-
positive neurites could be found within the elliptical clusters of laminin-stained cells (Figure
4.7A, B, F, I).
Chapter 4. Experimental Spinal Cord Injury 90
Figure 4.6.: Regenerating neurites grow along transplanted hNP-AC. A-C: Low magnification image showing the distribution
of the hNP-AC at the different transplantation sites (i.e. rostral to- (A), within- (B) and caudal to- (C) the lesion site).
The human nestin staining reveals a dense network of donor cells, sometimes elongated, which follows the longitudinal axis
of the spinal cord (C). D-L: Higher magnification images demonstrating a close spatial relationship between regenerating,
neurofilament-positive neurites (green) and the transplanted hNP-AC (human nestin, red) rostral to- (D-F), within- (G-I) and
caudal to- (J-L) to the lesion site. Individual elongated human nestin-positive cells with intermingling processes which followed
the longitudinal orientation of the spinal cord (arrows, J-L) can be found next to the dense cluster of donor cells.
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Figure 4.7.: Donor hNP-AC-grafted animals demonstrate enhanced axonal growth into the lesion site. A, B: Example of a
neurofilament- (red) and laminin- (green) staining on a transverse section caudal to the lesion epicentre. The neurofilament
immunoreactivity is evenly distributed throughout the whole section, whereas the laminin demonstrates a patchy distribu-
tion, apart from one concentrated elliptical region - highlighted (white box shown in greater magnification in F, I ). C, D:
Close the lesion epicentre, the neurofilament-positive regenerating axons demonstrate a high degree of colocalisation with the
laminin-positive substrate. F, I: Higher magnification of the highlighted area in A, B showing that the spot of highly con-
centrated laminin also contains a large amount of neurofilament-positive axons. G, H, J, K: The close relationship between
laminin-positive and neurofilament-positive structures can be found throughout the sections close to the lesion epicentre. Such
relationships can be observed for axons following the orientation of the spinal cord (H, K) and also for those growing per-
pendicular to it (G, J). E: Evaluation of the amount of pixel stained for neurofilament immunoreactivity shows that donor
hNP-AC promote the greatest in-growth of neurites into the lesion site, which reaches statistical significance over the control
and the control + IS groups (** p < 0.01), but not over the donor hFbl group (p > 0.05). Donor hFbl group demonstrates a
significantly greater amount of neurofilament-positive pixels than the control + IS group (* p < 0.05, control, control + IS and
hNP-AC: n=8, hFbl: n=7).
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Schwann Cell Migration into the Lesion Site
Schwann cells (p75-positive host cells) migrated in high numbers into the lesion site (e.g.
Figure 4.8A, B). Furthermore an accumulation of p75-positive cells could be found in close
relationship with the elliptical cluster of intense fibronectin-immunoreactivity in the hFbl
transplanted animals(presumably reflecting clusters of transplanted hFbl) (Figure 4.8C, D).
Quantification of the amount of positively stained p75 pixels revealed that the transplanta-
tion of hFbl (26.2±0.7%) promoted a signficantly greater Schwann cell migration into the
lesion site compared to the other groups (p < 0.05 compared to control (24.2±0.5%) and
hNP-AC (24±0.5%), p < 0.01 compared to control + IS (23.8±0.4%); Figure 4.8G). Trans-
plantation of hNP-AC did not change the amount of p75-positive profiles within the lesion
compared to the control and control + IS groups. However, similar to donor hFbl, a close
relationship between migrating Schwann cells and donor hNP-AC could be found (p > 0.05;
Figure 4.8E-F).
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Figure 4.8.: Schwann cell migration into the lesion site is enhanced by the presence of donor hFbl. A, B: Low magnification
images providing an overview of p75-positive Schwann cell migration into the lesion site of animals receiving donor hFbl (A) and
donor hNP-AC (B) cells (control and control + IS groups were similar to the hNP-AC group and are therefore not shown). The
highlighted area (white box, A) shows an elliptically shaped accumulation of p75-positive cells that is demonstrated at higher
magnification in C, D, where a close intermingling with fibronectin-immunoreactivity can be seen. E, F: Higher magnification
demonstrates the close interactions of human nestin- and p75-positive cells. G: Estimation of the amount of Schwann cell
migration into the lesion site shows that transplantation of donor hFbl promotes a significantly greater degree of Schwann cell
migration than seen in any other group (* p < 0.05, ** p < 0.01). Transplantation of hNP-AC does not change the amount of
Schwann cell migration compared to the control and control + IS groups (p > 0.05; control, control + IS and hNP-AC: n=8,
hFbl: n=7 animals).
GFAP and CSPG Immunoreactivity at the Lesion Site
Reactive host astrocytes (e.g. in the spared white matter) expressed GFAP and CSPG
(Figure 4.9A-C). Similary, grafted astrocytes (identified by human nuclei on an adjacent
section) also expressed both proteins (Figure 4.9D-F). Nonetheless, CSPG was not exclu-
sivly expressed by astrocytes; GFAP-negative areas at the lesion site also included CSPG
expressing cells (presumably host fibroblasts and Schwann cells) (Figure 4.9G-I). Further-
more, the expression of CSPG was especially strong at the elliptical cluster of transplanted
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hFbl (Figure 4.9J-L). Evaluation of the intensity of GFAP and CSPG expression demon-
strated that transplanted hNP-AC reduced the amount of both proteins compared to the
control and the control + IS groups (0.36±0.01, p < 0.01 compared to control: 0.48±0.02
and control + IS: 0.46±0.02 groups for GFAP, 0.97±0.01, p < 0.01 compared to the control:
1.1±0.02 and p < 0.05 compared to control + IS: 1.03±0.02 for CSPG). However, although
there was a clear trend for reduced GFAP and CGSP expression in comparison to donor
hFbl, the levels never achieved statistical significance (p > 0.05, GFAP: 0.41±0.02, CSPG:
1.03±0.02; Figure 4.9M,N). Interestingly, transplantation of hFbl also led to reduced over-
all GFAP and CSPG levels, despite the high expression of CSPG at the elliptical clusters.
However this reduction only reached statistical significance when compared to the control
group (p < 0.01; Figure 4.9M,N).
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Figure 4.9.: Donor hNP-AC reduce the amount of intensity of CSPG and GFAP staining at the lesion site. A-C: Reactive
host white matter astrocytes (stained for GFAP, green) express CSPG (red). D-F: Transplanted hNP-AC (region identified by
human nuclei-positive cells in the same area of an adjacent section) also express CSPG. G-I: GFAP-negative, CSPG-positive
areas demonstrate that GFAP-positive cells are not the only CSPG expressing cells to be found in the samples. Furthermore
GFAP-positive cells do not necessarily express large amounts of CSPG (arrows). J-L: Transplanted hFbl (region identified by
human nuclei-positive cells in the same area of an adjacent section; note the typical elliptical transplant form) also express
CSPG. The rounded profiles of astrocytic GFAP (green, arrows in K and L) demonstrate the isolation and compartmentalisation
of the donor fibroblasts by the host tissue. M, N: Transplantation of hNP-AC lead to a significant reduction in the intensity
of the GFAP (M) and CSPG (N) staining compared to the control and the control + IS groups (** p < 0.01, * p < 0.05), but
not compared to the donor hFbl group (p > 0.05; control, control + IS and hNP-AC: n=8, hFbl: n=7 animals).
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Inflammatory Response at the Lesion Site
Iba1-positive macrophages/microglia could be found throughout the lesioned spinal cord
(Figure 4.10A,B). At high magnification, the Iba-positive cells could be differentiated by
their rounded morphology (Figure 4.10C), sometimes including cell debris (Figure 4.10D),
which appeared throughout the section at the lesion epicentre as well as in areas further away,
such as white matter tracts undergoing Wallerian degeneration. A ramified morphology was
observed, predominantely in the spared grey matter (Figure 4.10E). Evaluation of Iba1-
immunoreactivity showed a statistically significant increase for the rounded cells for the
control + IS group compared to all groups (p < 0.01, control + IS: 0.29±0.01, control:
0.22±0.01, hFbl: 0.23±0.01, hNP-AC: 0.23±0.01) and an increase for the ramified cells
compared to the control and the hNP-AC group (p < 0.01, control + IS: 0.25±0.01, control:
0.20±0.01, hFbl: 0.23±0.01, hNP-AC: 0.21±0.01; Figure 4.10F). Furthermore the hFbl
group demonstrated a higher immunoreactivity for the ramified cells compared to the control
(p < 0.05; Figure 4.10F).
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Figure 4.10.: Iba1 immunoreactivity is increased in the presence of immunosuppression. A, B: Low magnification images of
Iba1 close to- (A) and caudal to (B) the lesion epicenter. Iba1-positive cells can be found throughout the sections. Highlighted
areas (white boxes) are shown in higher magnification in C-E: The Iba1-positive cells can be broadly divided by their rounded
(C) or ramified (E) morphology. Cells with high amounts of debri (D) are included into the rounded group. Cells with rounded
morphology are mainly located throughout the sections at the lesion epicentre, but distant from the lesion can be found in the
white matter (white box with circle, A) whereas cells with the more ramified morphology can be located in the grey matter
(white box with asterisk, B). F: Evaluation of Iba1 immunoreactivity shows a significant increase of the intensity for the control
+ IS group compared to all groups for the rounded cells (** p < 0.01) and an increase compared to the control and the donor
hNP-AC group for the ramified cells (** p < 0.01). Furthermore, the donor hFbl group demonstrates a higher immunoreactivity
for the ramified cells compared to the control (* p < 0.05; control, control + IS and hNP-AC: n=8, hFbl: n=7 animals).
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Spared Tissue
Only a limited area, if any, of spared tissue could be found at the lesion epicenter of all
groups (as indicated by white outlines with shaded areas; Figure 4.11A-E). The amount
of spared tissue was enhanced when hFbl were transplanted. This increased tissue sparing
reached the level of statistical significance when compared to controls at the epicentre and at
-800 µm (epicentre: hFbl: 0.04±0.02, control: 0.0±0.0; -800 µm: hFbl: 0.12±0.05, control:
0.02±0.01; p < 0.05) and to the hNP-AC treated animals at 1200 µm epicentre, -400 µm,
-800 µm, and -1200 µm (1200 µm: hFbl: 0.1±0.03, hNP-AC: 0.01±0.0; epicentre: hFbl:
0.04±0.02, hNP-AC: 0.0±0.0; -400 µm: hFbl: 0.07±0.03, hNP-AC: 0.0±0.0; -800 µm: hFbl:
0.12±0.05, hNP-AC: 0.0±0.0; -1200 µm: hFbl: 0.12±0.05, hNP-AC: 0.02±0.01; p < 0.05).
No other statistically significant differences were observed. With increasing distance to the
lesion epicentre, rostral and caudal, the amount of spared tissue increased, with reoccurrence
of spared grey matter as well (data not shown).
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Figure 4.11.: Transplantation of hFbl excert tissue sparing effects. A-D: Thionin staining of the lesion epicentre for donor
hFbl (A), control + IS (B), control (C) and donor hNP-AC (D) groups. White outlines with shaded areas indicate areas of
spared tissue as assessed by inspection of high magnification images (A, B). E: Quantification of the amount of spared tissue.
Donor hFbl treated animals reveal a significantly greater amount of spared tissue compared to the control group (epicentre,
-800 µm; #: p < 0.05) and to the hNP-AC group (1200 µm epicentre, -400 µm, -800 µm, -1200 µm; ∼: p < 0.05; control,
control + IS and hNP-AC: n=8, hFbl: n=7 animals).
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4.2.3. Tissue Engineering Approach to Promote Repair after Lateral
Funiculotomy of the Thoracic Spinal Cord
Behavioural Analysis
Catwalk: All animals (for a list of animal numbers per experimental group, see Table 2.4)
were able to support their weight and walk in a coordinated manner 4 weeks after injury,
as indicated by the regularity index (i.e. the use of normal step sequence patterns during
uninterrupted locomotion) and the stride length, which remained unchanged after injury and
scaffold transplantation (p > 0.05; Figure 4.12A, B).
Determination of the base of support (BOS) indicated that there was a progressive reduc-
tion of the distance between the fore-paws of all experimental groups, which by 8 weeks was
significantly different from their pre-injury baseline levels (p < 0.01 for all groups). Surpris-
ingly, the fore-paw BOS data for the group receiving hFbl-seeded scaffolds was significantly
better (i.e. closer to baseline levels) than that of the group receiving hNP-AC seeded scaf-
folds (p < 0.01). Apart from the above observation, no other differences could be detected
between the groups (Figure 4.12C). In contrast to the fore-limb data, the BOS for the hind-
limbs all showed an increase in the inter-limb distance in comparison to their pre-surgery
baseline levels. Similar to the BOS of the front-paws, the group receiving hFbl-seeded scaf-
folds was significantly better than the hNP-AC group, and showed no statistically significant
difference from the baseline levels. Surprisingly even the control + IS group showed recovery
levels that were not statistically different from the baseline (Figure 4.12D).
Print area (complete area covered during the whole stance phase, equivalent to the foot-
print), max area (largest area in contact with the floor at one particular time point during
stance) and the intensity (average intensity of max area) of the affected hind-limb of all
groups were significantly reduced by 4 weeks in comparison to the pre-surgery baseline levels
(p < 0.01; Figure 4.12E-G). Interestingly, the groups receiving cell-seeded scaffolds (i.e. hFbl
and hNP-AC) both showed significantly better performances than the empty scaffold + IS
control group. All groups subsequently showed a trend for improved function between 4 and
8 weeks to the extent that there were no longer any significant differences between the groups
for print area or max area (Figure 4.12E-F). However the values for the recovery of intensity
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of paw placement were much better in the group receiving hNP-AC seeded scaffolds, to the
extent that by 8 weeks the data for this group was still significantly greater than that of the
scaffold plus IS control group and the hFbl-seeded scaffold group (p < 0.01 and p < 0.05
respectively; Figure 4.12G).
The data for the duty cycle (stance duration divided by the sum of stance and swing
duration) and the stance duration showed very similar patterns of recovery. All groups
demonstrated a significant reduction in comparison to the pre-surgery baseline values (p
< 0.01 for all groups). However by 4 weeks post implantation, animal groups receiving
hFbl-seeded scaffolds and hNP-AC seeded scaffolds demonstrated a significantly improved
duty cycle in comparison to the empty scaffold + IS controls (p < 0.05; Figure 4.12H).
Improvement in duty cycle values progressed to the extent that, by 8 weeks, all groups
remained below pre-implantation baseline values, but the data obtained for groups receiving
cell-seeded scaffolds were no longer significantly better than those of the empty scaffold + IS
control group. An almost identical pattern of recovery was observed for the stance duration
data except that at 4 week post implantation, the group receiving hNP-AC seeded scaffolds
had failed to show a significantly greater improvement than that seen in the empty scaffold
+ IS control group (Figure 4.12I). For swing duration, all animal groups demonstrated a
significant increase by 4 weeks in comparison to the baseline levels (p < 0.01 for all groups),
however, once again, groups receiving the cell-seeded scaffolds performed significantly better
than the control + IS group (p < 0.05 for both seeded scaffold implantation groups in
comparison to the non-seeded control scaffold). Recovery of performance was prominent in
all groups between 4 and 8 weeks but none of the groups reached pre-surgery baseline levels.
However, by 8 weeks only the hFbl-seeded scaffold group showed a significant improvement
in relation to the control scaffold + IS group (p < 0.05; Figure 4.12J).
Gridwalk: Similar functional trends were observed in the gridwalk analysis as were ob-
served with the CatWalk. All groups demonstrated a significant increase in the number of
footfalls by 4 weeks post surgery (p < 0 .01 for all groups; Figure 4.13A). However, both
groups receiving cell-seeded scaffolds showed a significantly better performance than demon-
strated by the control group receiving the empty scaffold + IS (p < 0.05 for both cell-seeded
scaffold groups). Progressive recovery between 4-8 weeks was evident in the control + IS
group as well as the group receiving hFbl-seeded scaffolds but not in the hNP-AC seeded
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scaffold group. Values for all groups at 8 weeks post surgery were still below the initial
baseline values, but no significant differences could be detected between individual groups
(Figure 4.13A)
Von Frey filaments: Evaluation of the potential development of allodynia with the von
Frey filaments was performed in all 4 paws over the 8 week investigation period. The values
obtained for all groups showed substantial variability, to the extent that no statistically
significant effects could be demonstrated at any time point (p > 0.05; Figure 4.14A-D).
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Figure 4.12.: No recovery of function can be detected after implantation of non-seeded- or cell-seeded scaffolds. A, B: The
regularity index and stride length remained unchanged after injury and after scaffold implantation. C, E, F, G, H, I: Values
for the base of support (BOS) of the fore-paws, print area, max area, intensity (with the exception of the hNP-AC group at
the end-point), duty cycle and the stance duration all show reduced values after injury (4 weeks) with a small tendency to
recovery back to the (pre-lesion) baseline values. The BOS for the fore-paws reveals a more pronounced narrowing (C). D, J:
The values for the BOS of the hind-paws and the swing duration increase after injury and show no signs of recovery during the
investigation (** p < 0.01, * p < 0.05 compared to the baseline; ++ p < 0.01, + p < 0.05 compared to the control + IS group;
## p < 0.01, # p < 0.05 compared to the donor hFbl group for all graphs; control + IS: n=9, hFbl: n=10, hNP-AC: n=11
animals).
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Figure 4.13.: Cell transplantation increases recovery of fine motor coordination during intermediate time points. Transplan-
tation of either hFbl or hNP-AC lead to a significant improvement in the number of foot-falls in comparison to the control +
IS group by 4 weeks. However, the extent of improvement is no longer significant in comparison to the control + IS group by
the end-point. Recovery fails to reach (pre-lesion) baseline values (** p < 0.01, compared to the baseline; + p < 0.05 compared
to the control + IS; control + IS: n=9, hFbl: n=10, hNP-AC: n=11 animals).
Figure 4.14.: Evaluation with von Frey filaments shows no signs of allodynia after injury in all groups. A-D: Standardised
withdrawal reflex for all four paws. No statistically significant difference can be found at any time point (p > 0.05; control +
IS: n=9, hFbl: n=10, hNP-AC: n=11 animals).
Survival of Transplanted Cells
In only 10% of the grafted animals could a few human nuclei-positive donor cells be found
following implantation of the hFbl-seeded scaffolds. However, the scaffold still demonstrated
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an intense staining for the ECM molecule, fibronectin (Figure 4.15A-C, J). Many human
nuclei-negative host cells could be found in the immediate vicinity of the donor cells. There
was no indication of donor cell migration out of the scaffolds. In contrast, a much better
degree of donor cell survival was observed following the implantation of hNP-AC seeded scaf-
folds (human nuclei-positive donor cells could be found in 55% of the transplanted animals
(Figure 4.15D-F, J). Similar to the earlier in vitro observations, the donor cells appeared to
redistribute themselves and form orientated columns within the scaffolds (Figure 4.15D-F).
Nonetheless the amount of surviving cells visible in each section was normally quite low.
Furthermore, use of anti-human nestin immunohistochemistry demonstrated that not all
donor cells remained within the scaffolds. Individual hNP-AC could be identified within the
host white matter, close to the implant, where they had adopted an elongated, (probably)
migratory morphology (Figure 4.15G-I).
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Figure 4.15.: Implantation of cell-seeded scaffolds into lateral funiculotomies results in only limited donor cell survival.A-C:
Only few human nuclei-positive (hNuc) donor cells can be found inside of the hFbl-seeded scaffolds after implantation (arrows).
Nonetheless, implanted scaffolds show an intense, evenly distributed, staining for fibronectin. D-F: Human nuclei-positive donor
hNP-AC cells form columns within the scaffolds (arrows). G-I: Furthermore, they may be identified as elongated, migratory
cells inside of the adjacent host tissues using antibodies to human nestin (hNestin, arrows). J: Only a limited numbers of host
animals receiving hFbl-seeded scaffolds show viable human nuclei-positive cells after implantation. In contrast, over 50% of host
animals receiving hNP-AC-seeded scaffolds show viable hNuc / hNestin-positive cells (hFbl: n=10, hNP-AC: n=11 animals).
Regeneration of NF200 Positive Axons into the Scaffold
Host axons were able to regenerate into empty and cell-seeded scaffolds. Regenetrating
axons clearly followed the orientation of the pores (Figure 4.16A-C). Whereas no clear cell-
guided growth could be found in the hFbl and control + IS groups, higher magnification
of a hNP-AC-seeded scaffold demonstrated the ability of regenerating axons to grow along
GFAP-positive cells within the scaffold, as well as along GFAP-negative areas (Figure 4.16B,
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C). Since the survival of transplanted hNP-AC was rather low, most NF-positive axons must
have been growing along host GFAP-positive profiles. However, it was clear that donor
hNP-AC-seeded scaffolds had promoted a significant increase in the number of regenetrating
axons inside of the scaffold, compared to the control empty scaffold + IS group, (p < 0.05;
Figure 4.16D). The hFbl-seeded scaffold supported axon growth that was intermediate in
extent between the values observed for the hNP-AC-seeded and empty scaffolds (p > 0.05).
Figure 4.16.: Implantation of hNP-AC-seeded scaffolds promotes enhanced axon regeneration into the scaffold. A: Example
of axon regeneration into the scaffold. The regenerating axons follow the longitudinal orientation of the microchannels within
the scaffold in all groups. B, C: Higher magnification of an hNP-AC-seeded scaffold demonstrates the ability of axons to grow
along GFAP-positive cells (arrows) as well as along GFAP-negative areas (arrowhead). D: Quantification of axon regeneration
into implanted scaffolds at three different positions (100 µm from the rostral- and caudal- graft-host interface and also at the
scaffold midline). hNP-AC seeded scaffolds induce a significantly greater extent of axon regeneration compared to the control
group (* p < 0.05; control + IS: n=9, hFbl: n=10, hNP-AC: n=11 animals).
GFAP and CSPG Immunoreactivity
Low magnification overview of GFAP stained sections of control + IS (Figure 4.17A), hFbl-
seeded (Figure 4.17B) and hNP-AC-seeded (Figure 4.17C) scaffolds highlighted the marked
increase of GFAP-positive profiles within the hNP-AC seeded scaffolds, the orientation of
which generally followed the longitudinal orientation of the scaffold’s pores. Since the GFAP-
positive columns could also be found in areas of the scaffold where no human nuclei-positive
cells could be demonstrated or even in animals with no identifiable human nuclei at all, it is
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likely that such profiles were due to the infiltration of host astrocytic processes. The highly
sulphated proteoglycan, CSPG, was clearly associated with the GFAP-positive cells (Figure
4.17G-I), but could also be found in GFAP-negative areas (Figure 4.17D-F). Quantification of
the intensity of immunoreactivity revealed that the empty scaffold + IS group demonstrated
the greatest degree of astrocytic reactivity (as revealed by increased GFAP expression at
the implant host interface). The implantation of either cell-seeded scaffold into the lesioned
spinal cord resulted in a significantly reduced intensity of GFAP immunoreactivity in these
regions compared to the control + IS group (p < 0.01; Figure 4.17J). Quantification of
the intensity of CSPG immunoreactivity also revealed that the control + IS group had
the highest expression of CSPG. Although both groups that received cell-seeded scaffolds
showed reduced mean values in comparison to the control + IS group, only the values for
the hFbl-seeded scaffold group reached the level of statistical significance (p < 0.05; Figure
4.17K).
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Figure 4.17.: hNP-AC-seeded scaffolds improve host astrocytic integration. A-C: Low magnification images of GFAP im-
munohistochemistry in non-seeded- (control + IS, A), hFbl-seeded- (B) and hNP-AC-seeded- (C ) scaffolds. The high numbers
of GFAP-positive processes within the scaffold and following the orientation of the microchannels, are clearly visible in the
hNP-AC-seeded scaffolds (C ). The extent of GFAP immunoreactivity inside the scaffolds is the same whether implants contain
viable donor cells or not (identified by human nuclei staining). D-F: CSPG can be found in GFAP-negative areas of hNP-AC-
seeded scaffolds (as well as inside of control + IS and hFbl-seeded scaffolds). G-I: GFAP-positive columns inside of the scaffold
express CSPG. J: Cell seeding of the scaffold leads to a reduced intensity of GFAP staining compared to the non-seeded scaffold
group (** p < 0.01). K: The intensity of CSPG staining is reduced for the hFbl-seeded scaffolds compared to the control + IS
group (* p < 0.05; control + IS: n=9, hFbl: n=10, hNP-AC: n=11 animals).
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Inflammatory Response
Immunohistochemistry for ED1 demonstrated cells with a rounded morphology (presumably
macrophages) that could be found in the region of the host-scaffold interface (Figure 4.18A,
C), with relatively few cells being found deep within the scaffold. The intensity of ED1
immunoreactivity was clearly greatest in the control group receiving the empty scaffold + IS
treatment. Implantation of cell-seeded scaffolds reduced the intensity of ED1 immunoreac-
tivity but only the values associated with the hNP-AC seeded scaffolds achieved the level of
statistical significance (p < 0.01; Figure 4.18E). In stark contrast to the observations made
with ED1 staining, Iba1-positive cells could be found throughout the host spinal cord as
well as rounded cells at the host-scaffold interface and both rounded- and process bearing
morphologies inside of the scaffold (Figure 4.18B). Higher magnification of Iba1-positive cells
inside of the scaffold showed that the process bearing cells had adopted an elongated mor-
phology, which followed the orientation of the pores (Figure 4.18D). This is in contrast to
the more rounded morphology they show in the host tissue (Figure 4.18G). Both cell-seeded
scaffold groups (i.e. hFbl and hNP-AC) demonstrated a reduced intensity of Iba1 staining
compared to that seen in the control empty scaffold + IS group (p < 0.01; Figure 4.18F).
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Figure 4.18.: Implanted hNP-AC-seeded scaffolds modulate the host immune response. A: ED1-positive cells can be found
along the host-scaffold interface, but not within the scaffold. B: Iba1-positive cells can be found in the host spinal cord, at the
interface and within the scaffold. C: High magnification of the highlighted area in A (white box with circle). ED1-positive cells
demonstrate a rounded morphology. D: High magnification of Iba1-positive cells inside of the scaffold (white box with lines in
B) shows that they adopt an elongated morphology, which follows the orientation of the pores. This is in contrast to the more
rounded morphology they show in the host tissues (G, highlighted area in B (white box with circle)). E: Animals transplanted
with hNP-AC-seeded scaffolds show a reduced intensity of ED1 compared to the control + IS group (** p < 0.01). F: Both
cell-seeded groups (hFbl and hNP-AC) demonstrate a reduced intensity of Iba1 staining compared to the control + IS group
(** p < 0.01; control + IS: n=9, hFbl: n=10, hNP-AC: n=11 animals).
4.3. Discussion
Biomaterial- and tissue engineering-based intervention strategies for the treatment of spinal
cord injury (SCI) are a fast moving field with a broad range of research. In general, strategies
for bridging SCI aim to replace damaged tissue with an axon growth promoting substrate
that is able to integrate within the host tissue, supporting neural cell survival, and promoting
axon regeneration and functional improvement. In early experimental studies autologous or
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allogenic living tissue was used, comprising of foetal spinal cord tissue, peripheral nerve
grafts or neuronal tissue [83, 98, 208, 213, 375, 383]. An alternative approach to promote
axonal regeneration in SCI has been the transplantation of cell suspensions to bridge the
cyst or spinal injury (for reviews see [31, 90, 114, 351, 466]). Most of these studies support
some degree of CNS axon regeneration into the grafts, however, there are a number of
ethical (e.g. embryonic or foetal tissue/cells) and practical concerns (e.g. the need for
immunosuppression in case of allografts and donor site morbidity in case of autologous
nerves) for all of these approaches [184, 374]. As the field of regenerative medicine has
grown, the focus of many studies has shifted to include the development of artificial growth
promoting scaffolds, using natural or synthetic polymers. In this study, the use of hNP-
AC either alone (balloon compression injury model), or in combination with an orientated
collagen scaffold (lateral funiculotomy, resection injury model) as a tissue engineering-based
intervention strategy after spinal cord injury, have been investigated. In both models, we
have described the functional outcome (BBB/Gridwalk and Catwalk/Gridwalk respectively),
sensitivity (Hargreaves’ heat sensitivity test and von Frey filaments respectively), survival
of transplanted cells, amount of spared/regenerated axons as well as GFAP, CSPG and Iba1
immunoreactivity. Furthermore, the amount of p75-positive Schwann cell migration into the
injury site and the amount of spared tissue were evaluated in the balloon compression injury
model as well as ED1 immunoreactivity in the resection injury model.
Human SCI results from a variety of mechanical stresses applied to the spinal cord, but
most commonly, acute traumatic SCI consists of both impaction (contusion-type injury) and
persistent compression (maceration-type injury). We chose an experimental model of com-
pression injury for our study because it reproduces many of the aspects of severe compression-
type injuries seen in the clinical situation [271]. Although the lateral funiculotomy does not
represent a common clinical model, it does to some extent reproduce changes caused by
spinal cord laceration and allows us to use a more sophisticated intervention strategy; the
implantation of the 3D orientated collagen scaffold as a replacement of the resected white
matter. Furthermore, an advantage of these models is that animals subjected to experi-
mental SCI show behavioural changes (including recovery) over a number of weeks, thereby
allowing assessment of locomotor functions. The lateral funiculotomy model allowed for
rapid recovery of postural control and therefore a more sophisticated type of analysis than
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the balloon compression injury model (i.e. CatWalk gait analysis system). In any case, it is
essential that the lesion model induces a reproducible deficit in at least one area of sensory,
motor or autonomic function, otherwise, the model’s value for assessing the effectiveness of
particular intervention strategies would be compromised [89].
4.3.1. Characterization of hFbl
hFbl were chosen to serve as a “neutral” or control cell population and were characterised
by the expression of vimentin, fibronectin and CSPG [72, 332, 333].
4.3.2. Comments on the behavioural analyses of both SCI models
Locomotor recovery after balloon compression injury was monitored using the BBB locomo-
tor rating scale [30]. The CatWalk method is a gait analysis method that allows computer
assisted quantification of a large number of locomotor parameters and was used to assess
locomotor recovery after lateral funiculotomy [181, 241, 449]. Fine motor coordination was
assessed using a horizontal wire grid (also known as the gridwalk) [247]. Furthermore it was
important to include the evaluation of the potential development of neuropathic pain. Since
grafted cells are intended to support axonal sprouting, synaptogenesis and the formation of
new circuitry, it is difficult to exclude the possibility that the donor cells might also pro-
mote the formation of aberrant connections, which could cause unwanted side-effects such
as enhanced pain perception (hyperalgesia) or the shifting of inocuous sensations to become
painful (allodynia). However, the current sensory tests are difficult to interpret because they
all depend on a functioning motor response (e.g. paw flexion withdrawal).
Transplantation of hNP-AC after the balloon compression injury promoted a better
functional recovery (BBB score) compared to the control (lesion only) group, but not when
compared to the control + IS group. Although the recovery of the control + IS group
showed a trend of being lower than that of the cell implantation groups, it also showed a
trend of being better than that of the control (lesion only) group. Interestingly and some-
what surprisingly, the cell control group (hFbl) performed better than the hNP-AC group.
This pattern of behavioural responses was also supported by the gridwalk, where both cell
implantation groups as well as the control + IS group performed better than the control
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group. This demonstrated that all treatment groups revealed a better recovery of fine mo-
tor control than was seen in the untreated group. The resulting BBB score of the treated
groups is in accordance with previous results for a 15 µl lesion (untreated), where a score
of around 10 was achieved after 4 weeks. However, longer time points were not included in
that particular study [443]. The slightly lower score in the controls used in the present study
may be explained by the lower body weight of the animals and the resulting smaller size
of the spinal canal (body weight of ∼270g in the present study compared to ∼315g in the
published study [443]). Similar results were obtained with a 12 µl lesion, where the animals
(∼315g) reached a BBB score of above 10 after 4 week, but which did not recover further
[357]. The compression injury induced in the present study was probably to severe to allow
for a better degree of spontaneous recovery and a more detailed analysis of gait. No sign of
thermal allodynia/hyperalgesia (the Hargreaves test with its long cut off does not discrimi-
nate between thermal allodynia and thermal hyperalgesia [472]) could be found using a heat
sensitivity test. In the present study, the latency of paw withdrawal tended to increase for
all groups over time, with no apparent differences between the groups. However, none of
the groups were insensitive (analgesia) to noxious heat stimuli. Similar results have been
obtained in a dorsolateral funiculus transection-type injury, where implanted rat BMP4-
derived astrocytes (type I astrocytes) induced no signs of thermal allodynia/hyperalgesia, in
stark contrast to implanted rat CNTF-derived astrocytes (type II astrocytes) [99]. Unfor-
tunately, a subsequent study comparing using human BMP4- and CNTF-derived astrocytes
only concentrated on motor behaviour and failed to include any sensory tests [101].
The Regularity Index initially decreased following resection injury, but recovered quickly
and completely, as observed by others, demonstrating that the animals were able to cross the
runway using a coordinated step pattern [104, 181, 182, 192, 234, 241, 242]. Stride length
was not affected by the resection injury, as expected [181, 182]. Hind-limb BOS increased
following injury, but this effect was not significant for the hFbl-implanted group. By the end-
point of the experiment hind-limb BOS was also not significantly changed from the baseline
values for the control + IS group, and the hNP-AC implanted group showed a BOS value that
increased even further over time. This behaviour might be interpreted as a compensation for
an unstable gait [181, 182]. Interestingly, a decrease of the BOS of the fore-paws was observed
for all groups [181, 182], which may also be interpreted in a similar manner as that for the
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changes in hind-limb BOS. The related paw parameters, max- and print contact areas of the
affected ipsilateral hind-paw, decreased in all groups, however, with an earlier recovery for the
cell-seeded scaffolds. The similar pattern of recovery for both parameters indicates that the
toes were not being dragged during gait [181]. The lesion induced decrease in values indicates
a reduction of toe spreading and weight loading of the affected hind-paw [182]. This is backed
up by the decreased intensity, indicating an unloading of the affected foot as well [182]. It
might be suggested that a decreased stepping intensity could be an indication of altered
behaviour due to the onset of mechanical allodynia [182, 449]. There were, however, no signs
of pain to mechanical stimulation as observed using von Frey filaments. Even the control +
IS group, which had the lowest stepping intensity values (being significantly different from
both cell implantation groups) showed no sign of allodynia using the von Frey filaments. All
groups showed a tendency to recover over time. The stepping intensity value for the hNP-AC
implanted group even recovered back to baseline levels, indicating a full return of body weight
support by the affected hind-limb. The absence of increased sensitivity to mechanical stimuli
is in accordance with the literature, where implanted rat BMP4-derived astrocytes, human
fibroblasts and even control animals did not show signs of increased mechanical allodynia in
a number of different models of SCI [99, 100, 216, 359]. However, it has been reported that
lesioned rats receiving transplanted CNTF-derived astrocytes did show signs of mechanical
allodynia [99]. However, unfortunately the study assessing human BMP4- and CNTF-derived
astrocytes failed to demonstrate any sensory data [101]. Duty cycle and stance duration also
decreased after injury, and the swing duration accordingly increased. The changes in all of
the above mentioned parameters may be considered as the CatWalk providing a quantitative
description of lesion-inducing limping. All of these parameters demonstrated a tendency to
recover back to the baseline. Interestingly, others have reported an decrease of swing duration
following contusion SCI, whereas dorsal spinal cord transection injuries have been reported
to have no effect [181, 182, 192], or to induce increases of this parameter [182, 222]. The
gridwalk also showed an early effect of cell-seeded scaffold transplantation, with the control
+ IS group also demonstrating a pattern of recovery that eventually reached a similar value
as that of the hFbl- and hNP-AC-implantation groups.
The results suggest a role of immunosuppression (cyclosporine A and azathioprine) in com-
bination with an anti-inflammatory drug (methlypredisolone) alone on functional recovery,
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with a trend to further increased locomotor performance after cell transplantation. Several
studies suggest that immunosuppression or anti-inflammatory drugs can act as a promoter
of functional recovery after SCI [5, 34, 179, 204], although others have reported no im-
provement in functional recovery after immunosuppression or anti-inflammatory treatment
[100, 178, 205, 283, 335, 336, 415].
Fibroblasts are often used as a cell control group, for comparison with other cell transplants
(e.g. NPC) or genetically modified fibroblasts [92, 93, 359, 405]. Interestingly, many groups
have found an increased in-growth of axons into spinal cord lesion sites that have been treated
with fibroblast grafts [150, 190]. Most studies have reported no improved functional recovery
after fibroblasts transplantation [92, 93, 359], but some improvement has been reported by
others [405]. Possible mechanisms for the effects of donor fibroblasts on axonal growth and
functional recovery are discussed below. Some studies were able to show functional recovery
from SCI following the implantation of rat or human glial restricted progenitor BMP4-
derived astrocytes (GDA) [99–101], whereas others have reported no- or only temporary
functional improvements following the grafting of human GDA or neonatal rat astrocytes
[216, 222]. Interestingly the studies assessing human or rat BMP4- and CNTF-derived
astrocytes demonstrated a recovery of function using the gridwalk at 4 weeks. This matches
with the findings obtained here, where a better recovery was observed for the cell-seeded
scaffolds at 4 weeks, but not at the later end-point stage. It is unfortunate that later time
points were not investigated in the other studies [99–101]. It is of further interest, that the
region of donor cell isolation might also play a role in any transplant mediated effects, apart
from the differentiation status (i.e. into type I or type II astrocytes).
Whereas the astrocytes generated in this study, as well as those used by Jin and colleagues,
were derived from brain progenitor cells [216], Davies and colleagues employed embryonic
(rat) or foetal (human) spinal cord tissue [99–101]. Some differences have been reported
between NPC derived from hippocampus or spinal cord [120], and also between NPC derived
from hippocampus or subventricular zone [246]. Interestingly, only the Davies group has,
so far, been able to demonstrate functional recovery. However only a direct comparison
employing the same animal model would clarify whether the different donor cell sources
results in different effects on spinal cord regeneration and repair.
Housing animals in an enriched environment has also been reported to increase the extent
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of recovery or even to prevent some of the spinal cord contusion-induced parameter changes
as measured by CatWalk [182, 251]. Since future experimental treatments for SCI will
most likely include the use of different or multiple intervention strategies, it is likely that
the use of an enhanced environment could produce added benefits when combined with
cell/biomaterial-based strategies. The testing of such a possibility was, however, not within
the scope of this investigation.
4.3.3. Survival of transplanted cells
In the balloon compression model, approximately 1x106 cells were injected into the spinal
cord. Since the 3D scaffolds were trimmed to fit into the resected part of the spinal cord, the
estimation of the number of cells transplanted along with the scaffold is rather imprecise,
but was in the range of 4-6x105. In the literature, the number of cells transplanted after rat
SCI has ranged from 1.8x105 to 2x106 [99–101, 150, 190, 216, 219, 323, 405, 430]. Therefore,
the cell number of 1x106 is in the middle of the above range and the number of 4-6x105 at
the lower end.
In earlier transplantation studies a number of nuclear (BrdU, Hoechst) and cytoplasmic
dyes (PKH26) have been employed in vivo to identify grafted cells (e.g. Schwann cells, NPC,
olfactory ensheathing glia [71, 123, 338, 339]). Although the dyes label cells well in vitro,
once transplanted, the death of the labelled cells may release the dye so that it can be taken
up by host cells or label other host structures [12, 193, 198], making identification of the
grafted cells very difficult. More recently viral vectors have been employed to deliver genes
such as lacZ or GFP to cells ex vivo prior to implantation [250]. These early generation
delivery systems, however, have suffered from apparent short-term expression due to rapid
down-regulation of the inserted gene [46, 191, 352], preventing the long-term tracking of
the cell’s fate. Here we used a monoclonal antibody against human nuclei [440, 446] to
identify donor cells (hNP-AC and hFbl), however axonal association was difficult to identify
as the distinct labelling of the cell nucleus made it impossible to detect the entire donor cell
morphology. This was somewhat circumvented by the use of the anti-human nestin antibody
[286] to identify donor hNP-AC, where regenerating axons could be identified to grow along
hNP-AC processes (further discussed below).
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The transplantation of suspensions of hNP-AC, either alone or in combination with the 3D
collagen scaffold, were found to survive better than suspensions of hFbl. Delayed transplan-
tation appeared to greatly increase the survival of both populations of donor cells, although
there are many more factors which might play a role in donor cell survival and which are
different in the two models (e.g. type of injury, form of cell transplantation), which make
a direct comparison difficult. However, an increased survival after delayed transplantation
is in accordance with the literature, where a delayed transplantation (e.g. of Schwann cells
and olfactory ensheathing glia) enhanced donor cell survival [195, 324]. At this delayed stage
of SCI, the detrimental excitotoxic and inflammatory processes may have declined, but sub-
stantial amounts of growth factors, cytokines and neurotrophic factors could be still present
that may potentially aid in donor cell survival and differentiation. However for the purpose
of promoting rescue of compromised neural cells by neurotrophic activity and stimulating
endogenous plasticity, implantation in the early phase after injury may still prove to be most
beneficial. The high cell death observed after transplantation of cell-seeded scaffolds might
also be due to an inadequate vascularization in the scaffold resulting in decreased oxygen
supply, increased carbon dioxide and altered acidity [317]. Although many other studies have
demonstrated the survival of transplanted fibroblasts, even a crude analysis of the extent
of cell survival (i.e. how many animals still showed signs of the transplanted cells) is often
missing [269, 323, 405]. However, similar to the results for the balloon compression injury
model, other groups have reported a compact graft morphology with donor fibroblasts stay-
ing confined to the transplantation site [150, 359, 405]. The survival of the hNP-AC after
acute transplantation (i.e. in association with the 3D collagen scaffolds) was comparable to
the survival obtained for BMP4- and CNTF-derived human astrocytes (66% and 50% respec-
tively) [101]. However, survival of donor GDA was better in NOD-scid (athymic) host rats
transplanted 9 days after injury, where all animals showed robust survival of transplanted
GDA [216]. This is in accordance with the enhanced survival after delayed transplantation
in the balloon compression injury model. The reasons for the differences in hNP-AC survival
when grafted into the sites rostral- and caudal to the lesion epicentre (balloon compression
injury) remain unclear. Previous studies employing olfactory ensheathing glia for SCI repair
have rather demonstrated better survival when the cells were transplanted at positions both
rostral- and caudal- [144, 338, 339], rather than within [19] the injury site. The lesion and
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cavitation after compression extend several segments rostral and caudal from the initial site
of injury and it might be that there is a difference in the expression of certain inhibitory
substances (e.g. CSPG) at different levels, which could have influenced donor cell survival.
However, a comparison of CSPG expression levels in different segments (total length ∼1cm)
after contusion injury failed to demonstrate any differences [203].Clearly more animal num-
bers would be required for this effect (i.e. difference in cell survival related to position of
transplant) to be a completely reliable observation.
It is possible that the use of alternative or more potent immunosuppressants (i.e. FK506
(tacrolimus) rather than cyclosporine) could have increased the survival of the donor cells
even following transplantation into acute injuries [190]. However immunosuppression can also
cause serious side-effects, such as anaemia, infections, chronic kidney damage, increased risk
of cardiovascular disease, metabolic syndrome, bone loss, tremors, seizures, and malignancy
[257, 347, 399, 445, 477]. Nonetheless, at present, immune suppression seems unavoidable
for implanted non-compatible cells or tissues, because it is required to prevent rejection
reactions, which themselves may lead not only to the loss of the grafted cells, but also to
inflammatory reactions that cause secondary damage [24]. Strategies which harvest autol-
ogous cells from the patients themselves (including iPS cells [436]), for in vitro expansion
and transplantation back into original donor would greatly increase the survival of the trans-
planted cells, as shown for example for fibroblasts in a primate model of spinal cord injury
[439]. Although the sub-acute phase and therefore the time window for transplantation in
humans may be longer than in animals, the slower proliferation of human cells and the
greater extent of the injury may make it hard to achieve sufficient cell numbers or may even
raise additional problems (e.g. insufficient nutrition at the core of the transplant).
Suspensions of hNP-AC that had been transplanted in the absence of a supporting scaffold
were able to migrate relatively far through the host spinal cord parenchyma. Even donor
hNP-AC that were transplanted with the scaffold were able show some degree of migration
into areas close to the host-graft interface. This migratory behaviour of human astrocytes
has been demonstrated by others who reported greater migration through spinal cord white
matter than through grey matter [101, 216].
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4.3.4. Axonal regeneration
In both injury models, donor hNP-AC were able to promote greater axonal growth than
the other investigated groups. This is in accordance with the potential such cells have
already demonstrated in vitro [136]. Although some investigators have reported similar
effects of donor rat or human GDA on axonal growth in vivo [99–101] others have failed to
demonstrate such effects [216]. It is clear that the axons found inside the scaffold can be
regarded as having regenerated, but such an interpretation is not so certain in the present
balloon compression injury model. However, earlier reports have demonstrated a lack of any
spared NF-positive axons at the lesion site early after severe balloon compression injuries
[57]. Nonetheless, even when we take the small amount of spared tissue at the lesion epicentre
into account (see result section and below), it is highly likely that most of the axons that
can be demonstrated at the lesion core must have regenerated. Some of those regenerating
axons could be found in close association with transplanted hNP-AC in both injury models,
although they showed a greater tendency to grow along laminin-positive structures (i.e. most
likely associated with migrating host Schwann cells or newly formed blood vessels) at the
lesion site in the balloon compression injury model. Both astrocytes and Schwann cells have
already been shown to be capable of directing the orientation of regenerating neurites in
vitro [38, 103, 373, 428].
Interestingly, large numbers of axons were also detected inside the elliptical clusters of
donor hFbl, where a great number of laminin expressing cells could also be found (presumably
migrating Schwann cells, [39, 88, 143]). Furthermore, animals receiving fibroblast grafts
also showed a tendency for increased axonal regeneration into the lesion site in general,
not only into the elliptical clusters. This observation was not totally unexpected since
other groups have demonstrated a similar effect of either modified fibroblasts (e.g. for the
expression of NGF, Wnt3a, BDNF or NT-3) or native fibroblasts. This may be due to
the intrinsic expression of ECM molecules (i.e. fibronectin) or growth factors (e.g. NGF,
NT-3, VEGFa and bFGF), or to indirect mechanisms such as the promotion of enhanced
Schwann cell migration [150, 219, 298, 405, 430, 438]. Furthermore the importance of a
guidance structure to orientate regenerating axons became evident when comparing the
patterns of axonal growth in the two different lesion models. Axon growth appeared random
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in the balloon compression injury model, while there was clear orientation which followed
the longitudinally orientated pores of the collagen scaffold.
It would clearly be of interest for future investigations to use retrograde labelling or more
specific axonal markers, such as calcitonin gene-related peptide (CGRP) for sub-populations
of sensory DRG axons or 5-hydroxytryptamine (5-HT, serotonin) for serotonergic axons, to
allow a more precise analysis of the phenotype of which axonal populations were responding
to the presence of particular donor cell types [53, 161, 348].
4.3.5. Schwann cell migration
Whereas a substantial amount of migrating Schwann cells could be found at the lesion site
of the balloon compression injury model, very few, if any, Schwann cells were found in the
lesion sites of the lateral funiculotomy injury model. The reason for the limited Schwann
cell migration in the lateral funiculotomy model could be due to the transection of the nerve
roots and the associated severance of the migration route of de-differentiating Schwann cells.
The balloon compression injury model, on the other hand, not only compresses the spinal
cord but also the local spinal nerve roots. Unlike the resection injury, the damaged nerve
roots maintain anatomical continuity with the damaged spinal cord, thus providing a route
for significant Schwann cell migration into the lesion site. Schwann cells migration into the
compression-, transaction- and contusion type spinal cord injuries has already reported by
others. Such studies were also able to demonstrate a close association between regenerating
axons and the migrating Schwann cells [57, 60, 61]. However the evaluation and quantifi-
cation of Schwann cell migration was restricted to the balloon compression model in this
investigation because practically none could be detected following the lateral funiculotomy.
In addition to the generally large number of migrating Schwann cells found at the lesion
epicentre, a particularly high density of Schwann cells could also be detected at the elliptical
clusters of donor hFbl transplantation. The recruitment of large numbers of axon growth-
promoting Schwann cells into the lesion site may have contributed to the ability of donor
hFbl to promote a degree of functional recovery that was similar to that supported by
donor hNP-AC. Schwann cells produce a variety of growth factors (including NGF, BDNF
and CNTF), a number of cell adhesion molecules (including integrins, N-cadherin, N-CAM,
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L1 and contactin) and extracellular matrix proteins (such as laminin and collagens) which
could support axonal growth as well as the survival of damaged neurons close to the lesion
site [39, 88, 143]. It is not surprising then, that transplanted Schwann cells have been
reported to be able to fill cystic cavities, increase white matter sparing, remyelinate axons
of both PNS and CNS origin and to promote axonal regeneration in a variety of SCI models
[40, 262, 275, 310, 414, 469]. Furthermore BDNF or GDNF expressing fibroblasts have
also been shown to enhance Schwann cell migration after dorsal spinal cord hemisection
lesions [41, 42]. However, the above studies failed to demonstrate the extent of Schwann cell
migration or functional consequences of such behaviour in their non-treated control group
[41, 42].
It is widely acknowledged that the mutually repulsive properties of Schwann cells and
astrocytes usually results in boundary formation between populations of these PNS and
CNS glia. Such boundaries have been identified as natural barriers to cell migration and
axon regeneration [73, 162, 270]. Interestingly, in the present investigation, donor hNP-AC
did not hinder the migration of the Schwann cells. This might be due to the immature
phenotype of the hNP-AC. However even when some degree of intermingling between host
Schwann cells and donor hNP-AC could be observed, it was not as extensive as that seen
between the host Schwann cells and the donor hFbl.
4.3.6. GFAP and CSPG expression
GFAP staining was clearly visible in both lesion models, demonstrating the distribution
and morphology of host and donor astrocytes. A clear expression of CSPG by host and
grafted astrocytes, grafted fibroblasts, and other GFAP-negative host cells (host fibroblasts
or Schwann cells) could be demonstrated after balloon compression. After lateral funiculo-
tomy only a weak staining, if any, was visible, which partly colocalised with GFAP-positive
cells inside of the scaffold. Only occasionally, could stronger CSPG expression be observed
that was associated with GFAP-negative cells (presumably host fibroblasts). Previous stud-
ies have demonstrated that CSPGs are generally up-regulated after spinal cord injury, with
a peak expression at 1-2 weeks post injury. However after 8 weeks a clear reduction was
observed for several members of the CPSG family (e.g neurocan, versican) following transec-
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tion injury, which explains the weak staining observed in this study [203, 218]. Spinal cord
compression injuries are significantly different and are accompanied by more extensive cell
death, inflammation, cavitation and scarring [203]. This might explain the different patterns
and extent of CSPG expression in the different types of injury [203]. The present study
was able to confirm these findings with the continued expression and clear staining of CSPG
after balloon compression injury (compared to the resection injury).
While in the balloon compression model, donor hNP-AC caused a small reduction of both
GFAP and CSPG immunoreactivity compared to the control and control + IS, only GFAP
was reduced after lateral funiculotomy (compared to the control). Although this seems
contradictory, keeping in mind that (host and donor) astrocytes could only be found inside
the hNP-AC-seeded scaffolds, it must be emphasised that GFAP-intensity was evaluated,
not astrocyte number or area occupied by astrocytic profiles. There was, nonetheless, a
trend for reduced CSPG immunoreactivity following hNP-AC transplantation. Interestingly
donor hFbl also provoked an overall reduction of GFAP and CSPG levels in both models.
This is not so suprising for GFAP as for CSPG, since a high focal expression of CSPG at the
hFbl transplantation site (i.e. in the balloon compression injury) could be found. However
this local expression seemed not to influence their general beneficial effect. Furthermore
despite their low survival after lateral funiculotoy and scaffold implantation, hFbl where
able to excert a benfecial effect. Whereas the levels of both proteins were clearly lower after
hNP-AC transplantation in the balloon compression model compared to the hFbl, this was
reversed in the lateral funiculotomy model. This is most likely due to the presence of reactive
host astrocytes and their processes inside the hNP-AC-seeded scaffold. This profound host
astroglial response within the scaffolds was apparently absent in the hFbl-seeded scaffolds.
This observation may simply reflect that the initial presence of hNP-AC on the scaffolds
promoted a better degree of host astroglial integration than seen with the implanted naive
or hFbl cell-seeded scaffolds. The fact that substatial GFAP immunoreactivity could be
observed, even in scaffolds where no viable donor hNP-AC could be detected, only serves
to emphasise the interpreation that such immunoreactivity was derived from host cells.
This is in accordance with the literature, where immature rat astrocytes were found to
support the integration of millipore filters implanted into the rodent brain [380, 389, 390].
In contrast to the earlier published works which showed infiltration of the surface of the
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implanted millipore, the present investigation has clearly demonstrated the novel observation
that this effect can be supported throughout the 3D porous microarchitecture of the collagen
scaffold. It may well be the case that the phenotype of the host astrocytes may not be as
benefical for neurite extension as the donor hNP-AC, but the hNP-AC seeded scaffolds
supported significantly greater axonal growth than the non-seeded scaffolds (and a trend for
greater axonal growth than the hFbl-seeded scaffolds). Other studies, using different kinds
of scaffolds, have demonstrated a close relationship between host GFAP-positive profiles and
regenerating axons, even if those host astrocytic profiles showed a limited pentration into the
scaffold [158, 226, 328, 467, 471]. This highlights the fact that reactive or activated astrocytes
are not only involved in the generation of the glial scar but are also capable of promoting and
directing axon regeneration [226, 300, 328, 471]. Interestingly, the few studies which reported
astrocyte migration into the implants used scaffolds that were prepared from either collagen
or xyloglucan/PDL in their liquid form with gelation after injection [221, 300]. Another
factor might be the reduction of the glial scar around the implant, which normally acts
as a barrier, not only to regenerating neurites, but also to some populations of migrating
cells [24, 381, 397]. Reduced glial scarring and CSPG expression after transplantation of
human- or rat-derived immature astrocytes has also been reported by others [216, 388–
390]. The reduced glial scarring might therefore have been beneficial for migration of host
astrocytes into the scaffold. However there are certainly other mechanism that may be
involved (e.g. AQP4, STAT3, integrins [288, 463]) in the enhanced host astrocyte migration
since GFAP and CPSG staining at the graft-host interface were also reduced after donor
hFbl transplantation (where no significant host astrocyte migration into the scaffold was
observed). Nonetheless, it must be reiterated that glial scarring after injury is beneficial to
overall tissue integrity during the acute phase (1-2 weeks) after spinal cord injury [127, 305,
342]. The formation of an astroglial barrier is responsible for the protection of adjacent, non-
injured spinal cord tissues, but such protection comes at the price of reducing spontaneous
axon regeneration. The mechanisms that control the phenotype of reactive astrocytes to be
either scarring/axon growth inhibitory or axon growth promoting remain unclear at present.
However, future research into such behaviour may substantially help the development of
tissue engineering strategies aimed at promoting spinal cord repair.
It is also possible that the presence of donor hNP-AC may have assisted in tissue repair,
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supporting the remyleination of demylinated, spared axons. Endogenous oligodendrocyte
precursor cells have been reported to be unable to remyelinate axons in the absence of
astrocytes [417].
4.3.7. Inflammatory response
The balloon compression injury model greatly affected both grey and white matter microglia.
Microglial responses to traumatic injuries are, to some extent, more severe in white matter
than in grey matter [105, 365] and it has been shown that in damaged white matter, mi-
croglia became enlarged, often with retracted processes while in damaged grey matter they
remained ramified [279]. Therefore the analysis of Iba1 immunoreactivity following com-
pression injury was divided between cells of a rounded morphology and those of a ramified
morphology. In contrast, the evaluation of inflammatory response after lateral funiculo-
tomy was restricted only to white matter microglia (with the inclusion of supplementary
ED1 immunohistochemistry). Iba1 identifies the ionized calcium binding adapter molecule
1 [207], which is expressed by microglia and monocytes [215]. After CNS injury Iba1 is up-
regulated in activated microglia close to and at the primary injury site [209, 210, 442]. ED1
(CD68) recognizes a single chain glycoprotein that is predominantly expressed on the lyso-
somal compartment of activated monocytes and macrophages, and is absent in the normal
CNS [106, 238, 334]. Following acute traumatic injuries, ED1 antigen is expressed rapidly
on microglia that are engaged in phagocytosis of tissue debris (i.e. on reactive microglia)
[106, 403]. However, ED1 expression is restricted to the most severe areas of insult [210].
Since an increased expression of Iba1 has been reported in the spinal cord after injury
[442, 447], we analysed the intensity (mean grey value) of Iba1 staining after injury and
implantation of the scaffold.
After balloon compression injury and accompanying immunsuppression, Iba1 expres-
sion increased in both types of microglia. However the number of microglia and the intensity
of staining are not completely independent paramters, since an increase in the number of
microglia could also lead to an increase in the intensity of an image. In this context, oth-
ers have reported that the neuroprotective effect of FK506 on motor neuron survival after
sciatic nerve transection was accompanied by increased microglia numbers (compared to an
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untreated control). However, reactive microglia, as indicated by MHC-II expression, were
reduced after FK506 treatment [361]. Similarly, in the context of activation, earlier stud-
ies have also demonstrated that methylpredisolone and cyclosporine reduced the number of
activated microglia after CNS injury [309, 424]. It might be hypothesised that the triple
immunosuppresion used in the present study had a similar effect (i.e. increasing microglial
numbers in response to injury but modifying their staus of activation). However, since MHC-
II expression has also been reported to be present in non-reactive ramified microglia and may
not be a consistent surface marker for reactive microglia [403], it was not included in the
present investigation.
Interestingly the effect of the immunosuppression was apparently counteracted by the
cell transplantation, especially for the rounded white matter microglia. In this context, it
is well established that both astrocytes and fibroblasts have modulatory effects on mono-
cyte/microglia [63, 244, 392]. However, it is at present difficult to understand why donor
hFbl exerted a different effect on grey and white matter microglia.
After lateral funiculotomy and scaffold implantation, Iba1 and ED1 distribution
were quite distinct. The Iba1-positive cells could be found around and and within the scaf-
fold, while ED1-positive cells remained around the scaffold. Although the origin of microglia
is under debate, it is widely acknowledged that circulating (ED1 positive) monocytes, which
have a higher migratory capacity then microglia [403], do enter the pathological CNS where
they can differentiate into cells that are phenotypically and morphologically indistinguish-
able from resident microglia [189]. The Iba1 positive cells detected inside the scaffold may
therefore be derived from monocytes which had migrated into the scaffold and differentiated
into non-reactive (i.e. ED1 negative) microglia. Previous studies have reported that Iba1-
positive, ED1-negative, activated microglia, were involved in neuronal regeneration within
the axotomized motor nucleus [168, 209].
However the expression profiles of surface and cytoplasmic antigens often overlap, making
it difficult to assign a definitive phenotype or function to a given cell type [189], therefore it
is difficult to pin down the exact type of inflammatory cell that is inside of the scaffold or
even around.
Similar to the results obtained with the balloon compression injury, the intensity of Iba1
was reduced after implantation of the cell-seeded scaffolds as compared to the control animal
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which received naive scaffolds plus immunosuppression. Interestingly, ED1 intensity was
only reduced following the implantation of hNP-AC-seeded scaffolds, although a trend for a
reduced intensity was also observed with hFbl-seeded scaffolds. This might not only indicate
reduced macrophage activation, but also reduced reactive microglia. However it remains
unclear if this effect was overall beneficial or detrimental, since the inflammatory response
is known as having both an early neurodegenerative component and a later neuroprotective
component [74, 248]. Since the present investigation was only able to demonstrate the
morphology and phenotype of the microglia/macrophages at 8 weeks after injury, future
studies will be required to assess whether the effects of implanting cell-seeded scaffolds are
mediated through modification of early (i.e. detrimental) inflammatory events or the later
(i.e. beneficial) inflammatory events.
4.3.8. Spared tissue
After balloon compression injury and hFbl transplantation, enhanced Schwann cell migration
and a reduction of lesion size at its epicenter could be detected. The effects of fibroblast
implantation on tissue sparing are relatively unknown, although a trend for increased tissue
sparing was also observed when these cells were used as a control cell population in a model of
contusion-type SCI [359]. The ability of Schwann cells to increase tissue sparing is fairly well
documented and, since we have already demonstrated that donor hFbl supported enhanced
Schwann cell migration into the lesion site, it is tempting to speculate that the tissue sparing
may have been due to indirect mechanisms mediated through Schwann cells [40, 262, 275,
310, 414, 469]. However, other as yet unidentified mechanisms (e.g. growth factor expression,
see above) cannot be discounted. Nonetheless, since the sparing of as little as 1-10% of spinal
cord axons can have significant benefits on functional outcome [43, 45, 115], the beneficial
effects of donor hFbl (via direct or indirect mechanisms) may have been mediated by such
an outcome.
Despite otherwise promising results, donor hNP-AC failed to demonstrate any recognisable
tissue sparing effect: the amount of spared tissue was even smaller than that induced by the
donor hFbl. However, it is possible that the relatively good survival of the donor hNP-AC and
their intimate integration into host tissues may have resulted in observer misinterpretation
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of the extent of tissue sparing. It is conceivable that mixed donor/host regions may have
been interpreted as cell-rich areas of lesion site rather than cell-rich areas of spared tissue.
The control + IS group showed a general trend for a reduced lesion size. However, most of
the previous published results of the effect of cyclosporine on lesion size showed no statistical
effect as well [190, 204, 335]. Only rarely could a beneficial effect of immunosuppression
be observed [249]. Methylpredisolone demonstrated reduced lesion volumes and functional
benefits in some studies [85, 179, 307], however other studies failed to reproduce these effects
[167, 179, 336]. The effect of azathioprine is less well studied, but some promising results
have been demonstrated [5].
4.4. Conclusion
Balloon compression model: Both hNP-AC and hFbl cell transplants resulted in a greater
degree of functional recovery than the untreated control. However, no significant differences
were observed between the extent of recovery supported by cell transplantation groups and
the control + IS group. The beneficial effects observed with the different strategies might
result from a number of different mechanism: (I) immunosuppresion greatly affected the
intensity of Iba1 and therefore may have altered the inflammatory response leading to some
degree of tissue sparing, (II) donor hFbl promoted a greater degree of Schwann cells migration
into the lesion site, leading to enhanced axon regeneration as well as tissue sparing, (III)
donor hNP-AC promoted the least amount of glial scarring at the graft-host interface (as
indicated by the intensity of GFAP- and CSPG-immunoreactivity) as well as the greatest
extent of axon regeneration.
Tissue engineering strategy: Donor hNP-AC promoted also the greatest degree of
axon regeneration and host astrocytic migration and integration into the implanted scaffold.
Despite these promising results, hNP-AC failed to support a greater degree of functional
recovery when compared to the other animal groups. The mechanism behind the enhanced
behavioural recovery seen following implantation of hFbl-seeded scaffolds is likely to be dif-
ferent from that suggested for the balloon compression injury model since Schwann cell
migration was not observed in these experiments. However animals receiving hFbl-seeded
scaffolds showed reduced GFAP and CSPG intensity at the graft-host interface and a moder-
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ate effect on neurite growth into the scaffold. Both cell-scaffold transplantation groups also
demonstrated reduced intensity of ED1 and Iba1 immunoreactivity, however the relevance
of this observation remains obscure. It is feasible that the relatively poor survival of the
transplanted cells in this experimental model might have contributed to the lack of clear
and unequivocal effects. Future experiments that maintain the survival of large numbers of
donor cells will, thus, be important for the clearer understanding of the therapeutic value
hNP-AC in regenerative medicine, in particular for spinal cord injury.
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5. General Discussion
The notion that stem/progenitor cells represent an inexhaustible source of neurons and glia
for cell replacement therapies (in particular for the treatment of SCI) is no longer a scientific
hope, but a realistic goal. Recent discussions and concerns relate to the relative merits of
therapeutic potential when comparing cells from different sources (e.g. embryonic-, foetal-,
adult- or iPS-stem/progenitor cells) as well as which particular phenotype (e.g. undiffer-
entiated, lineage restricted or fully differentiated) of cell will provide the best regenerative
benefit. Biomaterials are also a new and rapidly expanding discipline in the field of regener-
ative medicine, and have showed great potential for promoting tissue repair in combination
with stem/progenitor cells and their derivatives [402]. However, promoting functional recov-
ery after spinal cord injury is at present still a challenge and there is still a long way before
we can move to the clinic. However, some clinical trials assessing the potential of human
neural progenitor cells are currently being conducted [435].
Here we adopted and developed further the relatively simple concept that immature rat
astrocytes were capable of promoting axon regeneration and improved scaffold integration
[236, 380, 389–391] and the main hypothesis that was proposed in the present thesis was:
“That human immature neural progenitor-derived astrocytes are capable of promoting axon
regeneration and scaffold integration, similar to properties demonstrated for immature rat
astrocytes.”
To address this hypothesis, the following four goals were formulated and the achievements
presented in this thesis will be discussed shortly.
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5.1. To generate highly enriched populations of immature
astrocytes from human neural progenitor cells
(hNP-AC)
After the characterisation of the undifferentiated cells, the ability to differentiate hNPC into
highly enriched populations of immature type I astrocytes was demonstrated. Following
the reports that immature rat astrocytes promoted axon regeneration [236, 380, 389–391],
rat neural progenitor cell-derived type I astrocytes were shown, in stark contrast to type II
astrocytes, to be able to promote recovery as well as limiting allodynia after SCI [99]. As an
alternative of obtaining NPC from aborted foetuses, recent advances in stem cell technology
have indicated that it may be possible to generate NPC from somatic cells, taken from the
patients themselves. This could be done either using therapeutic cloning techniques, or by
the generation of inducible pluripotent stem (iPS) cells by “reprogramming” somatic cells
[284, 297, 312, 413]. Since the donor cells would be derived from the patients themselves, the
ethical and immunological issues often raised in regard to the use of embryonic- or foetal-
derived NPC would be avoided. However, a significant drawback of such an approach may
be that such cells would only be generated for therapeutic use after the patient had been
involved in an accident. Thus, it would be unlikely that such cells could be used to treat
the acute phase of an injury. Moreover, quality control of these cells is likely to be difficult
and expensive, since each individual patient will require a separate batch of iPS cells to be
produced.
5.2. To determine cell-substrate interactions between
hNP-AC and orientated bioengineered substrates
(I) When associated with the orientated PCL and C/PCL nanofibres, hNP-AC adopted
an elongated morphology, following the orientation of the fibres. Functionalisation of the
nanofibres with collagen did not affect the proliferation or process length of hNP-AC, whereas
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adhesion and migration were enhanced. The sPEG-mediated attachment of low density, ori-
ented nanofibers to glass cover-slips enabled the interactions between single cells and single
nanofibers to be studied in relatively simple “2D” cultures [159]. Improving the functional
properties of such scaffolds to support greater axonal regeneration, host- and donor-cell sur-
vival (tissue sparing), proliferation and migration by the incorporation of ECM components
(i.e. type I collagen), or their functional peptide sequences (e.g. DGEA [362]) is an area
of increasing interest in regenerative medicine [159]. Furthermore, the development of such
approaches requires the technology to move from relatively simple 2D into a 3D orientated
scaffolds, ready for further in vitro and in vivo testing.
(II) hNP-AC seeded onto orientated 3D collagen scaffolds continued to proliferate and
formed columns of orientated cells which followed the orientation of the micro-channels.
Furthermore, in addition to the observed cell-substrate interactions, novel cell-cell interac-
tions were also documented: the intermingling of seeded hNP-AC with migrating fibroblasts
and Schwann cells within the collagen scaffolds represented a surprising finding. Astro-
cytes and Schwann cells/fibroblast normally demonstrate mutually repulsive properties and
distinct boundaries are formed where the two cell types meet. Such boundaries exert con-
siderable influence over the ability of regenerating axons to cross from one territory to the
other and their effects have been studied in detail in 2D in vitro assays [163, 164, 377].
The present investigation has demonstrated that when these cells encountered each other
within an orientated 3D scaffold, substantial intermixing- rather than mutual repulsion was
evident. This raises the possibility that the topography of the scaffold may have altered
the properties of one or more populations of cells. However the observed effect could also
be due to the immature nature of the astrocytes, although a possible role of both factors
is most likely. Although some of the basic principles controlling cell-substrate and cell-cell
interactions have already been established in relatively simple 2D systems, the future design
of biomaterial-based scaffolds that are intended to promote nervous tissue repair depend a
better understanding of such principles in more complex 3D environments, which resemble
the in vivo situation more closely [1, 136].
Chapter 5. General Discussion 133
5.3. To identify the axon growth-promoting properties of
the hNP-AC in 2D and 3D systems using adult neu-
ronal populations
(I) hNP-AC demonstrated their ability to promote neurite regeneration in a simple 2D assay
using dissociated adult DRG neurons. Surprisingly, axon growth was even greater than that
observed over the PLL/laminin positive control substrate. This effect was due to contact-
mediated mechanisms and the release of diffusible substances into the medium. It has already
been demonstrated that immature rat astrocytes are able to promote neurite regeneration of
embryonic neuronal populations [391], however the extension of this axon growth promoting
behaviour to human cells and its demonstration with adult neuronal populations had, until
now, never been reported. The identification of the specific ECM- and growth factor-related
molecules involved in this behaviour was not included in the present investigation, but a
precise analysis of the mechanisms behind the growth promoting properties of the hNP-AC
could help in the development of improved cell- and biomaterial-based intervention strategies
for nerve regeneration.
(II) Seeding of the 3D collagen scaffold with hNP-AC promoted a greater ingrowth of
regenerating neurites from hemisected adult DRG compared to the non-seeded, control scaf-
folds. The present investigation showed that the topography of the scaffold helped guide
axonal growth. This is widely regarded as a crucial step in nerve repair. Furthermore, the
translation of the growth promoting properties of the hNP-AC from 2D- to a 3D environment
has been demonstrated. This phase of the investigation should not be regarded as the simple
validation of the results obtained in 2D, since many aspects of cell form and function (i.e.
morphology, ECM & integrin expression) are known to be different in 3D culture systems
[1, 91].
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5.4. To determine the axon growth promoting properties/
graft-host interactions of hNP-AC when implanted
into experimental models of SCI, either alone- or in
combination with a 3D collagen scaffold
In the first SCI model investigated, hNP-AC cell suspensions were transplanted one week
after compression injury of the spinal cord. In the second SCI model, hNP-AC-seeded
3D collagen scaffolds were implanted into an acute spinal cord resection injury. Although
donor hNP-AC cell suspensions promoted greater functional recovery than was seen in non-
transplanted controls in the first SCI model, no functional improvement could be observed
following implantation of the hNP-AC-seeded scaffolds in the second SCI model. Some other
studies were able to show functional recovery following the implantation of rat or human glial
restricted progenitor BMP4-derived astrocytes (GDA) after 4 weeks [99–101], whereas others
reported no- or only temporary functional improvements following the grafting of human
or neonatal rat GDA [216, 222]. Unfortunately, the other investigations did not include a
“neutral” cell control group, such as the hFbl used in the present investigation. Different time
scales and injury models further complicate a direct comparison between results obtained
from different publications. Therefore, it remains unclear if transplantation of progenitor-
derived type I astrocytes has beneficial effects or no effects on functional recovery after spinal
cord injury. It might be that different combinations of cell populations and biomaterials
could be more suitable for a specific type of injury or best used at different time points after
injury (e.g. for acute, delayed or even chronic injuries), but such eventualities still require
verification by further studies. The world-wide adoption of standardised techniques would
facilitate such studies and more readily allow the comparison of data that was obtained by
different groups.
No sign of graft-induced allodynia/hyperalgesia could be found in either model of SCI.
Similar results have been obtained with rat BMP4-derived astrocytes (type I astrocytes), in
stark contrast to implanted rat CNTF-derived astrocytes (type II astrocytes) [99]. Unfor-
tunately, a subsequent study comparing human BMP4- and CNTF-derived astrocytes only
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concentrated on motor behaviour and failed to include any sensory tests [101]. The present
investigation was only able to conclude that human type I astrocytes do not promote al-
lodynia, similar to the rat type I astrocytes; however human type II astrocytes were not
included in the present investigation. The differences of donor type I and type II astrocytes
on functional and sensitivity outcomes [99] demonstrates the importance of including tests
for possible unwanted side-effects, an issue that has, to date, largely been over-looked.
Morphological investigations demonstrated that hNP-AC survived and integrated well into
the balloon compression injured spinal cords. In contrast, only limited donor cell survival
was observed after implantation of cell-seeded scaffolds. This effect may have been due to
the delayed transplantation of the cell suspension, since the detrimental excitotoxic and in-
flammatory processes at the lesion epicentre may have declined at that stage, but substantial
amounts of growth factors, cytokines and neurotrophic factors could still be present that may
have assisted donor cell survival. However the two models are so different in severity and
type of lesion as well as in the means of importing donor cells into the spinal cord that direct
comparison is not possible. The survival of the hNP-AC after acute transplantation (i.e. in
the second model) was comparable to the survival obtained for acutely transplanted BMP4-
and CNTF-derived human astrocytes (66% and 50% respectively) [101]. However, survival
of donor BMP4-derived astrocytes was better in NOD-scid (athymic) host rats transplanted
9 days after injury, where all animals showed robust survival of transplanted GDA [216]. The
poor survival of donor cells after implantation might have prevented a better functional out-
come. However, some early beneficial effects, despite low cell survival, were demonstrated,
also by others [101]. The duration of cell survival is uncertain and it might be that donor
cells were able have beneficial effects, which declined when donor cell death occurred.
Most spinal cord injured patients have an almost normal life expectancy and the functional
benefits observed in animal models are, at most, restricted to a few months. Thus, a robust
survival of transplanted cells might be crucial for long lasting beneficial effects. Furthermore
the size of injuries suffered by patients is much greater compared to the rat counterpart
and nutritional deficits and an insufficient blood supply might increase the difficulties of
cell/biomaterial-based intervention strategies in humans. Nonetheless, if the beneficial effects
of donor cell transplantation are via improved host cell survival/neuroprotection (rather then
neurite regeneration) it may be anticipated that any improved functional consequences will
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be seen at relatively early survival times.
Reduced host glial scarring was observed in both models and despite limited donor cell
survival, donor hNP-AC-seeded scaffolds promoted a greater degree of graft-host tissue in-
tegration than seen in controls. Similar results were obtained with immature rat astrocytes,
which were found to support the integration of millipore filters implanted into the rodent
brain [380, 389, 390]. In contrast to the earlier published works which only showed infiltration
of the surface of the implanted millipore, the present investigation has clearly demonstrated
the novel observation that this effect can be supported throughout the 3D microarchitecture
of the porous collagen scaffold. Another factor might be the reduction of the glial scarring
around the implant, which normally acts as a barrier, not only to regenerating neurites, but
also to some populations of migrating cells [24, 381, 397]. Reduced glial scarring and CSPG
expression after transplantation of human- or rat-derived immature astrocytes has also been
reported by others [216, 388–390]. The reduced glial scarring might therefore have been
beneficial for migration of host astrocytes into the scaffold. Within the scaffold, similar to
the in vitro studies, the few surviving hNP-AC formed columns of orientated cells. Some
hNP-AC even migrated out of the scaffold and into the surrounding host tissue, where they
adopted an elongated, migratory, morphology which was similar to the migratory capacity
of the cells observed in the balloon compression model.
Donor hNP-AC were able to enhance axonal regeneration in both models of SCI. Some
of those regenerating neurites were found in close contact with donor cells. A clear effect
of donor cell-mediated axonal guidance could be observed when the two different models
were compared: non-oriented neurite regeneration was observed in the first SCI model but
orientated growth that followed the direction of the donor cells within the micro-channels
was observed in the second SCI model. The enhanced neurite regeneration indicates that
the promising results obtained in vitro were translated to the in vivo situation. This is
in accordance with the literature, where human- and rat immature astrocytes were able
to promote neurite regeneration in different CNS injury models [101, 236, 380, 389, 390].
Further investigations will be required to clarify the reasons for the apparent inability of the
donor hNP-AC to promote any significant functional improvement. However, despite the fact
that there is an impressive (and growing) list of treatments focusing on neurite regeneration,
there are at least three important caveats that need to be borne in mind for such studies:
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(I) the contribution of axonal regeneration to any demonstrated functional recovery may be
inferred but largely remains unproven, (II) the proportion of fibres that regenerate is small,
(III) the distances covered by regrowing axons is usually modest, especially when considering
the size of comparable human lesions [52].
Interestingly, donor hNP-AC did not reduce the number of migrating Schwann cells (SC)
into the lesion site, whereas donor hFbl actually supported greater SC migration. This
suggests that the close interaction of hNP-AC with either migrating fibroblasts or Schwann
cells within the 3D collagen scaffold may have been due to the intrinsic properties of the
hNP-AC rather than to the topography of the scaffold. However, this point remains to be
elucidated. Unfortunately no SC migration was observed in the second SCI model. This is
likely to be due to the manner in which the spinal cord resection injuries were made: the
cutting and removal of part of the lateral funiculus may have also severed a number of spinal
nerve roots. The loss of physical continuity between the roots and lesioned spinal cord may
thus have prevented the migration of any reactive, de-differentiated cells. Irrespective of the
mechanism(s) by which the hNP-AC-seeded scaffolds supported better cell intermingling, the
present data suggests that the use of such intervention strategies may also be appropriate
for the bridging of injured dorsal and ventral roots to the spinal cord (i.e. avulsion-type
injuries), where boundaries between astrocytes and Schwann cells/fibroblasts naturally occur
[73, 147, 148, 162, 270].
Microglial activation, which was increased by immunosuppression (IS), was counter-balanced
by the presence of donor hNP-AC and hFbl after balloon compression. In the absence of
a control group of animals which were lesioned but lacked IS, it remains unclear if the IS
also led to an increased microglial activation in the lateral funiculotomy/scaffold implanta-
tion model as well. Nonetheless, a reduced microglial activation of the cell-seeded scaffolds
compared to the control scaffold + IS was observed, supporting the effects observed in the
compression injury model. However, it remains unclear from the present data whether this
effect had an overall beneficial or detrimental influence on scaffold-host integration and axon
regeneration. This uncertainty is compounded by the fact that the inflammatory response
is known as having both an early neurodegenerative component and a later neuroprotective
component [74, 248]. Further experiments will be required to address this specific question.
Despite otherwise promising results, hNP-AC failed to demonstrate a detectable tissue
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sparing effect in the compression injury model, and tissue sparing was not the focus of
the lateral funiculotomy model. However, it is possible that the relatively good survival of
the donor hNP-AC in the compression model and their intimate integration into the host
tissues may have resulted in observer misinterpretation of the extent of tissue sparing. It is
conceivable that mixed donor/host regions may have been interpreted as cell-rich areas of
lesion site rather than cell-rich areas of spared tissue.
Nonetheless although the achievement of complete functional recovery by long distance
axon regeneration following SCI is a worthwhile aspiration, a more realistic goal would be the
induction of short distance axon regeneration resulting in the effective lowering of the level of
the spinal deficit. Even seemingly small improvements in function can have a disproportion-
ately large impact on the quality of life of SCI patients. For example, a treatment-induced
return in the ability to grip with the hands or to regain some degree of manual dexterity
could lead to the patient being able to regain a greater degree of independence of patients
suffering from cervical spinal cord injuries.
5.5. Conclusion
The in vitro results demonstrated a more detailed characterisation of the hNP and their
differentiated progeny: the hNP-AC. The basic axon growth promoting properties of the
differentiated cells have been demonstrated in tissue culture as well as the cell-substrate
interactions with bioengineered materials in 2D (orientated nanofibres) and 3D (collagen
scaffold) studies. The ability of the hNP-AC-seeded scaffolds to support improved graft-
host integration and host axonal growth, and hNP-AC supensions to improve host axonal
growth in vivo have also been demonstrated in experimental models of spinal cord injury.
It is now clear that hNP-AC do indeed have similar properties to their rat coun-
terpart . However, donor cells failed to exert any substantial functional improvement in the
in vivo models of spinal cord injury. Further investigations will be required to clarify the
reasons for the apparent inability of the donor hNP-AC to promote any significant functional
improvement.
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